id	sid	tid	token	lemma	pos
bam-12939	1	1	layout	layout	NOUN
bam-12939	1	2	1	1	NUM
bam-12939	1	3	thematic	thematic	ADJ
bam-12939	1	4	section	section	NOUN
bam-12939	1	5	:	:	PUNCT
bam-12939	1	6	advances	advance	NOUN
bam-12939	1	7	in	in	ADP
bam-12939	1	8	musculoskeletal	musculoskeletal	ADJ
bam-12939	1	9	and	and	CCONJ
bam-12939	1	10	neuromuscular	neuromuscular	ADJ
bam-12939	1	11	rehabilitation	rehabilitation	NOUN
bam-12939	1	12	|	|	NOUN
bam-12939	1	13	maccarone	maccarone	PROPN
bam-12939	1	14	&	&	CCONJ
bam-12939	1	15	masiero	masiero	PROPN
bam-12939	1	16	eur	eur	PROPN
bam-12939	1	17	j	j	PROPN
bam-12939	1	18	transl	transl	PROPN
bam-12939	1	19	myol	myol	NOUN
bam-12939	1	20	34	34	NUM
bam-12939	1	21	(	(	PUNCT
bam-12939	1	22	4	4	NUM
bam-12939	1	23	)	)	PUNCT
bam-12939	1	24	12939	12939	NUM
bam-12939	1	25	,	,	PUNCT
bam-12939	1	26	2024	2024	NUM
bam-12939	1	27	doi	doi	NOUN
bam-12939	1	28	:	:	PUNCT
bam-12939	1	29	10.4081	10.4081	NUM
bam-12939	1	30	/	/	SYM
bam-12939	1	31	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	1	32	although	although	SCONJ
bam-12939	1	33	the	the	DET
bam-12939	1	34	causes	cause	NOUN
bam-12939	1	35	of	of	ADP
bam-12939	1	36	multiple	multiple	ADJ
bam-12939	1	37	sclerosis	sclerosis	NOUN
bam-12939	1	38	(	(	PUNCT
bam-12939	1	39	ms	ms	NOUN
bam-12939	1	40	)	)	PUNCT
bam-12939	1	41	are	be	AUX
bam-12939	1	42	still	still	ADV
bam-12939	1	43	unknown	unknown	ADJ
bam-12939	1	44	,	,	PUNCT
bam-12939	1	45	some	some	DET
bam-12939	1	46	studies	study	NOUN
bam-12939	1	47	have	have	AUX
bam-12939	1	48	shown	show	VERB
bam-12939	1	49	that	that	SCONJ
bam-12939	1	50	environmental	environmental	ADJ
bam-12939	1	51	factors	factor	NOUN
bam-12939	1	52	,	,	PUNCT
bam-12939	1	53	oxidative	oxidative	ADJ
bam-12939	1	54	stress	stress	NOUN
bam-12939	1	55	,	,	PUNCT
bam-12939	1	56	immune	immune	ADJ
bam-12939	1	57	system	system	NOUN
bam-12939	1	58	defects	defect	NOUN
bam-12939	1	59	,	,	PUNCT
bam-12939	1	60	and	and	CCONJ
bam-12939	1	61	inflammatory	inflammatory	ADJ
bam-12939	1	62	factors	factor	NOUN
bam-12939	1	63	may	may	AUX
bam-12939	1	64	play	play	VERB
bam-12939	1	65	a	a	DET
bam-12939	1	66	role	role	NOUN
bam-12939	1	67	in	in	ADP
bam-12939	1	68	this	this	PRON
bam-12939	1	69	disease.1	disease.1	ADP
bam-12939	1	70	some	some	DET
bam-12939	1	71	evidence	evidence	NOUN
bam-12939	1	72	suggests	suggest	VERB
bam-12939	1	73	that	that	SCONJ
bam-12939	1	74	some	some	DET
bam-12939	1	75	people	people	NOUN
bam-12939	1	76	with	with	ADP
bam-12939	1	77	inadequate	inadequate	ADJ
bam-12939	1	78	vitamin	vitamin	NOUN
bam-12939	1	79	d	d	NOUN
bam-12939	1	80	levels	level	NOUN
bam-12939	1	81	do	do	AUX
bam-12939	1	82	not	not	PART
bam-12939	1	83	develop	develop	VERB
bam-12939	1	84	ms.2	ms.2	NOUN
bam-12939	1	85	-	-	SYM
bam-12939	1	86	4	4	NUM
bam-12939	1	87	vitamin	vitamin	NOUN
bam-12939	1	88	d	d	NOUN
bam-12939	1	89	is	be	AUX
bam-12939	1	90	a	a	DET
bam-12939	1	91	nutrient	nutrient	NOUN
bam-12939	1	92	that	that	SCONJ
bam-12939	1	93	the	the	DET
bam-12939	1	94	body	body	NOUN
bam-12939	1	95	needs	need	VERB
bam-12939	1	96	to	to	PART
bam-12939	1	97	build	build	VERB
bam-12939	1	98	and	and	CCONJ
bam-12939	1	99	maintain	maintain	VERB
bam-12939	1	100	healthy	healthy	ADJ
bam-12939	1	101	bones	bone	NOUN
bam-12939	1	102	.	.	PUNCT
bam-12939	2	1	only	only	ADV
bam-12939	2	2	when	when	SCONJ
bam-12939	2	3	vitamin	vitamin	NOUN
bam-12939	2	4	d	d	NOUN
bam-12939	2	5	is	be	AUX
bam-12939	2	6	present	present	ADJ
bam-12939	2	7	can	can	AUX
bam-12939	2	8	the	the	DET
bam-12939	2	9	body	body	NOUN
bam-12939	2	10	absorb	absorb	VERB
bam-12939	2	11	calcium	calcium	NOUN
bam-12939	2	12	,	,	PUNCT
bam-12939	2	13	the	the	DET
bam-12939	2	14	main	main	ADJ
bam-12939	2	15	component	component	NOUN
bam-12939	2	16	of	of	ADP
bam-12939	2	17	bones	bone	NOUN
bam-12939	2	18	.	.	PUNCT
bam-12939	3	1	vitamin	vitamin	NOUN
bam-12939	3	2	d	d	PROPN
bam-12939	3	3	also	also	ADV
bam-12939	3	4	regulates	regulate	VERB
bam-12939	3	5	many	many	ADJ
bam-12939	3	6	other	other	ADJ
bam-12939	3	7	cellular	cellular	ADJ
bam-12939	3	8	functions	function	NOUN
bam-12939	3	9	in	in	ADP
bam-12939	3	10	the	the	DET
bam-12939	3	11	body.5	body.5	PROPN
bam-12939	3	12	its	its	PRON
bam-12939	3	13	anti	anti	ADJ
bam-12939	3	14	-	-	ADJ
bam-12939	3	15	inflammatory	inflammatory	ADJ
bam-12939	3	16	,	,	PUNCT
bam-12939	3	17	antioxidant	antioxidant	ADJ
bam-12939	3	18	and	and	CCONJ
bam-12939	3	19	neuroprotective	neuroprotective	ADJ
bam-12939	3	20	properties	property	NOUN
bam-12939	3	21	support	support	VERB
bam-12939	3	22	immune	immune	ADJ
bam-12939	3	23	system	system	NOUN
bam-12939	3	24	health	health	NOUN
bam-12939	3	25	,	,	PUNCT
bam-12939	3	26	muscle	muscle	NOUN
bam-12939	3	27	function	function	NOUN
bam-12939	3	28	and	and	CCONJ
bam-12939	3	29	brain	brain	NOUN
bam-12939	3	30	cell	cell	NOUN
bam-12939	3	31	activity	activity	NOUN
bam-12939	3	32	.	.	PUNCT
bam-12939	4	1	vitamin	vitamin	NOUN
bam-12939	4	2	d	d	NOUN
bam-12939	4	3	does	do	AUX
bam-12939	4	4	n’t	not	PART
bam-12939	4	5	occur	occur	VERB
bam-12939	4	6	naturally	naturally	ADV
bam-12939	4	7	in	in	ADP
bam-12939	4	8	many	many	ADJ
bam-12939	4	9	foods	food	NOUN
bam-12939	4	10	,	,	PUNCT
bam-12939	4	11	but	but	CCONJ
bam-12939	4	12	you	you	PRON
bam-12939	4	13	can	can	AUX
bam-12939	4	14	get	get	VERB
bam-12939	4	15	it	it	PRON
bam-12939	4	16	from	from	ADP
bam-12939	4	17	fortified	fortified	ADJ
bam-12939	4	18	milk	milk	NOUN
bam-12939	4	19	,	,	PUNCT
bam-12939	4	20	fortified	fortified	ADJ
bam-12939	4	21	cereals	cereal	NOUN
bam-12939	4	22	,	,	PUNCT
bam-12939	4	23	and	and	CCONJ
bam-12939	4	24	fatty	fatty	NOUN
bam-12939	4	25	fish	fish	NOUN
bam-12939	4	26	like	like	ADP
bam-12939	4	27	salmon	salmon	NOUN
bam-12939	4	28	,	,	PUNCT
bam-12939	4	29	mackerel	mackerel	NOUN
bam-12939	4	30	,	,	PUNCT
bam-12939	4	31	and	and	CCONJ
bam-12939	4	32	sardines.6	sardines.6	PROPN
bam-12939	4	33	according	accord	VERB
bam-12939	4	34	to	to	ADP
bam-12939	4	35	the	the	DET
bam-12939	4	36	studies	study	NOUN
bam-12939	4	37	carried	carry	VERB
bam-12939	4	38	out	out	ADP
bam-12939	4	39	,	,	PUNCT
bam-12939	4	40	adipokine	adipokine	ADJ
bam-12939	4	41	levels	level	NOUN
bam-12939	4	42	,	,	PUNCT
bam-12939	4	43	including	include	VERB
bam-12939	4	44	leptin	leptin	NOUN
bam-12939	4	45	and	and	CCONJ
bam-12939	4	46	fabs-4	fabs-4	PROPN
bam-12939	4	47	levels	level	NOUN
bam-12939	4	48	,	,	PUNCT
bam-12939	4	49	adiponectin	adiponectin	NOUN
bam-12939	4	50	,	,	PUNCT
bam-12939	4	51	obesity	obesity	NOUN
bam-12939	4	52	and	and	CCONJ
bam-12939	4	53	vitamin	vitamin	NOUN
bam-12939	4	54	d	d	PROPN
bam-12939	4	55	,	,	PUNCT
bam-12939	4	56	may	may	AUX
bam-12939	4	57	be	be	AUX
bam-12939	4	58	associated	associate	VERB
bam-12939	4	59	with	with	ADP
bam-12939	4	60	the	the	DET
bam-12939	4	61	onset	onset	NOUN
bam-12939	4	62	and	and	CCONJ
bam-12939	4	63	exacerbation	exacerbation	NOUN
bam-12939	4	64	of	of	ADP
bam-12939	4	65	ms	ms	PROPN
bam-12939	4	66	disease5	disease5	PROPN
bam-12939	4	67	-	-	PUNCT
bam-12939	4	68	7	7	NUM
bam-12939	4	69	and	and	CCONJ
bam-12939	4	70	,	,	PUNCT
bam-12939	4	71	on	on	ADP
bam-12939	4	72	the	the	DET
bam-12939	4	73	other	other	ADJ
bam-12939	4	74	hand	hand	NOUN
bam-12939	4	75	,	,	PUNCT
bam-12939	4	76	with	with	ADP
bam-12939	4	77	abstract	abstract	ADJ
bam-12939	4	78	adipocyte	adipocyte	ADJ
bam-12939	4	79	levels	level	NOUN
bam-12939	4	80	,	,	PUNCT
bam-12939	4	81	including	include	VERB
bam-12939	4	82	leptin	leptin	NOUN
bam-12939	4	83	and	and	CCONJ
bam-12939	4	84	fabs-4	fabs-4	PROPN
bam-12939	4	85	levels	level	NOUN
bam-12939	4	86	,	,	PUNCT
bam-12939	4	87	adiponectin	adiponectin	NOUN
bam-12939	4	88	,	,	PUNCT
bam-12939	4	89	obesity	obesity	NOUN
bam-12939	4	90	and	and	CCONJ
bam-12939	4	91	vitamin	vitamin	NOUN
bam-12939	4	92	d	d	PROPN
bam-12939	4	93	,	,	PUNCT
bam-12939	4	94	may	may	AUX
bam-12939	4	95	be	be	AUX
bam-12939	4	96	associated	associate	VERB
bam-12939	4	97	with	with	ADP
bam-12939	4	98	the	the	DET
bam-12939	4	99	occurrence	occurrence	NOUN
bam-12939	4	100	and	and	CCONJ
bam-12939	4	101	exacerbation	exacerbation	NOUN
bam-12939	4	102	of	of	ADP
bam-12939	4	103	multiple	multiple	ADJ
bam-12939	4	104	sclerosis	sclerosis	NOUN
bam-12939	4	105	.	.	PUNCT
bam-12939	5	1	this	this	DET
bam-12939	5	2	research	research	NOUN
bam-12939	5	3	aimed	aim	VERB
bam-12939	5	4	at	at	ADP
bam-12939	5	5	determining	determine	VERB
bam-12939	5	6	the	the	DET
bam-12939	5	7	relationship	relationship	NOUN
bam-12939	5	8	between	between	ADP
bam-12939	5	9	vitamin	vitamin	NOUN
bam-12939	5	10	d	d	NOUN
bam-12939	5	11	receptor	receptor	NOUN
bam-12939	5	12	changes	change	NOUN
bam-12939	5	13	and	and	CCONJ
bam-12939	5	14	clinical	clinical	ADJ
bam-12939	5	15	and	and	CCONJ
bam-12939	5	16	inflammatory	inflammatory	ADJ
bam-12939	5	17	factors	factor	NOUN
bam-12939	5	18	in	in	ADP
bam-12939	5	19	patients	patient	NOUN
bam-12939	5	20	with	with	ADP
bam-12939	5	21	relapsing	relapse	VERB
bam-12939	5	22	-	-	PUNCT
bam-12939	5	23	remitting	remit	VERB
bam-12939	5	24	multiple	multiple	ADJ
bam-12939	5	25	sclerosis	sclerosis	NOUN
bam-12939	5	26	(	(	PUNCT
bam-12939	5	27	rrms	rrm	NOUN
bam-12939	5	28	)	)	PUNCT
bam-12939	5	29	.	.	PUNCT
bam-12939	6	1	present	present	ADJ
bam-12939	6	2	case	case	NOUN
bam-12939	6	3	/	/	SYM
bam-12939	6	4	control	control	NOUN
bam-12939	6	5	study	study	NOUN
bam-12939	6	6	was	be	AUX
bam-12939	6	7	conducted	conduct	VERB
bam-12939	6	8	based	base	VERB
bam-12939	6	9	on	on	ADP
bam-12939	6	10	the	the	DET
bam-12939	6	11	helsinki	helsinki	PROPN
bam-12939	6	12	ethical	ethical	PROPN
bam-12939	6	13	principles	principle	NOUN
bam-12939	6	14	.	.	PUNCT
bam-12939	7	1	rrms	rrm	NOUN
bam-12939	7	2	disease	disease	NOUN
bam-12939	7	3	was	be	AUX
bam-12939	7	4	confirmed	confirm	VERB
bam-12939	7	5	based	base	VERB
bam-12939	7	6	on	on	ADP
bam-12939	7	7	history	history	NOUN
bam-12939	7	8	,	,	PUNCT
bam-12939	7	9	clinical	clinical	ADJ
bam-12939	7	10	symptoms	symptom	NOUN
bam-12939	7	11	,	,	PUNCT
bam-12939	7	12	radiological	radiological	ADJ
bam-12939	7	13	signs	sign	NOUN
bam-12939	7	14	and	and	CCONJ
bam-12939	7	15	neurologist	neurologist	ADJ
bam-12939	7	16	diagnosis	diagnosis	NOUN
bam-12939	7	17	.	.	PUNCT
bam-12939	8	1	the	the	DET
bam-12939	8	2	research	research	NOUN
bam-12939	8	3	population	population	NOUN
bam-12939	8	4	consisted	consist	VERB
bam-12939	8	5	of	of	ADP
bam-12939	8	6	healthy	healthy	ADJ
bam-12939	8	7	people	people	NOUN
bam-12939	8	8	and	and	CCONJ
bam-12939	8	9	patients	patient	NOUN
bam-12939	8	10	with	with	ADP
bam-12939	8	11	rrms	rrm	NOUN
bam-12939	8	12	who	who	PRON
bam-12939	8	13	were	be	AUX
bam-12939	8	14	referred	refer	VERB
bam-12939	8	15	to	to	ADP
bam-12939	8	16	hazrat	hazrat	PROPN
bam-12939	8	17	rasool	rasool	PROPN
bam-12939	8	18	akram	akram	PROPN
bam-12939	8	19	hospital	hospital	NOUN
bam-12939	8	20	between	between	ADP
bam-12939	8	21	2021	2021	NUM
bam-12939	8	22	and	and	CCONJ
bam-12939	8	23	2023	2023	NUM
bam-12939	8	24	and	and	CCONJ
bam-12939	8	25	met	meet	VERB
bam-12939	8	26	the	the	DET
bam-12939	8	27	criteria	criterion	NOUN
bam-12939	8	28	for	for	ADP
bam-12939	8	29	participation	participation	NOUN
bam-12939	8	30	in	in	ADP
bam-12939	8	31	the	the	DET
bam-12939	8	32	research	research	NOUN
bam-12939	8	33	.	.	PUNCT
bam-12939	9	1	the	the	DET
bam-12939	9	2	foki	foki	ADJ
bam-12939	9	3	polymorphism	polymorphism	NOUN
bam-12939	9	4	is	be	AUX
bam-12939	9	5	associated	associate	VERB
bam-12939	9	6	with	with	ADP
bam-12939	9	7	a	a	DET
bam-12939	9	8	significant	significant	ADJ
bam-12939	9	9	increase	increase	NOUN
bam-12939	9	10	in	in	ADP
bam-12939	9	11	risk	risk	NOUN
bam-12939	9	12	with	with	ADP
bam-12939	9	13	an	an	DET
bam-12939	9	14	odds	odd	NOUN
bam-12939	9	15	ratio	ratio	NOUN
bam-12939	9	16	of	of	ADP
bam-12939	9	17	7.28	7.28	NUM
bam-12939	9	18	for	for	ADP
bam-12939	9	19	individuals	individual	NOUN
bam-12939	9	20	with	with	ADP
bam-12939	9	21	the	the	DET
bam-12939	9	22	ff	ff	NOUN
bam-12939	9	23	genotype	genotype	NOUN
bam-12939	9	24	and	and	CCONJ
bam-12939	9	25	rrms	rrm	NOUN
bam-12939	9	26	compared	compare	VERB
bam-12939	9	27	to	to	ADP
bam-12939	9	28	healthy	healthy	ADJ
bam-12939	9	29	individuals	individual	NOUN
bam-12939	9	30	(	(	PUNCT
bam-12939	9	31	or	or	CCONJ
bam-12939	9	32	=	=	SYM
bam-12939	9	33	7.28	7.28	NUM
bam-12939	9	34	:	:	PUNCT
bam-12939	9	35	95	95	NUM
bam-12939	9	36	%	%	NOUN
bam-12939	9	37	ci	ci	NOUN
bam-12939	9	38	;	;	PUNCT
bam-12939	9	39	1.86	1.86	NUM
bam-12939	9	40	,	,	PUNCT
bam-12939	9	41	28.41	28.41	NUM
bam-12939	9	42	)	)	PUNCT
bam-12939	9	43	.	.	PUNCT
bam-12939	10	1	the	the	DET
bam-12939	10	2	presence	presence	NOUN
bam-12939	10	3	of	of	ADP
bam-12939	10	4	a	a	DET
bam-12939	10	5	foki	foki	ADJ
bam-12939	10	6	polymorphism	polymorphism	NOUN
bam-12939	10	7	significantly	significantly	ADV
bam-12939	10	8	increases	increase	VERB
bam-12939	10	9	the	the	DET
bam-12939	10	10	likelihood	likelihood	NOUN
bam-12939	10	11	of	of	ADP
bam-12939	10	12	developing	develop	VERB
bam-12939	10	13	rrms	rrm	NOUN
bam-12939	10	14	in	in	ADP
bam-12939	10	15	individuals	individual	NOUN
bam-12939	10	16	with	with	ADP
bam-12939	10	17	the	the	DET
bam-12939	10	18	ff	ff	NOUN
bam-12939	10	19	genotype	genotype	NOUN
bam-12939	10	20	compared	compare	VERB
bam-12939	10	21	to	to	ADP
bam-12939	10	22	healthy	healthy	ADJ
bam-12939	10	23	individuals	individual	NOUN
bam-12939	10	24	,	,	PUNCT
bam-12939	10	25	with	with	ADP
bam-12939	10	26	an	an	DET
bam-12939	10	27	odds	odd	NOUN
bam-12939	10	28	ratio	ratio	NOUN
bam-12939	10	29	of	of	ADP
bam-12939	10	30	28.7	28.7	NUM
bam-12939	10	31	.	.	PUNCT
bam-12939	11	1	rrms	rrm	NOUN
bam-12939	11	2	patients	patient	NOUN
bam-12939	11	3	with	with	ADP
bam-12939	11	4	genotypes	genotype	NOUN
bam-12939	11	5	did	do	AUX
bam-12939	11	6	not	not	PART
bam-12939	11	7	show	show	VERB
bam-12939	11	8	a	a	DET
bam-12939	11	9	significantly	significantly	ADV
bam-12939	11	10	increased	increase	VERB
bam-12939	11	11	risk	risk	NOUN
bam-12939	11	12	of	of	ADP
bam-12939	11	13	foki	foki	NOUN
bam-12939	11	14	,	,	PUNCT
bam-12939	11	15	apai	apai	NOUN
bam-12939	11	16	,	,	PUNCT
bam-12939	11	17	taqi	taqi	NOUN
bam-12939	11	18	and	and	CCONJ
bam-12939	11	19	bsmi	bsmi	NOUN
bam-12939	11	20	polymorphisms	polymorphism	NOUN
bam-12939	11	21	compared	compare	VERB
bam-12939	11	22	to	to	ADP
bam-12939	11	23	controls.none	controls.none	PROPN
bam-12939	11	24	of	of	ADP
bam-12939	11	25	the	the	DET
bam-12939	11	26	polymorphisms	polymorphism	NOUN
bam-12939	11	27	examined	examine	VERB
bam-12939	11	28	showed	show	VERB
bam-12939	11	29	a	a	DET
bam-12939	11	30	significant	significant	ADJ
bam-12939	11	31	risk	risk	NOUN
bam-12939	11	32	in	in	ADP
bam-12939	11	33	obese	obese	ADJ
bam-12939	11	34	patients	patient	NOUN
bam-12939	11	35	with	with	ADP
bam-12939	11	36	different	different	ADJ
bam-12939	11	37	genotypes	genotype	NOUN
bam-12939	11	38	compared	compare	VERB
bam-12939	11	39	to	to	ADP
bam-12939	11	40	obese	obese	ADJ
bam-12939	11	41	people	people	NOUN
bam-12939	11	42	.	.	PUNCT
bam-12939	12	1	further	further	ADJ
bam-12939	12	2	research	research	NOUN
bam-12939	12	3	,	,	PUNCT
bam-12939	12	4	including	include	VERB
bam-12939	12	5	additional	additional	ADJ
bam-12939	12	6	cases	case	NOUN
bam-12939	12	7	,	,	PUNCT
bam-12939	12	8	is	be	AUX
bam-12939	12	9	needed	need	VERB
bam-12939	12	10	to	to	PART
bam-12939	12	11	avoid	avoid	VERB
bam-12939	12	12	results	result	NOUN
bam-12939	12	13	that	that	PRON
bam-12939	12	14	could	could	AUX
bam-12939	12	15	be	be	AUX
bam-12939	12	16	inflated	inflate	VERB
bam-12939	12	17	by	by	ADP
bam-12939	12	18	small	small	ADJ
bam-12939	12	19	samples	sample	NOUN
bam-12939	12	20	or	or	CCONJ
bam-12939	12	21	low	low	ADJ
bam-12939	12	22	frequencies	frequency	NOUN
bam-12939	12	23	of	of	ADP
bam-12939	12	24	minor	minor	ADJ
bam-12939	12	25	alleles	allele	NOUN
bam-12939	12	26	.	.	PUNCT
bam-12939	13	1	key	key	ADJ
bam-12939	13	2	words	word	NOUN
bam-12939	13	3	:	:	PUNCT
bam-12939	13	4	vitamin	vitamin	NOUN
bam-12939	13	5	d	d	NOUN
bam-12939	13	6	receptor	receptor	NOUN
bam-12939	13	7	,	,	PUNCT
bam-12939	13	8	gene	gene	NOUN
bam-12939	13	9	changes	change	NOUN
bam-12939	13	10	,	,	PUNCT
bam-12939	13	11	clinical	clinical	ADJ
bam-12939	13	12	and	and	CCONJ
bam-12939	13	13	inflammatory	inflammatory	ADJ
bam-12939	13	14	factors	factor	NOUN
bam-12939	13	15	,	,	PUNCT
bam-12939	13	16	relapsingremitting	relapsingremitte	VERB
bam-12939	13	17	multiple	multiple	ADJ
bam-12939	13	18	sclerosis	sclerosis	NOUN
bam-12939	13	19	.	.	PUNCT
bam-12939	14	1	eur	eur	PROPN
bam-12939	14	2	j	j	PROPN
bam-12939	14	3	transl	transl	PROPN
bam-12939	14	4	myol	myol	NOUN
bam-12939	14	5	34	34	NUM
bam-12939	14	6	(	(	PUNCT
bam-12939	14	7	4	4	NUM
bam-12939	14	8	)	)	PUNCT
bam-12939	14	9	12939	12939	NUM
bam-12939	14	10	,	,	PUNCT
bam-12939	14	11	2024	2024	NUM
bam-12939	14	12	doi	doi	NOUN
bam-12939	14	13	:	:	PUNCT
bam-12939	14	14	10.4081	10.4081	NUM
bam-12939	14	15	/	/	SYM
bam-12939	14	16	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	14	17	evaluation	evaluation	NOUN
bam-12939	14	18	relationship	relationship	NOUN
bam-12939	14	19	between	between	ADP
bam-12939	14	20	vitamin	vitamin	NOUN
bam-12939	14	21	d	d	NOUN
bam-12939	14	22	receptor	receptor	NOUN
bam-12939	14	23	and	and	CCONJ
bam-12939	14	24	clinical	clinical	ADJ
bam-12939	14	25	and	and	CCONJ
bam-12939	14	26	inflammatory	inflammatory	ADJ
bam-12939	14	27	factors	factor	NOUN
bam-12939	14	28	in	in	ADP
bam-12939	14	29	patients	patient	NOUN
bam-12939	14	30	with	with	ADP
bam-12939	14	31	relapsing	relapse	VERB
bam-12939	14	32	-	-	PUNCT
bam-12939	14	33	remitting	remit	VERB
bam-12939	14	34	multiple	multiple	ADJ
bam-12939	14	35	sclerosis	sclerosis	NOUN
bam-12939	14	36	maryam	maryam	PROPN
bam-12939	14	37	milanifard,1	milanifard,1	PROPN
bam-12939	15	1	soraya	soraya	PROPN
bam-12939	15	2	mehrabi,2	mehrabi,2	PROPN
bam-12939	15	3	reza	reza	PROPN
bam-12939	15	4	ahadi,3	ahadi,3	VERB
bam-12939	15	5	mohsen	mohsen	PROPN
bam-12939	15	6	nabiuni,4	nabiuni,4	PROPN
bam-12939	15	7	samaneh	samaneh	PROPN
bam-12939	15	8	azimi	azimi	PROPN
bam-12939	15	9	souteh,5	souteh,5	PROPN
bam-12939	15	10	mohammad	mohammad	PROPN
bam-12939	15	11	taghi	taghi	PROPN
bam-12939	15	12	joghataei2,3,6	joghataei2,3,6	PROPN
bam-12939	15	13	1department	1department	NUM
bam-12939	15	14	of	of	ADP
bam-12939	15	15	anatomy	anatomy	NOUN
bam-12939	15	16	,	,	PUNCT
bam-12939	15	17	school	school	NOUN
bam-12939	15	18	of	of	ADP
bam-12939	15	19	medicine	medicine	NOUN
bam-12939	15	20	,	,	PUNCT
bam-12939	15	21	iran	iran	PROPN
bam-12939	15	22	university	university	PROPN
bam-12939	15	23	of	of	ADP
bam-12939	15	24	medical	medical	ADJ
bam-12939	15	25	sciences	sciences	PROPN
bam-12939	15	26	,	,	PUNCT
bam-12939	15	27	tehran	tehran	PROPN
bam-12939	15	28	,	,	PUNCT
bam-12939	15	29	iran	iran	PROPN
bam-12939	15	30	;	;	PUNCT
bam-12939	16	1	2department	2department	NUM
bam-12939	16	2	of	of	ADP
bam-12939	16	3	neuroscience	neuroscience	NOUN
bam-12939	16	4	,	,	PUNCT
bam-12939	16	5	faculty	faculty	NOUN
bam-12939	16	6	of	of	ADP
bam-12939	16	7	advanced	advanced	ADJ
bam-12939	16	8	technologies	technology	NOUN
bam-12939	16	9	in	in	ADP
bam-12939	16	10	medicine	medicine	NOUN
bam-12939	16	11	,	,	PUNCT
bam-12939	16	12	iran	iran	PROPN
bam-12939	16	13	university	university	PROPN
bam-12939	16	14	of	of	ADP
bam-12939	16	15	medical	medical	ADJ
bam-12939	16	16	sciences	sciences	PROPN
bam-12939	16	17	,	,	PUNCT
bam-12939	16	18	tehran	tehran	PROPN
bam-12939	16	19	,	,	PUNCT
bam-12939	16	20	iran	iran	PROPN
bam-12939	16	21	;	;	PUNCT
bam-12939	16	22	3department	3department	NUM
bam-12939	16	23	of	of	ADP
bam-12939	16	24	anatomical	anatomical	ADJ
bam-12939	16	25	sciences	science	NOUN
bam-12939	16	26	,	,	PUNCT
bam-12939	16	27	school	school	NOUN
bam-12939	16	28	of	of	ADP
bam-12939	16	29	medicine	medicine	NOUN
bam-12939	16	30	,	,	PUNCT
bam-12939	16	31	iran	iran	PROPN
bam-12939	16	32	university	university	PROPN
bam-12939	16	33	of	of	ADP
bam-12939	16	34	medical	medical	ADJ
bam-12939	16	35	sciences	sciences	PROPN
bam-12939	16	36	,	,	PUNCT
bam-12939	16	37	tehran	tehran	PROPN
bam-12939	16	38	,	,	PUNCT
bam-12939	16	39	iran	iran	PROPN
bam-12939	16	40	;	;	PUNCT
bam-12939	16	41	4assistant	4assistant	NUM
bam-12939	16	42	professor	professor	NOUN
bam-12939	16	43	of	of	ADP
bam-12939	16	44	neurosurgery	neurosurgery	NOUN
bam-12939	16	45	,	,	PUNCT
bam-12939	16	46	spine	spine	ADJ
bam-12939	16	47	fellowship	fellowship	NOUN
bam-12939	16	48	,	,	PUNCT
bam-12939	16	49	faculty	faculty	NOUN
bam-12939	16	50	member	member	NOUN
bam-12939	16	51	,	,	PUNCT
bam-12939	16	52	department	department	NOUN
bam-12939	16	53	of	of	ADP
bam-12939	16	54	neurosurgery	neurosurgery	NOUN
bam-12939	16	55	,	,	PUNCT
bam-12939	16	56	iran	iran	PROPN
bam-12939	16	57	university	university	PROPN
bam-12939	16	58	of	of	ADP
bam-12939	16	59	medical	medical	ADJ
bam-12939	16	60	sciences	sciences	PROPN
bam-12939	16	61	,	,	PUNCT
bam-12939	16	62	tehran	tehran	PROPN
bam-12939	16	63	,	,	PUNCT
bam-12939	16	64	iran	iran	PROPN
bam-12939	16	65	;	;	PUNCT
bam-12939	16	66	5department	5department	NUM
bam-12939	16	67	of	of	ADP
bam-12939	16	68	radiology	radiology	NOUN
bam-12939	16	69	,	,	PUNCT
bam-12939	16	70	school	school	NOUN
bam-12939	16	71	of	of	ADP
bam-12939	16	72	medicine	medicine	NOUN
bam-12939	16	73	,	,	PUNCT
bam-12939	16	74	iran	iran	PROPN
bam-12939	16	75	university	university	PROPN
bam-12939	16	76	of	of	ADP
bam-12939	16	77	medical	medical	ADJ
bam-12939	16	78	sciences	sciences	PROPN
bam-12939	16	79	,	,	PUNCT
bam-12939	16	80	tehran	tehran	PROPN
bam-12939	16	81	,	,	PUNCT
bam-12939	16	82	iran	iran	PROPN
bam-12939	16	83	;	;	PUNCT
bam-12939	16	84	6cellular	6cellular	NUM
bam-12939	16	85	and	and	CCONJ
bam-12939	16	86	molecular	molecular	ADJ
bam-12939	16	87	research	research	NOUN
bam-12939	16	88	center	center	NOUN
bam-12939	16	89	,	,	PUNCT
bam-12939	16	90	iran	iran	PROPN
bam-12939	16	91	university	university	PROPN
bam-12939	16	92	of	of	ADP
bam-12939	16	93	medical	medical	ADJ
bam-12939	16	94	sciences	sciences	PROPN
bam-12939	16	95	,	,	PUNCT
bam-12939	16	96	tehran	tehran	PROPN
bam-12939	16	97	,	,	PUNCT
bam-12939	16	98	iran	iran	PROPN
bam-12939	16	99	.	.	PUNCT
bam-12939	17	1	this	this	DET
bam-12939	17	2	article	article	NOUN
bam-12939	17	3	is	be	AUX
bam-12939	17	4	distributed	distribute	VERB
bam-12939	17	5	under	under	ADP
bam-12939	17	6	the	the	DET
bam-12939	17	7	terms	term	NOUN
bam-12939	17	8	of	of	ADP
bam-12939	17	9	the	the	DET
bam-12939	17	10	creative	creative	ADJ
bam-12939	17	11	commons	common	NOUN
bam-12939	17	12	attribution	attribution	NOUN
bam-12939	17	13	noncommercial	noncommercial	ADJ
bam-12939	17	14	license	license	NOUN
bam-12939	17	15	(	(	PUNCT
bam-12939	17	16	cc	cc	NOUN
bam-12939	17	17	by	by	ADP
bam-12939	17	18	-	-	PUNCT
bam-12939	17	19	nc	nc	PROPN
bam-12939	17	20	4.0	4.0	NUM
bam-12939	17	21	)	)	PUNCT
bam-12939	17	22	which	which	PRON
bam-12939	17	23	permits	permit	VERB
bam-12939	17	24	any	any	DET
bam-12939	17	25	noncommercial	noncommercial	ADJ
bam-12939	17	26	use	use	NOUN
bam-12939	17	27	,	,	PUNCT
bam-12939	17	28	distribution	distribution	NOUN
bam-12939	17	29	,	,	PUNCT
bam-12939	17	30	and	and	CCONJ
bam-12939	17	31	reproduction	reproduction	NOUN
bam-12939	17	32	in	in	ADP
bam-12939	17	33	any	any	DET
bam-12939	17	34	medium	medium	NOUN
bam-12939	17	35	,	,	PUNCT
bam-12939	17	36	provided	provide	VERB
bam-12939	17	37	the	the	DET
bam-12939	17	38	original	original	ADJ
bam-12939	17	39	author(s	author(s	NOUN
bam-12939	17	40	)	)	PUNCT
bam-12939	17	41	and	and	CCONJ
bam-12939	17	42	source	source	NOUN
bam-12939	17	43	are	be	AUX
bam-12939	17	44	credited	credit	VERB
bam-12939	17	45	.	.	PUNCT
bam-12939	18	1	33	33	NUM
bam-12939	18	2	non	non	ADJ
bam-12939	18	3	-co	-co	PROPN
bam-12939	18	4	mmerc	mmerc	PROPN
bam-12939	18	5	ial	ial	PROPN
bam-12939	18	6	us	us	PROPN
bam-12939	18	7	e	e	NOUN
bam-12939	18	8	o	o	NOUN
bam-12939	18	9	nly	nly	ADV
bam-12939	18	10	vitamin	vitamin	VERB
bam-12939	18	11	d	d	NOUN
bam-12939	18	12	receptor	receptor	NOUN
bam-12939	18	13	and	and	CCONJ
bam-12939	18	14	clinical	clinical	ADJ
bam-12939	18	15	and	and	CCONJ
bam-12939	18	16	inflammatory	inflammatory	ADJ
bam-12939	18	17	factors	factor	NOUN
bam-12939	18	18	in	in	ADP
bam-12939	18	19	patients	patient	NOUN
bam-12939	18	20	with	with	ADP
bam-12939	18	21	relapsing	relapse	VERB
bam-12939	18	22	-	-	PUNCT
bam-12939	18	23	remitting	remit	VERB
bam-12939	18	24	multiple	multiple	ADJ
bam-12939	18	25	sclerosis	sclerosis	NOUN
bam-12939	18	26	eur	eur	PROPN
bam-12939	18	27	j	j	PROPN
bam-12939	18	28	transl	transl	PROPN
bam-12939	18	29	myol	myol	NOUN
bam-12939	18	30	34	34	NUM
bam-12939	18	31	(	(	PUNCT
bam-12939	18	32	4	4	NUM
bam-12939	18	33	)	)	PUNCT
bam-12939	18	34	12939	12939	NUM
bam-12939	18	35	,	,	PUNCT
bam-12939	18	36	2024	2024	NUM
bam-12939	18	37	doi	doi	NOUN
bam-12939	18	38	:	:	PUNCT
bam-12939	18	39	10.4081	10.4081	NUM
bam-12939	18	40	/	/	SYM
bam-12939	18	41	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	18	42	vitamin	vitamin	NOUN
bam-12939	18	43	d	d	NOUN
bam-12939	18	44	deficiency	deficiency	NOUN
bam-12939	18	45	a	a	DET
bam-12939	18	46	deficiency	deficiency	NOUN
bam-12939	18	47	of	of	ADP
bam-12939	18	48	vitamin	vitamin	NOUN
bam-12939	18	49	d	d	NOUN
bam-12939	18	50	receptor	receptor	NOUN
bam-12939	18	51	(	(	PUNCT
bam-12939	18	52	vdr	vdr	NOUN
bam-12939	18	53	)	)	PUNCT
bam-12939	18	54	and	and	CCONJ
bam-12939	18	55	its	its	PRON
bam-12939	18	56	responsiveness	responsiveness	NOUN
bam-12939	18	57	can	can	AUX
bam-12939	18	58	therefore	therefore	ADV
bam-12939	18	59	influence	influence	VERB
bam-12939	18	60	the	the	DET
bam-12939	18	61	occurrence	occurrence	NOUN
bam-12939	18	62	of	of	ADP
bam-12939	18	63	ms.8	ms.8	PROPN
bam-12939	18	64	-	-	PUNCT
bam-12939	18	65	10	10	NUM
bam-12939	18	66	according	accord	VERB
bam-12939	18	67	to	to	ADP
bam-12939	18	68	reports	report	NOUN
bam-12939	18	69	,	,	PUNCT
bam-12939	18	70	some	some	DET
bam-12939	18	71	people	people	NOUN
bam-12939	18	72	with	with	ADP
bam-12939	18	73	insufficient	insufficient	ADJ
bam-12939	18	74	levels	level	NOUN
bam-12939	18	75	of	of	ADP
bam-12939	18	76	vitamin	vitamin	NOUN
bam-12939	18	77	d	d	NOUN
bam-12939	18	78	did	do	AUX
bam-12939	18	79	not	not	PART
bam-12939	18	80	develop	develop	VERB
bam-12939	18	81	ms	ms	NOUN
bam-12939	18	82	,	,	PUNCT
bam-12939	18	83	and	and	CCONJ
bam-12939	18	84	some	some	PRON
bam-12939	18	85	even	even	ADV
bam-12939	18	86	with	with	ADP
bam-12939	18	87	sufficient	sufficient	ADJ
bam-12939	18	88	or	or	CCONJ
bam-12939	18	89	even	even	ADV
bam-12939	18	90	high	high	ADJ
bam-12939	18	91	levels	level	NOUN
bam-12939	18	92	of	of	ADP
bam-12939	18	93	vitamin	vitamin	NOUN
bam-12939	18	94	d	d	NUM
bam-12939	18	95	developed	develop	VERB
bam-12939	18	96	this	this	DET
bam-12939	18	97	disease	disease	NOUN
bam-12939	18	98	,	,	PUNCT
bam-12939	18	99	indicating	indicate	VERB
bam-12939	18	100	that	that	SCONJ
bam-12939	18	101	attention	attention	NOUN
bam-12939	18	102	should	should	AUX
bam-12939	18	103	be	be	AUX
bam-12939	18	104	paid	pay	VERB
bam-12939	18	105	to	to	ADP
bam-12939	18	106	the	the	DET
bam-12939	18	107	possibility	possibility	NOUN
bam-12939	18	108	of	of	ADP
bam-12939	18	109	a	a	DET
bam-12939	18	110	connection	connection	NOUN
bam-12939	18	111	between	between	ADP
bam-12939	18	112	changes	change	NOUN
bam-12939	18	113	in	in	ADP
bam-12939	18	114	the	the	DET
bam-12939	18	115	vdr	vdr	NOUN
bam-12939	18	116	must	must	AUX
bam-12939	18	117	be	be	AUX
bam-12939	18	118	associated	associate	VERB
bam-12939	18	119	with	with	ADP
bam-12939	18	120	inflammatory	inflammatory	ADJ
bam-12939	18	121	and	and	CCONJ
bam-12939	18	122	clinical	clinical	ADJ
bam-12939	18	123	factors	factor	NOUN
bam-12939	18	124	such	such	ADJ
bam-12939	18	125	as	as	ADP
bam-12939	18	126	obesity	obesity	NOUN
bam-12939	18	127	,	,	PUNCT
bam-12939	18	128	three	three	NUM
bam-12939	18	129	major	major	ADJ
bam-12939	18	130	short	short	ADJ
bam-12939	18	131	chain	chain	NOUN
bam-12939	18	132	fatty	fatty	NOUN
bam-12939	18	133	acids	acid	NOUN
bam-12939	18	134	(	(	PUNCT
bam-12939	18	135	scfa	scfa	NOUN
bam-12939	18	136	)	)	PUNCT
bam-12939	18	137	,	,	PUNCT
bam-12939	18	138	including	include	VERB
bam-12939	18	139	propionate	propionate	NOUN
bam-12939	18	140	(	(	PUNCT
bam-12939	18	141	pa	pa	PROPN
bam-12939	18	142	)	)	PUNCT
bam-12939	18	143	,	,	PUNCT
bam-12939	18	144	butyrate	butyrate	NOUN
bam-12939	18	145	(	(	PUNCT
bam-12939	18	146	ba	ba	NOUN
bam-12939	18	147	)	)	PUNCT
bam-12939	18	148	and	and	CCONJ
bam-12939	18	149	acetate	acetate	PROPN
bam-12939	18	150	(	(	PUNCT
bam-12939	18	151	aa	aa	NOUN
bam-12939	18	152	)	)	PUNCT
bam-12939	18	153	,	,	PUNCT
bam-12939	18	154	adipokine	adipokine	PROPN
bam-12939	18	155	(	(	PUNCT
bam-12939	18	156	leptin	leptin	NOUN
bam-12939	18	157	and	and	CCONJ
bam-12939	18	158	adiponectin	adiponectin	NOUN
bam-12939	18	159	)	)	PUNCT
bam-12939	18	160	,	,	PUNCT
bam-12939	18	161	occurs	occur	VERB
bam-12939	18	162	in	in	ADP
bam-12939	18	163	patients	patient	NOUN
bam-12939	18	164	with	with	ADP
bam-12939	18	165	multiple	multiple	ADJ
bam-12939	18	166	sclerosis	sclerosis	NOUN
bam-12939	18	167	type	type	NOUN
bam-12939	18	168	rrms	rrm	NOUN
bam-12939	18	169	before.11,12	before.11,12	NOUN
bam-12939	18	170	therefore	therefore	ADV
bam-12939	18	171	,	,	PUNCT
bam-12939	18	172	the	the	DET
bam-12939	18	173	aim	aim	NOUN
bam-12939	18	174	of	of	ADP
bam-12939	18	175	present	present	ADJ
bam-12939	18	176	study	study	NOUN
bam-12939	18	177	was	be	AUX
bam-12939	18	178	evaluate	evaluate	VERB
bam-12939	18	179	the	the	DET
bam-12939	18	180	association	association	NOUN
bam-12939	18	181	between	between	ADP
bam-12939	18	182	vdr	vdr	NOUN
bam-12939	18	183	changes	change	NOUN
bam-12939	18	184	and	and	CCONJ
bam-12939	18	185	clinical	clinical	ADJ
bam-12939	18	186	and	and	CCONJ
bam-12939	18	187	inflammatory	inflammatory	ADJ
bam-12939	18	188	factors	factor	NOUN
bam-12939	18	189	in	in	ADP
bam-12939	18	190	patients	patient	NOUN
bam-12939	18	191	with	with	ADP
bam-12939	18	192	relapsing	relapse	VERB
bam-12939	18	193	-	-	PUNCT
bam-12939	18	194	remitting	remit	VERB
bam-12939	18	195	multiple	multiple	ADJ
bam-12939	18	196	sclerosis	sclerosis	NOUN
bam-12939	18	197	(	(	PUNCT
bam-12939	18	198	rrms	rrm	NOUN
bam-12939	18	199	)	)	PUNCT
bam-12939	18	200	.	.	PUNCT
bam-12939	19	1	materials	material	NOUN
bam-12939	19	2	and	and	CCONJ
bam-12939	19	3	methods	method	NOUN
bam-12939	19	4	the	the	DET
bam-12939	19	5	present	present	ADJ
bam-12939	19	6	study	study	NOUN
bam-12939	19	7	was	be	AUX
bam-12939	19	8	a	a	DET
bam-12939	19	9	case	case	NOUN
bam-12939	19	10	/	/	SYM
bam-12939	19	11	control	control	NOUN
bam-12939	19	12	study	study	NOUN
bam-12939	19	13	conducted	conduct	VERB
bam-12939	19	14	based	base	VERB
bam-12939	19	15	on	on	ADP
bam-12939	19	16	the	the	DET
bam-12939	19	17	helsinki	helsinki	PROPN
bam-12939	19	18	ethical	ethical	PROPN
bam-12939	19	19	principles13	principles13	NOUN
bam-12939	19	20	and	and	CCONJ
bam-12939	19	21	was	be	AUX
bam-12939	19	22	approved	approve	VERB
bam-12939	19	23	by	by	ADP
bam-12939	19	24	the	the	DET
bam-12939	19	25	department	department	PROPN
bam-12939	19	26	of	of	ADP
bam-12939	19	27	medical	medical	ADJ
bam-12939	19	28	ethics	ethic	NOUN
bam-12939	19	29	,	,	PUNCT
bam-12939	19	30	iranian	iranian	ADJ
bam-12939	19	31	university	university	PROPN
bam-12939	19	32	of	of	ADP
bam-12939	19	33	medical	medical	ADJ
bam-12939	19	34	sciences	science	NOUN
bam-12939	19	35	with	with	ADP
bam-12939	19	36	no	no	NOUN
bam-12939	19	37	.	.	PUNCT
bam-12939	20	1	ir.iums.fmd.rec.1401.429	ir.iums.fmd.rec.1401.429	PROPN
bam-12939	20	2	.	.	PROPN
bam-12939	20	3	rrms	rrm	NOUN
bam-12939	20	4	disease	disease	NOUN
bam-12939	20	5	was	be	AUX
bam-12939	20	6	confirmed	confirm	VERB
bam-12939	20	7	based	base	VERB
bam-12939	20	8	on	on	ADP
bam-12939	20	9	history	history	NOUN
bam-12939	20	10	,	,	PUNCT
bam-12939	20	11	clinical	clinical	ADJ
bam-12939	20	12	symptoms	symptom	NOUN
bam-12939	20	13	,	,	PUNCT
bam-12939	20	14	radiological	radiological	ADJ
bam-12939	20	15	signs	sign	NOUN
bam-12939	20	16	and	and	CCONJ
bam-12939	20	17	neurologist	neurologist	NOUN
bam-12939	20	18	’s	’s	PART
bam-12939	20	19	diagnosis	diagnosis	NOUN
bam-12939	20	20	.	.	PUNCT
bam-12939	21	1	the	the	DET
bam-12939	21	2	research	research	NOUN
bam-12939	21	3	population	population	NOUN
bam-12939	21	4	consisted	consist	VERB
bam-12939	21	5	of	of	ADP
bam-12939	21	6	healthy	healthy	ADJ
bam-12939	21	7	people	people	NOUN
bam-12939	21	8	and	and	CCONJ
bam-12939	21	9	patients	patient	NOUN
bam-12939	21	10	with	with	ADP
bam-12939	21	11	rrms	rrm	NOUN
bam-12939	21	12	who	who	PRON
bam-12939	21	13	visited	visit	VERB
bam-12939	21	14	hazrat	hazrat	NOUN
bam-12939	21	15	rasool	rasool	PROPN
bam-12939	21	16	akram	akram	PROPN
bam-12939	21	17	hospital	hospital	PROPN
bam-12939	21	18	between	between	ADP
bam-12939	21	19	2021	2021	NUM
bam-12939	21	20	to	to	ADP
bam-12939	21	21	2023	2023	NUM
bam-12939	21	22	and	and	CCONJ
bam-12939	21	23	met	meet	VERB
bam-12939	21	24	the	the	DET
bam-12939	21	25	inclusion	inclusion	NOUN
bam-12939	21	26	criteria	criterion	NOUN
bam-12939	21	27	.	.	PUNCT
bam-12939	22	1	inclusion	inclusion	NOUN
bam-12939	22	2	criteria	criterion	NOUN
bam-12939	22	3	the	the	DET
bam-12939	22	4	study	study	NOUN
bam-12939	22	5	included	include	VERB
bam-12939	22	6	:	:	PUNCT
bam-12939	22	7	i	i	PRON
bam-12939	22	8	)	)	PUNCT
bam-12939	22	9	patients	patient	NOUN
bam-12939	22	10	with	with	ADP
bam-12939	22	11	rrms	rrm	NOUN
bam-12939	22	12	diagnosed	diagnose	VERB
bam-12939	22	13	using	use	VERB
bam-12939	22	14	the	the	DET
bam-12939	22	15	2017	2017	NUM
bam-12939	22	16	mcdonald	mcdonald	PROPN
bam-12939	22	17	’s	’s	PART
bam-12939	22	18	criteria;14	criteria;14	PROPN
bam-12939	22	19	ii	ii	PROPN
bam-12939	22	20	)	)	PUNCT
bam-12939	22	21	both	both	CCONJ
bam-12939	22	22	female	female	ADJ
bam-12939	22	23	and	and	CCONJ
bam-12939	22	24	male	male	ADJ
bam-12939	22	25	gender	gender	NOUN
bam-12939	22	26	;	;	PUNCT
bam-12939	22	27	iii	iii	X
bam-12939	22	28	)	)	PUNCT
bam-12939	22	29	age	age	NOUN
bam-12939	22	30	group	group	NOUN
bam-12939	22	31	from	from	ADP
bam-12939	22	32	18	18	NUM
bam-12939	22	33	to	to	PART
bam-12939	22	34	65	65	NUM
bam-12939	22	35	years	year	NOUN
bam-12939	22	36	;	;	PUNCT
bam-12939	22	37	iv	iv	X
bam-12939	22	38	)	)	PUNCT
bam-12939	22	39	edss	edss	ADV
bam-12939	22	40	between	between	ADP
bam-12939	22	41	1	1	NUM
bam-12939	22	42	and	and	CCONJ
bam-12939	22	43	3	3	NUM
bam-12939	22	44	;	;	PUNCT
bam-12939	22	45	v	v	X
bam-12939	22	46	)	)	PUNCT
bam-12939	22	47	patients	patient	NOUN
bam-12939	22	48	who	who	PRON
bam-12939	22	49	have	have	AUX
bam-12939	22	50	not	not	PART
bam-12939	22	51	taken	take	VERB
bam-12939	22	52	vitamin	vitamin	NOUN
bam-12939	22	53	d	d	NOUN
bam-12939	22	54	in	in	ADP
bam-12939	22	55	the	the	DET
bam-12939	22	56	last	last	ADJ
bam-12939	22	57	6	6	NUM
bam-12939	22	58	months	month	NOUN
bam-12939	22	59	.	.	PUNCT
bam-12939	23	1	exclusion	exclusion	NOUN
bam-12939	23	2	criteria	criterion	NOUN
bam-12939	23	3	the	the	DET
bam-12939	23	4	study	study	NOUN
bam-12939	23	5	excluded	exclude	VERB
bam-12939	23	6	:	:	PUNCT
bam-12939	23	7	i	i	PRON
bam-12939	23	8	)	)	PUNCT
bam-12939	23	9	patients	patient	NOUN
bam-12939	23	10	in	in	ADP
bam-12939	23	11	other	other	ADJ
bam-12939	23	12	phases	phase	NOUN
bam-12939	23	13	of	of	ADP
bam-12939	23	14	rrms	rrm	NOUN
bam-12939	23	15	except	except	SCONJ
bam-12939	23	16	relapse	relapse	NOUN
bam-12939	23	17	;	;	PUNCT
bam-12939	23	18	ii	ii	X
bam-12939	23	19	)	)	PUNCT
bam-12939	23	20	patients	patient	NOUN
bam-12939	23	21	with	with	ADP
bam-12939	23	22	diabetes	diabetes	NOUN
bam-12939	23	23	,	,	PUNCT
bam-12939	23	24	liver	liver	NOUN
bam-12939	23	25	disease	disease	NOUN
bam-12939	23	26	(	(	PUNCT
bam-12939	23	27	cirrhosis	cirrhosis	NOUN
bam-12939	23	28	and	and	CCONJ
bam-12939	23	29	types	type	NOUN
bam-12939	23	30	of	of	ADP
bam-12939	23	31	hepatitis	hepatitis	NOUN
bam-12939	23	32	)	)	PUNCT
bam-12939	23	33	,	,	PUNCT
bam-12939	23	34	kidney	kidney	NOUN
bam-12939	23	35	disease	disease	NOUN
bam-12939	23	36	,	,	PUNCT
bam-12939	23	37	congestive	congestive	ADJ
bam-12939	23	38	heart	heart	NOUN
bam-12939	23	39	failure	failure	NOUN
bam-12939	23	40	,	,	PUNCT
bam-12939	23	41	high	high	ADJ
bam-12939	23	42	blood	blood	NOUN
bam-12939	23	43	pressure	pressure	NOUN
bam-12939	23	44	,	,	PUNCT
bam-12939	23	45	and	and	CCONJ
bam-12939	23	46	cancer	cancer	NOUN
bam-12939	23	47	;	;	PUNCT
bam-12939	23	48	iii	iii	X
bam-12939	23	49	)	)	PUNCT
bam-12939	23	50	taking	take	VERB
bam-12939	23	51	other	other	ADJ
bam-12939	23	52	drugmedications	drugmedication	NOUN
bam-12939	23	53	.	.	PUNCT
bam-12939	24	1	in	in	ADP
bam-12939	24	2	the	the	DET
bam-12939	24	3	present	present	ADJ
bam-12939	24	4	case	case	NOUN
bam-12939	24	5	/	/	SYM
bam-12939	24	6	control	control	NOUN
bam-12939	24	7	study	study	NOUN
bam-12939	24	8	,	,	PUNCT
bam-12939	24	9	25	25	NUM
bam-12939	24	10	patients	patient	NOUN
bam-12939	24	11	(	(	PUNCT
bam-12939	24	12	female	female	NOUN
bam-12939	24	13	:	:	PUNCT
bam-12939	24	14	17	17	NUM
bam-12939	24	15	;	;	PUNCT
bam-12939	24	16	male	male	NOUN
bam-12939	24	17	:	:	PUNCT
bam-12939	24	18	7	7	NUM
bam-12939	24	19	;	;	PUNCT
bam-12939	24	20	mean	mean	ADJ
bam-12939	24	21	age	age	NOUN
bam-12939	24	22	:	:	PUNCT
bam-12939	24	23	32.16±5.87	32.16±5.87	NUM
bam-12939	24	24	years	year	NOUN
bam-12939	24	25	)	)	PUNCT
bam-12939	24	26	with	with	ADP
bam-12939	24	27	rrms	rrm	NOUN
bam-12939	24	28	(	(	PUNCT
bam-12939	24	29	test	test	NOUN
bam-12939	24	30	group	group	NOUN
bam-12939	24	31	)	)	PUNCT
bam-12939	24	32	and	and	CCONJ
bam-12939	24	33	12	12	NUM
bam-12939	24	34	healthy	healthy	ADJ
bam-12939	24	35	individuals	individual	NOUN
bam-12939	24	36	(	(	PUNCT
bam-12939	24	37	female	female	NOUN
bam-12939	24	38	:	:	PUNCT
bam-12939	24	39	5	5	NUM
bam-12939	24	40	;	;	PUNCT
bam-12939	24	41	male	male	NOUN
bam-12939	24	42	:	:	PUNCT
bam-12939	24	43	7	7	NUM
bam-12939	24	44	;	;	PUNCT
bam-12939	24	45	mean	mean	ADJ
bam-12939	24	46	age	age	NOUN
bam-12939	24	47	:	:	PUNCT
bam-12939	24	48	31	31	NUM
bam-12939	24	49	.58±8.14	.58±8.14	NOUN
bam-12939	24	50	years	year	NOUN
bam-12939	24	51	;	;	PUNCT
bam-12939	24	52	control	control	NOUN
bam-12939	24	53	group	group	NOUN
bam-12939	24	54	)	)	PUNCT
bam-12939	24	55	were	be	AUX
bam-12939	24	56	evaluated	evaluate	VERB
bam-12939	24	57	between	between	ADP
bam-12939	24	58	2021	2021	NUM
bam-12939	24	59	and	and	CCONJ
bam-12939	24	60	2023	2023	NUM
bam-12939	24	61	.	.	PUNCT
bam-12939	25	1	all	all	DET
bam-12939	25	2	study	study	NOUN
bam-12939	25	3	participants	participant	NOUN
bam-12939	25	4	gave	gave	AUX
bam-12939	25	5	written	write	VERB
bam-12939	25	6	informed	informed	ADJ
bam-12939	25	7	consent	consent	NOUN
bam-12939	25	8	and	and	CCONJ
bam-12939	25	9	stated	state	VERB
bam-12939	25	10	that	that	SCONJ
bam-12939	25	11	there	there	PRON
bam-12939	25	12	would	would	AUX
bam-12939	25	13	be	be	AUX
bam-12939	25	14	no	no	DET
bam-12939	25	15	additional	additional	ADJ
bam-12939	25	16	costs	cost	NOUN
bam-12939	25	17	,	,	PUNCT
bam-12939	25	18	threats	threat	NOUN
bam-12939	25	19	or	or	CCONJ
bam-12939	25	20	problems	problem	NOUN
bam-12939	25	21	imposed	impose	VERB
bam-12939	25	22	on	on	ADP
bam-12939	25	23	them	they	PRON
bam-12939	25	24	by	by	ADP
bam-12939	25	25	the	the	DET
bam-12939	25	26	study	study	NOUN
bam-12939	25	27	.	.	PUNCT
bam-12939	26	1	if	if	SCONJ
bam-12939	26	2	they	they	PRON
bam-12939	26	3	were	be	AUX
bam-12939	26	4	unable	unable	ADJ
bam-12939	26	5	to	to	PART
bam-12939	26	6	cooperate	cooperate	VERB
bam-12939	26	7	and	and	CCONJ
bam-12939	26	8	continue	continue	VERB
bam-12939	26	9	to	to	PART
bam-12939	26	10	participate	participate	VERB
bam-12939	26	11	,	,	PUNCT
bam-12939	26	12	they	they	PRON
bam-12939	26	13	were	be	AUX
bam-12939	26	14	excluded	exclude	VERB
bam-12939	26	15	from	from	ADP
bam-12939	26	16	the	the	DET
bam-12939	26	17	study	study	NOUN
bam-12939	26	18	without	without	ADP
bam-12939	26	19	negligence	negligence	NOUN
bam-12939	26	20	.	.	PUNCT
bam-12939	27	1	data	datum	NOUN
bam-12939	27	2	collection	collection	NOUN
bam-12939	27	3	:	:	PUNCT
bam-12939	27	4	methods	method	NOUN
bam-12939	27	5	,	,	PUNCT
bam-12939	27	6	process	process	NOUN
bam-12939	27	7	,	,	PUNCT
bam-12939	27	8	and	and	CCONJ
bam-12939	27	9	tools	tool	NOUN
bam-12939	27	10	in	in	ADP
bam-12939	27	11	the	the	DET
bam-12939	27	12	present	present	ADJ
bam-12939	27	13	study	study	NOUN
bam-12939	27	14	,	,	PUNCT
bam-12939	27	15	a	a	DET
bam-12939	27	16	questionnaire	questionnaire	NOUN
bam-12939	27	17	was	be	AUX
bam-12939	27	18	used	use	VERB
bam-12939	27	19	to	to	PART
bam-12939	27	20	collect	collect	VERB
bam-12939	27	21	demographic	demographic	ADJ
bam-12939	27	22	and	and	CCONJ
bam-12939	27	23	clinical	clinical	ADJ
bam-12939	27	24	information	information	NOUN
bam-12939	27	25	,	,	PUNCT
bam-12939	27	26	including	include	VERB
bam-12939	27	27	age	age	NOUN
bam-12939	27	28	of	of	ADP
bam-12939	27	29	onset	onset	NOUN
bam-12939	27	30	(	(	PUNCT
bam-12939	27	31	years	year	NOUN
bam-12939	27	32	)	)	PUNCT
bam-12939	27	33	,	,	PUNCT
bam-12939	27	34	duration	duration	NOUN
bam-12939	27	35	of	of	ADP
bam-12939	27	36	ms	ms	PROPN
bam-12939	27	37	disease	disease	NOUN
bam-12939	27	38	(	(	PUNCT
bam-12939	27	39	months	month	NOUN
bam-12939	27	40	)	)	PUNCT
bam-12939	27	41	,	,	PUNCT
bam-12939	27	42	comprehensive	comprehensive	ADJ
bam-12939	27	43	disability	disability	NOUN
bam-12939	27	44	status	status	NOUN
bam-12939	27	45	scale	scale	NOUN
bam-12939	27	46	(	(	PUNCT
bam-12939	27	47	edss/1	edss/1	PROPN
bam-12939	27	48	-	-	SYM
bam-12939	27	49	3	3	NUM
bam-12939	27	50	)	)	PUNCT
bam-12939	27	51	score	score	NOUN
bam-12939	27	52	,	,	PUNCT
bam-12939	27	53	and	and	CCONJ
bam-12939	27	54	the	the	DET
bam-12939	27	55	severity	severity	NOUN
bam-12939	27	56	of	of	ADP
bam-12939	27	57	the	the	DET
bam-12939	27	58	multiple	multiple	ADJ
bam-12939	27	59	sclerosis	sclerosis	NOUN
bam-12939	27	60	scores	score	NOUN
bam-12939	27	61	(	(	PUNCT
bam-12939	27	62	msss	msss	PROPN
bam-12939	27	63	)	)	PUNCT
bam-12939	27	64	,	,	PUNCT
bam-12939	27	65	the	the	DET
bam-12939	27	66	annual	annual	ADJ
bam-12939	27	67	recurrence	recurrence	NOUN
bam-12939	27	68	rate	rate	NOUN
bam-12939	27	69	since	since	SCONJ
bam-12939	27	70	the	the	DET
bam-12939	27	71	beginning	beginning	NOUN
bam-12939	27	72	of	of	ADP
bam-12939	27	73	the	the	DET
bam-12939	27	74	year	year	NOUN
bam-12939	27	75	of	of	ADP
bam-12939	27	76	this	this	DET
bam-12939	27	77	disease	disease	NOUN
bam-12939	27	78	,	,	PUNCT
bam-12939	27	79	the	the	DET
bam-12939	27	80	number	number	NOUN
bam-12939	27	81	of	of	ADP
bam-12939	27	82	recurrences	recurrence	NOUN
bam-12939	27	83	two	two	NUM
bam-12939	27	84	years	year	NOUN
bam-12939	27	85	ago	ago	ADV
bam-12939	27	86	and	and	CCONJ
bam-12939	27	87	doctors	doctor	NOUN
bam-12939	27	88	at	at	ADP
bam-12939	27	89	the	the	DET
bam-12939	27	90	time	time	NOUN
bam-12939	27	91	of	of	ADP
bam-12939	27	92	conducting	conduct	VERB
bam-12939	27	93	the	the	DET
bam-12939	27	94	research	research	NOUN
bam-12939	27	95	,	,	PUNCT
bam-12939	27	96	gender	gender	NOUN
bam-12939	27	97	,	,	PUNCT
bam-12939	27	98	disease	disease	NOUN
bam-12939	27	99	and	and	CCONJ
bam-12939	27	100	smoking	smoking	NOUN
bam-12939	27	101	history	history	NOUN
bam-12939	27	102	,	,	PUNCT
bam-12939	27	103	vitamin	vitamin	NOUN
bam-12939	27	104	d	d	NOUN
bam-12939	27	105	consumption	consumption	NOUN
bam-12939	27	106	in	in	ADP
bam-12939	27	107	the	the	DET
bam-12939	27	108	last	last	ADJ
bam-12939	27	109	6	6	NUM
bam-12939	27	110	months.15	months.15	NOUN
bam-12939	27	111	msss	msss	NOUN
bam-12939	27	112	is	be	AUX
bam-12939	27	113	a	a	DET
bam-12939	27	114	useful	useful	ADJ
bam-12939	27	115	measure	measure	NOUN
bam-12939	27	116	of	of	ADP
bam-12939	27	117	ms	ms	NOUN
bam-12939	27	118	severity	severity	NOUN
bam-12939	27	119	that	that	PRON
bam-12939	27	120	includes	include	VERB
bam-12939	27	121	edss	edss	ADV
bam-12939	27	122	and	and	CCONJ
bam-12939	27	123	disease	disease	NOUN
bam-12939	27	124	duration	duration	NOUN
bam-12939	27	125	.	.	PUNCT
bam-12939	28	1	achieving	achieve	VERB
bam-12939	28	2	an	an	DET
bam-12939	28	3	msss	msss	NOUN
bam-12939	28	4	score	score	NOUN
bam-12939	28	5	≥	≥	NOUN
bam-12939	28	6	4.8	4.8	NUM
bam-12939	28	7	indicates	indicate	VERB
bam-12939	28	8	a	a	DET
bam-12939	28	9	severe	severe	ADJ
bam-12939	28	10	phase	phase	NOUN
bam-12939	28	11	of	of	ADP
bam-12939	28	12	the	the	DET
bam-12939	28	13	disease	disease	NOUN
bam-12939	28	14	,	,	PUNCT
bam-12939	28	15	and	and	CCONJ
bam-12939	28	16	an	an	DET
bam-12939	28	17	msss	msss	NOUN
bam-12939	28	18	<	<	X
bam-12939	28	19	4.8	4.8	NUM
bam-12939	28	20	indicates	indicate	VERB
bam-12939	28	21	a	a	DET
bam-12939	28	22	mild	mild	ADJ
bam-12939	28	23	phase	phase	NOUN
bam-12939	28	24	of	of	ADP
bam-12939	28	25	the	the	DET
bam-12939	28	26	disease.15	disease.15	NOUN
bam-12939	28	27	peripheral	peripheral	ADJ
bam-12939	28	28	blood	blood	NOUN
bam-12939	28	29	(	(	PUNCT
bam-12939	28	30	5	5	NUM
bam-12939	28	31	ml	ml	NOUN
bam-12939	28	32	)	)	PUNCT
bam-12939	28	33	samples	sample	NOUN
bam-12939	28	34	with	with	ADP
bam-12939	28	35	edta	edta	NOUN
bam-12939	28	36	were	be	AUX
bam-12939	28	37	collected	collect	VERB
bam-12939	28	38	from	from	ADP
bam-12939	28	39	rrms	rrm	NOUN
bam-12939	28	40	patients	patient	NOUN
bam-12939	28	41	and	and	CCONJ
bam-12939	28	42	healthy	healthy	ADJ
bam-12939	28	43	volunteers	volunteer	NOUN
bam-12939	28	44	(	(	PUNCT
bam-12939	28	45	from	from	ADP
bam-12939	28	46	8	8	NUM
bam-12939	28	47	am	am	NOUN
bam-12939	28	48	to	to	ADP
bam-12939	28	49	11	11	NUM
bam-12939	28	50	am	am	NOUN
bam-12939	28	51	)	)	PUNCT
bam-12939	28	52	.	.	PUNCT
bam-12939	29	1	two	two	NUM
bam-12939	29	2	blood	blood	NOUN
bam-12939	29	3	collection	collection	NOUN
bam-12939	29	4	tubes	tube	NOUN
bam-12939	29	5	containing	contain	VERB
bam-12939	29	6	sodium	sodium	NOUN
bam-12939	29	7	citrate	citrate	NOUN
bam-12939	29	8	were	be	AUX
bam-12939	29	9	used	use	VERB
bam-12939	29	10	for	for	ADP
bam-12939	29	11	cell	cell	NOUN
bam-12939	29	12	and	and	CCONJ
bam-12939	29	13	plasma	plasma	NOUN
bam-12939	29	14	separation	separation	NOUN
bam-12939	29	15	.	.	PUNCT
bam-12939	30	1	peripheral	peripheral	ADJ
bam-12939	30	2	blood	blood	NOUN
bam-12939	30	3	mononuclear	mononuclear	ADJ
bam-12939	30	4	cells	cell	NOUN
bam-12939	30	5	(	(	PUNCT
bam-12939	30	6	pbmc	pbmc	NOUN
bam-12939	30	7	)	)	PUNCT
bam-12939	30	8	were	be	AUX
bam-12939	30	9	isolated	isolate	VERB
bam-12939	30	10	using	use	VERB
bam-12939	30	11	gradient	gradient	ADJ
bam-12939	30	12	centrifugation	centrifugation	NOUN
bam-12939	30	13	(	(	PUNCT
bam-12939	30	14	920	920	NUM
bam-12939	30	15	g	g	NOUN
bam-12939	30	16	,	,	PUNCT
bam-12939	30	17	30	30	NUM
bam-12939	30	18	min	min	NOUN
bam-12939	30	19	)	)	PUNCT
bam-12939	30	20	.	.	PUNCT
bam-12939	31	1	they	they	PRON
bam-12939	31	2	were	be	AUX
bam-12939	31	3	frozen	freeze	VERB
bam-12939	31	4	in	in	ADP
bam-12939	31	5	serum	serum	NOUN
bam-12939	31	6	(	(	PUNCT
bam-12939	31	7	fbs	fbs	PROPN
bam-12939	31	8	)	)	PUNCT
bam-12939	31	9	with	with	ADP
bam-12939	31	10	dmso	dmso	NOUN
bam-12939	31	11	(	(	PUNCT
bam-12939	31	12	10	10	NUM
bam-12939	31	13	%	%	NOUN
bam-12939	31	14	)	)	PUNCT
bam-12939	31	15	and	and	CCONJ
bam-12939	31	16	stored	store	VERB
bam-12939	31	17	in	in	ADP
bam-12939	31	18	liquid	liquid	ADJ
bam-12939	31	19	nitrogen	nitrogen	NOUN
bam-12939	31	20	(	(	PUNCT
bam-12939	31	21	−196	−196	NOUN
bam-12939	31	22	°	°	PROPN
bam-12939	31	23	c	c	PROPN
bam-12939	31	24	)	)	PUNCT
bam-12939	31	25	.	.	PUNCT
bam-12939	32	1	the	the	DET
bam-12939	32	2	serum	serum	NOUN
bam-12939	32	3	was	be	AUX
bam-12939	32	4	separated	separate	VERB
bam-12939	32	5	into	into	ADP
bam-12939	32	6	serum	serum	NOUN
bam-12939	32	7	separation	separation	NOUN
bam-12939	32	8	tubes	tube	NOUN
bam-12939	32	9	by	by	ADP
bam-12939	32	10	centrifugation	centrifugation	NOUN
bam-12939	32	11	(	(	PUNCT
bam-12939	32	12	920	920	NUM
bam-12939	32	13	g	g	NOUN
bam-12939	32	14	,	,	PUNCT
bam-12939	32	15	15	15	NUM
bam-12939	32	16	min	min	NOUN
bam-12939	32	17	,	,	PUNCT
bam-12939	32	18	room	room	NOUN
bam-12939	32	19	temperature	temperature	NOUN
bam-12939	32	20	)	)	PUNCT
bam-12939	32	21	.	.	PUNCT
bam-12939	33	1	after	after	ADP
bam-12939	33	2	centrifugation	centrifugation	NOUN
bam-12939	33	3	,	,	PUNCT
bam-12939	33	4	the	the	DET
bam-12939	33	5	plasma	plasma	NOUN
bam-12939	33	6	and	and	CCONJ
bam-12939	33	7	serum	serum	NOUN
bam-12939	33	8	samples	sample	NOUN
bam-12939	33	9	were	be	AUX
bam-12939	33	10	divided	divide	VERB
bam-12939	33	11	into	into	ADP
bam-12939	33	12	individual	individual	ADJ
bam-12939	33	13	parts	part	NOUN
bam-12939	33	14	and	and	CCONJ
bam-12939	33	15	stored	store	VERB
bam-12939	33	16	at	at	ADP
bam-12939	33	17	a	a	DET
bam-12939	33	18	temperature	temperature	NOUN
bam-12939	33	19	of	of	ADP
bam-12939	33	20	−80	−80	PROPN
bam-12939	33	21	°	°	ADP
bam-12939	33	22	c	c	NOUN
bam-12939	33	23	.	.	PUNCT
bam-12939	34	1	the	the	DET
bam-12939	34	2	redirection	redirection	NOUN
bam-12939	34	3	fragment	fragment	NOUN
bam-12939	34	4	length	length	NOUN
bam-12939	34	5	polymorphism	polymorphism	NOUN
bam-12939	34	6	(	(	PUNCT
bam-12939	34	7	pcrrflp	pcrrflp	ADJ
bam-12939	34	8	)	)	PUNCT
bam-12939	34	9	technique	technique	NOUN
bam-12939	34	10	was	be	AUX
bam-12939	34	11	used	use	VERB
bam-12939	34	12	,	,	PUNCT
bam-12939	34	13	which	which	PRON
bam-12939	34	14	is	be	AUX
bam-12939	34	15	one	one	NUM
bam-12939	34	16	of	of	ADP
bam-12939	34	17	the	the	DET
bam-12939	34	18	standard	standard	ADJ
bam-12939	34	19	methods	method	NOUN
bam-12939	34	20	for	for	ADP
bam-12939	34	21	identifying	identify	VERB
bam-12939	34	22	polymorphisms	polymorphism	NOUN
bam-12939	34	23	.	.	PUNCT
bam-12939	35	1	for	for	ADP
bam-12939	35	2	this	this	DET
bam-12939	35	3	purpose	purpose	NOUN
bam-12939	35	4	,	,	PUNCT
bam-12939	35	5	the	the	DET
bam-12939	35	6	pcr	pcr	ADJ
bam-12939	35	7	product	product	NOUN
bam-12939	35	8	was	be	AUX
bam-12939	35	9	mixed	mix	VERB
bam-12939	35	10	with	with	ADP
bam-12939	35	11	restriction	restriction	NOUN
bam-12939	35	12	enzymes	enzyme	NOUN
bam-12939	35	13	according	accord	VERB
bam-12939	35	14	to	to	ADP
bam-12939	35	15	the	the	DET
bam-12939	35	16	manufacturer	manufacturer	NOUN
bam-12939	35	17	’s	’s	PART
bam-12939	35	18	instructions	instruction	NOUN
bam-12939	35	19	and	and	CCONJ
bam-12939	35	20	the	the	DET
bam-12939	35	21	best	good	ADJ
bam-12939	35	22	temperature	temperature	NOUN
bam-12939	35	23	for	for	ADP
bam-12939	35	24	cutting	cut	VERB
bam-12939	35	25	was	be	AUX
bam-12939	35	26	chosen	choose	VERB
bam-12939	35	27	according	accord	VERB
bam-12939	35	28	to	to	ADP
bam-12939	35	29	the	the	DET
bam-12939	35	30	cutting	cutting	NOUN
bam-12939	35	31	time	time	NOUN
bam-12939	35	32	of	of	ADP
bam-12939	35	33	the	the	DET
bam-12939	35	34	enzyme	enzyme	NOUN
bam-12939	35	35	in	in	ADP
bam-12939	35	36	the	the	DET
bam-12939	35	37	instructions	instruction	NOUN
bam-12939	35	38	.	.	PUNCT
bam-12939	36	1	after	after	SCONJ
bam-12939	36	2	the	the	DET
bam-12939	36	3	product	product	NOUN
bam-12939	36	4	was	be	AUX
bam-12939	36	5	incubated	incubate	VERB
bam-12939	36	6	,	,	PUNCT
bam-12939	36	7	it	it	PRON
bam-12939	36	8	was	be	AUX
bam-12939	36	9	electrophoresed	electrophorese	VERB
bam-12939	36	10	on	on	ADP
bam-12939	36	11	a	a	DET
bam-12939	36	12	2	2	NUM
bam-12939	36	13	%	%	NOUN
bam-12939	36	14	agarose	agarose	NOUN
bam-12939	36	15	gel	gel	NOUN
bam-12939	36	16	.	.	PUNCT
bam-12939	37	1	based	base	VERB
bam-12939	37	2	on	on	ADP
bam-12939	37	3	the	the	DET
bam-12939	37	4	pattern	pattern	NOUN
bam-12939	37	5	of	of	ADP
bam-12939	37	6	restriction	restriction	NOUN
bam-12939	37	7	enzyme	enzyme	NOUN
bam-12939	37	8	cleavage	cleavage	NOUN
bam-12939	37	9	,	,	PUNCT
bam-12939	37	10	the	the	DET
bam-12939	37	11	different	different	ADJ
bam-12939	37	12	polymorphisms	polymorphism	NOUN
bam-12939	37	13	of	of	ADP
bam-12939	37	14	the	the	DET
bam-12939	37	15	vdr	vdr	NOUN
bam-12939	37	16	examined	examine	VERB
bam-12939	37	17	in	in	ADP
bam-12939	37	18	each	each	DET
bam-12939	37	19	participant	participant	NOUN
bam-12939	37	20	were	be	AUX
bam-12939	37	21	separated	separate	VERB
bam-12939	37	22	using	use	VERB
bam-12939	37	23	the	the	DET
bam-12939	37	24	gel	gel	NOUN
bam-12939	37	25	device	device	NOUN
bam-12939	37	26	and	and	CCONJ
bam-12939	37	27	photographed	photograph	VERB
bam-12939	37	28	.	.	PUNCT
bam-12939	38	1	documentation	documentation	NOUN
bam-12939	38	2	has	have	AUX
bam-12939	38	3	been	be	AUX
bam-12939	38	4	created	create	VERB
bam-12939	38	5	.	.	PUNCT
bam-12939	39	1	the	the	DET
bam-12939	39	2	adipocytes	adipocyte	NOUN
bam-12939	39	3	were	be	AUX
bam-12939	39	4	quantified	quantify	VERB
bam-12939	39	5	using	use	VERB
bam-12939	39	6	elisa	elisa	NOUN
bam-12939	39	7	.	.	PUNCT
bam-12939	40	1	the	the	DET
bam-12939	40	2	samples	sample	NOUN
bam-12939	40	3	were	be	AUX
bam-12939	40	4	diluted	dilute	VERB
bam-12939	40	5	1:5,000	1:5,000	NUM
bam-12939	40	6	to	to	ADP
bam-12939	40	7	1:10,000	1:10,000	NUM
bam-12939	40	8	for	for	ADP
bam-12939	40	9	adiponectin	adiponectin	NOUN
bam-12939	40	10	and	and	CCONJ
bam-12939	40	11	1:40	1:40	NUM
bam-12939	40	12	for	for	ADP
bam-12939	40	13	leptin	leptin	NOUN
bam-12939	40	14	(	(	PUNCT
bam-12939	40	15	human	human	ADJ
bam-12939	40	16	abts	abts	PROPN
bam-12939	40	17	standard	standard	PROPN
bam-12939	40	18	development	development	PROPN
bam-12939	40	19	kit	kit	PROPN
bam-12939	40	20	,	,	PUNCT
bam-12939	40	21	peprotech	peprotech	NOUN
bam-12939	40	22	,	,	PUNCT
bam-12939	40	23	london	london	PROPN
bam-12939	40	24	,	,	PUNCT
bam-12939	40	25	uk	uk	PROPN
bam-12939	40	26	)	)	PUNCT
bam-12939	40	27	and	and	CCONJ
bam-12939	40	28	randomly	randomly	ADV
bam-12939	40	29	distributed	distribute	VERB
bam-12939	40	30	among	among	ADP
bam-12939	40	31	the	the	DET
bam-12939	40	32	plates	plate	NOUN
bam-12939	40	33	.	.	PUNCT
bam-12939	41	1	samples	sample	NOUN
bam-12939	41	2	from	from	ADP
bam-12939	41	3	each	each	DET
bam-12939	41	4	participant	participant	NOUN
bam-12939	41	5	were	be	AUX
bam-12939	41	6	analyzed	analyze	VERB
bam-12939	41	7	in	in	ADP
bam-12939	41	8	duplicate	duplicate	NOUN
bam-12939	41	9	in	in	ADP
bam-12939	41	10	one	one	NUM
bam-12939	41	11	run	run	NOUN
bam-12939	41	12	,	,	PUNCT
bam-12939	41	13	and	and	CCONJ
bam-12939	41	14	each	each	DET
bam-12939	41	15	plate	plate	NOUN
bam-12939	41	16	contained	contain	VERB
bam-12939	41	17	a	a	DET
bam-12939	41	18	sample	sample	NOUN
bam-12939	41	19	from	from	ADP
bam-12939	41	20	a	a	DET
bam-12939	41	21	control	control	NOUN
bam-12939	41	22	donor	donor	NOUN
bam-12939	41	23	to	to	PART
bam-12939	41	24	control	control	VERB
bam-12939	41	25	within	within	ADP
bam-12939	41	26	-	-	PUNCT
bam-12939	41	27	assay	assay	NOUN
bam-12939	41	28	variability	variability	NOUN
bam-12939	41	29	.	.	PUNCT
bam-12939	42	1	the	the	DET
bam-12939	42	2	interand	interand	NOUN
bam-12939	42	3	intraassay	intraassay	NOUN
bam-12939	42	4	variability	variability	NOUN
bam-12939	42	5	was	be	AUX
bam-12939	42	6	29	29	NUM
bam-12939	42	7	%	%	NOUN
bam-12939	42	8	and	and	CCONJ
bam-12939	42	9	21	21	NUM
bam-12939	42	10	%	%	NOUN
bam-12939	42	11	,	,	PUNCT
bam-12939	42	12	respectively	respectively	ADV
bam-12939	42	13	,	,	PUNCT
bam-12939	42	14	for	for	ADP
bam-12939	42	15	leptin	leptin	NOUN
bam-12939	42	16	and	and	CCONJ
bam-12939	42	17	12	12	NUM
bam-12939	42	18	%	%	NOUN
bam-12939	42	19	and	and	CCONJ
bam-12939	42	20	11	11	NUM
bam-12939	42	21	%	%	NOUN
bam-12939	42	22	,	,	PUNCT
bam-12939	42	23	respectively	respectively	ADV
bam-12939	42	24	,	,	PUNCT
bam-12939	42	25	for	for	ADP
bam-12939	42	26	adiponectin	adiponectin	NOUN
bam-12939	42	27	.	.	PUNCT
bam-12939	43	1	serum	serum	NOUN
bam-12939	43	2	levels	level	NOUN
bam-12939	43	3	of	of	ADP
bam-12939	43	4	interleukin-6	interleukin-6	PROPN
bam-12939	43	5	(	(	PUNCT
bam-12939	43	6	il-6	il-6	NOUN
bam-12939	43	7	)	)	PUNCT
bam-12939	43	8	were	be	AUX
bam-12939	43	9	measured	measure	VERB
bam-12939	43	10	using	use	VERB
bam-12939	43	11	the	the	DET
bam-12939	43	12	single	single	ADJ
bam-12939	43	13	molecule	molecule	NOUN
bam-12939	43	14	array	array	NOUN
bam-12939	43	15	method	method	NOUN
bam-12939	43	16	(	(	PUNCT
bam-12939	43	17	simoa	simoa	PROPN
bam-12939	43	18	)	)	PUNCT
bam-12939	43	19	.	.	PUNCT
bam-12939	44	1	whole	whole	ADJ
bam-12939	44	2	blood	blood	NOUN
bam-12939	44	3	was	be	AUX
bam-12939	44	4	collected	collect	VERB
bam-12939	44	5	into	into	ADP
bam-12939	44	6	paxgene	paxgene	ADJ
bam-12939	44	7	tubes	tube	NOUN
bam-12939	44	8	and	and	CCONJ
bam-12939	44	9	total	total	ADJ
bam-12939	44	10	rna	rna	NOUN
bam-12939	44	11	was	be	AUX
bam-12939	44	12	extracted	extract	VERB
bam-12939	44	13	using	use	VERB
bam-12939	44	14	the	the	DET
bam-12939	44	15	paxgene	paxgene	ADJ
bam-12939	44	16	blood	blood	NOUN
bam-12939	44	17	mirna	mirna	PROPN
bam-12939	44	18	kit	kit	PROPN
bam-12939	44	19	.	.	PUNCT
bam-12939	45	1	one	one	NUM
bam-12939	45	2	microgram	microgram	NOUN
bam-12939	45	3	of	of	ADP
bam-12939	45	4	rna	rna	PROPN
bam-12939	45	5	was	be	AUX
bam-12939	45	6	then	then	ADV
bam-12939	45	7	reverse	reverse	VERB
bam-12939	45	8	transcribed	transcribed	NOUN
bam-12939	45	9	using	use	VERB
bam-12939	45	10	a	a	DET
bam-12939	45	11	high	high	ADJ
bam-12939	45	12	-	-	PUNCT
bam-12939	45	13	capacity	capacity	NOUN
bam-12939	45	14	cdna	cdna	NOUN
bam-12939	45	15	reverse	reverse	NOUN
bam-12939	45	16	transcription	transcription	NOUN
bam-12939	45	17	kit	kit	NOUN
bam-12939	45	18	(	(	PUNCT
bam-12939	45	19	life	life	NOUN
bam-12939	45	20	technologies	technology	NOUN
bam-12939	45	21	europe	europe	PROPN
bam-12939	45	22	b.v	b.v	PROPN
bam-12939	45	23	.	.	PROPN
bam-12939	45	24	)	)	PUNCT
bam-12939	45	25	.	.	PUNCT
bam-12939	46	1	using	use	VERB
bam-12939	46	2	taqman	taqman	NOUN
bam-12939	46	3	technology	technology	NOUN
bam-12939	46	4	,	,	PUNCT
bam-12939	46	5	duplicate	duplicate	VERB
bam-12939	46	6	qpcr	qpcr	ADV
bam-12939	46	7	was	be	AUX
bam-12939	46	8	performed	perform	VERB
bam-12939	46	9	on	on	ADP
bam-12939	46	10	cdna	cdna	PROPN
bam-12939	46	11	diluted	dilute	VERB
bam-12939	46	12	1:1	1:1	NUM
bam-12939	46	13	(	(	PUNCT
bam-12939	46	14	il10	il10	PROPN
bam-12939	46	15	)	)	PUNCT
bam-12939	46	16	,	,	PUNCT
bam-12939	46	17	1:10	1:10	NUM
bam-12939	46	18	,	,	PUNCT
bam-12939	46	19	or	or	CCONJ
bam-12939	46	20	1:50	1:50	NUM
bam-12939	46	21	with	with	ADP
bam-12939	46	22	taqman	taqman	NOUN
bam-12939	46	23	universal	universal	ADJ
bam-12939	46	24	fast	fast	ADJ
bam-12939	46	25	pcr	pcr	PROPN
bam-12939	46	26	master	master	NOUN
bam-12939	46	27	.	.	PUNCT
bam-12939	47	1	serum	serum	NOUN
bam-12939	47	2	and	and	CCONJ
bam-12939	47	3	plasma	plasma	NOUN
bam-12939	47	4	samples	sample	NOUN
bam-12939	47	5	were	be	AUX
bam-12939	47	6	used	use	VERB
bam-12939	47	7	to	to	PART
bam-12939	47	8	evaluate	evaluate	VERB
bam-12939	47	9	adipokine	adipokine	NOUN
bam-12939	47	10	and	and	CCONJ
bam-12939	47	11	adiponectin	adiponectin	NOUN
bam-12939	47	12	.	.	PUNCT
bam-12939	48	1	first	first	ADJ
bam-12939	48	2	scfa	scfa	PROPN
bam-12939	48	3	concentrations	concentration	NOUN
bam-12939	48	4	were	be	AUX
bam-12939	48	5	examined	examine	VERB
bam-12939	48	6	and	and	CCONJ
bam-12939	48	7	metabolic	metabolic	NOUN
bam-12939	48	8	pathways	pathway	NOUN
bam-12939	48	9	associated	associate	VERB
bam-12939	48	10	with	with	ADP
bam-12939	48	11	inflammatory	inflammatory	ADJ
bam-12939	48	12	biomarkers	biomarker	NOUN
bam-12939	48	13	and	and	CCONJ
bam-12939	48	14	clinical	clinical	ADJ
bam-12939	48	15	variables	variable	NOUN
bam-12939	48	16	were	be	AUX
bam-12939	48	17	examined	examine	VERB
bam-12939	48	18	in	in	ADP
bam-12939	48	19	two	two	NUM
bam-12939	48	20	cohorts	cohort	NOUN
bam-12939	48	21	:	:	PUNCT
bam-12939	48	22	a	a	DET
bam-12939	48	23	group	group	NOUN
bam-12939	48	24	of	of	ADP
bam-12939	48	25	individuals	individual	NOUN
bam-12939	48	26	without	without	ADP
bam-12939	48	27	health	health	NOUN
bam-12939	48	28	problems	problem	NOUN
bam-12939	48	29	and	and	CCONJ
bam-12939	48	30	a	a	DET
bam-12939	48	31	group	group	NOUN
bam-12939	48	32	of	of	ADP
bam-12939	48	33	individuals	individual	NOUN
bam-12939	48	34	diagnosed	diagnose	VERB
bam-12939	48	35	with	with	ADP
bam-12939	48	36	rrms	rrm	NOUN
bam-12939	48	37	.	.	PUNCT
bam-12939	49	1	34	34	NUM
bam-12939	49	2	non	non	ADJ
bam-12939	49	3	-co	-co	PROPN
bam-12939	49	4	mmerc	mmerc	PROPN
bam-12939	49	5	ial	ial	PROPN
bam-12939	49	6	us	us	PROPN
bam-12939	49	7	e	e	NOUN
bam-12939	49	8	o	o	NOUN
bam-12939	49	9	nly	nly	ADV
bam-12939	49	10	vitamin	vitamin	VERB
bam-12939	49	11	d	d	NOUN
bam-12939	49	12	receptor	receptor	NOUN
bam-12939	49	13	and	and	CCONJ
bam-12939	49	14	clinical	clinical	ADJ
bam-12939	49	15	and	and	CCONJ
bam-12939	49	16	inflammatory	inflammatory	ADJ
bam-12939	49	17	factors	factor	NOUN
bam-12939	49	18	in	in	ADP
bam-12939	49	19	patients	patient	NOUN
bam-12939	49	20	with	with	ADP
bam-12939	49	21	relapsing	relapse	VERB
bam-12939	49	22	-	-	PUNCT
bam-12939	49	23	remitting	remit	VERB
bam-12939	49	24	multiple	multiple	ADJ
bam-12939	49	25	sclerosis	sclerosis	NOUN
bam-12939	49	26	eur	eur	PROPN
bam-12939	49	27	j	j	PROPN
bam-12939	49	28	transl	transl	PROPN
bam-12939	49	29	myol	myol	NOUN
bam-12939	49	30	34	34	NUM
bam-12939	49	31	(	(	PUNCT
bam-12939	49	32	4	4	NUM
bam-12939	49	33	)	)	PUNCT
bam-12939	49	34	12939	12939	NUM
bam-12939	49	35	,	,	PUNCT
bam-12939	49	36	2024	2024	NUM
bam-12939	49	37	doi	doi	NOUN
bam-12939	49	38	:	:	PUNCT
bam-12939	49	39	10.4081	10.4081	NUM
bam-12939	49	40	/	/	SYM
bam-12939	49	41	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	49	42	statistical	statistical	ADJ
bam-12939	49	43	analysis	analysis	NOUN
bam-12939	49	44	was	be	AUX
bam-12939	49	45	performed	perform	VERB
bam-12939	49	46	using	use	VERB
bam-12939	49	47	spss	spss	PROPN
bam-12939	49	48	software	software	NOUN
bam-12939	49	49	version	version	NOUN
bam-12939	49	50	23	23	NUM
bam-12939	49	51	.	.	PUNCT
bam-12939	50	1	the	the	DET
bam-12939	50	2	p	p	NOUN
bam-12939	50	3	-	-	PUNCT
bam-12939	50	4	value	value	NOUN
bam-12939	50	5	less	less	ADJ
bam-12939	50	6	than	than	ADP
bam-12939	50	7	0.05	0.05	NUM
bam-12939	50	8	,	,	PUNCT
bam-12939	50	9	judged	judge	VERB
bam-12939	50	10	as	as	ADP
bam-12939	50	11	“	"	PUNCT
bam-12939	50	12	significant	significant	ADJ
bam-12939	50	13	,	,	PUNCT
bam-12939	50	14	to	to	PART
bam-12939	50	15	check	check	VERB
bam-12939	50	16	the	the	DET
bam-12939	50	17	normality	normality	NOUN
bam-12939	50	18	of	of	ADP
bam-12939	50	19	the	the	DET
bam-12939	50	20	data	datum	NOUN
bam-12939	50	21	,	,	PUNCT
bam-12939	50	22	the	the	DET
bam-12939	50	23	kolmogorovsmirnov	kolmogorovsmirnov	NOUN
bam-12939	50	24	test	test	NOUN
bam-12939	50	25	was	be	AUX
bam-12939	50	26	used	use	VERB
bam-12939	50	27	.	.	PUNCT
bam-12939	51	1	two	two	NUM
bam-12939	51	2	study	study	NOUN
bam-12939	51	3	groups	group	NOUN
bam-12939	51	4	were	be	AUX
bam-12939	51	5	examined	examine	VERB
bam-12939	51	6	for	for	ADP
bam-12939	51	7	demographic	demographic	ADJ
bam-12939	51	8	variables	variable	NOUN
bam-12939	51	9	.	.	PUNCT
bam-12939	52	1	to	to	PART
bam-12939	52	2	measure	measure	VERB
bam-12939	52	3	the	the	DET
bam-12939	52	4	relationship	relationship	NOUN
bam-12939	52	5	between	between	ADP
bam-12939	52	6	the	the	DET
bam-12939	52	7	factors	factor	NOUN
bam-12939	52	8	and	and	CCONJ
bam-12939	52	9	ms	ms	NOUN
bam-12939	52	10	risk	risk	NOUN
bam-12939	52	11	,	,	PUNCT
bam-12939	52	12	odds	odd	VERB
bam-12939	52	13	ratio	ratio	NOUN
bam-12939	52	14	and	and	CCONJ
bam-12939	52	15	95	95	NUM
bam-12939	52	16	%	%	NOUN
bam-12939	52	17	confidence	confidence	NOUN
bam-12939	52	18	limits	limit	NOUN
bam-12939	52	19	were	be	AUX
bam-12939	52	20	calculated	calculate	VERB
bam-12939	52	21	.	.	PUNCT
bam-12939	53	1	the	the	DET
bam-12939	53	2	relationship	relationship	NOUN
bam-12939	53	3	between	between	ADP
bam-12939	53	4	ms	ms	PROPN
bam-12939	53	5	patients	patient	NOUN
bam-12939	53	6	and	and	CCONJ
bam-12939	53	7	clinical	clinical	ADJ
bam-12939	53	8	factors	factor	NOUN
bam-12939	53	9	was	be	AUX
bam-12939	53	10	evaluated	evaluate	VERB
bam-12939	53	11	by	by	ADP
bam-12939	53	12	the	the	DET
bam-12939	53	13	chi	chi	ADJ
bam-12939	53	14	-	-	PUNCT
bam-12939	53	15	square	square	NOUN
bam-12939	53	16	test	test	NOUN
bam-12939	53	17	and	and	CCONJ
bam-12939	53	18	fisher	fisher	PROPN
bam-12939	53	19	’s	’s	PART
bam-12939	53	20	exact	exact	ADJ
bam-12939	53	21	test	test	NOUN
bam-12939	53	22	.	.	PUNCT
bam-12939	54	1	an	an	DET
bam-12939	54	2	odds	odd	NOUN
bam-12939	54	3	ratio	ratio	NOUN
bam-12939	54	4	and	and	CCONJ
bam-12939	54	5	95	95	NUM
bam-12939	54	6	%	%	NOUN
bam-12939	54	7	confidence	confidence	NOUN
bam-12939	54	8	limits	limit	NOUN
bam-12939	54	9	are	be	AUX
bam-12939	54	10	calculated	calculate	VERB
bam-12939	54	11	.	.	PUNCT
bam-12939	55	1	snp	snp	PROPN
bam-12939	55	2	analyzer	analyzer	PROPN
bam-12939	55	3	software	software	NOUN
bam-12939	55	4	was	be	AUX
bam-12939	55	5	used	use	VERB
bam-12939	55	6	to	to	PART
bam-12939	55	7	analyze	analyze	VERB
bam-12939	55	8	the	the	DET
bam-12939	55	9	frequency	frequency	NOUN
bam-12939	55	10	of	of	ADP
bam-12939	55	11	alleles	allele	NOUN
bam-12939	55	12	associated	associate	VERB
bam-12939	55	13	with	with	ADP
bam-12939	55	14	each	each	DET
bam-12939	55	15	polymorphism	polymorphism	NOUN
bam-12939	55	16	in	in	ADP
bam-12939	55	17	healthy	healthy	ADJ
bam-12939	55	18	and	and	CCONJ
bam-12939	55	19	diseased	diseased	ADJ
bam-12939	55	20	people	people	NOUN
bam-12939	55	21	and	and	CCONJ
bam-12939	55	22	compare	compare	VERB
bam-12939	55	23	the	the	DET
bam-12939	55	24	values	value	NOUN
bam-12939	55	25	.	.	PUNCT
bam-12939	56	1	results	result	VERB
bam-12939	56	2	the	the	DET
bam-12939	56	3	mean	mean	ADJ
bam-12939	56	4	age	age	NOUN
bam-12939	56	5	of	of	ADP
bam-12939	56	6	participants	participant	NOUN
bam-12939	56	7	in	in	ADP
bam-12939	56	8	the	the	DET
bam-12939	56	9	case	case	NOUN
bam-12939	56	10	and	and	CCONJ
bam-12939	56	11	control	control	NOUN
bam-12939	56	12	groups	group	NOUN
bam-12939	56	13	was	be	AUX
bam-12939	56	14	32.16±5.87	32.16±5.87	NUM
bam-12939	56	15	years	year	NOUN
bam-12939	56	16	and	and	CCONJ
bam-12939	56	17	31.58±8.14	31.58±8.14	NUM
bam-12939	56	18	years	year	NOUN
bam-12939	56	19	,	,	PUNCT
bam-12939	56	20	respectively	respectively	ADV
bam-12939	56	21	(	(	PUNCT
bam-12939	56	22	p=0.829	p=0.829	NOUN
bam-12939	56	23	)	)	PUNCT
bam-12939	56	24	.	.	PUNCT
bam-12939	57	1	according	accord	VERB
bam-12939	57	2	to	to	ADP
bam-12939	57	3	the	the	DET
bam-12939	57	4	endocrine	endocrine	NOUN
bam-12939	57	5	society	society	NOUN
bam-12939	57	6	clinical	clinical	ADJ
bam-12939	57	7	guidelines	guideline	NOUN
bam-12939	57	8	,	,	PUNCT
bam-12939	57	9	25	25	NUM
bam-12939	57	10	-	-	PUNCT
bam-12939	57	11	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	57	12	d	d	NOUN
bam-12939	57	13	levels	level	NOUN
bam-12939	57	14	are	be	AUX
bam-12939	57	15	divided	divide	VERB
bam-12939	57	16	into	into	ADP
bam-12939	57	17	deficiency	deficiency	NOUN
bam-12939	57	18	(	(	PUNCT
bam-12939	57	19	less	less	ADJ
bam-12939	57	20	than	than	ADP
bam-12939	57	21	20	20	NUM
bam-12939	57	22	ng	ng	NOUN
bam-12939	57	23	/	/	SYM
bam-12939	57	24	ml	ml	NOUN
bam-12939	57	25	)	)	PUNCT
bam-12939	57	26	,	,	PUNCT
bam-12939	57	27	inadequate	inadequate	ADJ
bam-12939	57	28	vitamin	vitamin	NOUN
bam-12939	57	29	d	d	NOUN
bam-12939	57	30	(	(	PUNCT
bam-12939	57	31	21	21	NUM
bam-12939	57	32	-	-	SYM
bam-12939	57	33	29	29	NUM
bam-12939	57	34	ng	ng	PROPN
bam-12939	57	35	/	/	SYM
bam-12939	57	36	ml	ml	NOUN
bam-12939	57	37	)	)	PUNCT
bam-12939	57	38	and	and	CCONJ
bam-12939	57	39	optimal	optimal	ADJ
bam-12939	57	40	vitamin	vitamin	NOUN
bam-12939	57	41	d	d	NOUN
bam-12939	57	42	(	(	PUNCT
bam-12939	57	43	30	30	NUM
bam-12939	57	44	-	-	SYM
bam-12939	57	45	20	20	NUM
bam-12939	57	46	ng	ng	PROPN
bam-12939	57	47	/	/	SYM
bam-12939	57	48	ml	ml	NOUN
bam-12939	57	49	)	)	PUNCT
bam-12939	57	50	groups	group	NOUN
bam-12939	57	51	(	(	PUNCT
bam-12939	57	52	85	85	NUM
bam-12939	57	53	ng	ng	NOUN
bam-12939	57	54	/	/	SYM
bam-12939	57	55	ml	ml	NOUN
bam-12939	57	56	)	)	PUNCT
bam-12939	57	57	were	be	AUX
bam-12939	57	58	divided.16	divided.16	PROPN
bam-12939	57	59	in	in	ADP
bam-12939	57	60	the	the	DET
bam-12939	57	61	test	test	NOUN
bam-12939	57	62	group	group	NOUN
bam-12939	57	63	,	,	PUNCT
bam-12939	57	64	88	88	NUM
bam-12939	57	65	%	%	NOUN
bam-12939	57	66	of	of	ADP
bam-12939	57	67	participants	participant	NOUN
bam-12939	57	68	had	have	VERB
bam-12939	57	69	25	25	NUM
bam-12939	57	70	-	-	PUNCT
bam-12939	57	71	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	57	72	d	d	NOUN
bam-12939	57	73	deficiency	deficiency	NOUN
bam-12939	57	74	and	and	CCONJ
bam-12939	57	75	in	in	ADP
bam-12939	57	76	the	the	DET
bam-12939	57	77	control	control	NOUN
bam-12939	57	78	group	group	NOUN
bam-12939	57	79	,	,	PUNCT
bam-12939	57	80	66.7	66.7	NUM
bam-12939	57	81	%	%	NOUN
bam-12939	57	82	of	of	ADP
bam-12939	57	83	participants	participant	NOUN
bam-12939	57	84	had	have	VERB
bam-12939	57	85	vitamin	vitamin	NOUN
bam-12939	57	86	d	d	NOUN
bam-12939	57	87	deficiency	deficiency	NOUN
bam-12939	57	88	.	.	PUNCT
bam-12939	58	1	according	accord	VERB
bam-12939	58	2	to	to	ADP
bam-12939	58	3	the	the	DET
bam-12939	58	4	results	result	NOUN
bam-12939	58	5	of	of	ADP
bam-12939	58	6	the	the	DET
bam-12939	58	7	spearman	spearman	NOUN
bam-12939	58	8	test	test	NOUN
bam-12939	58	9	,	,	PUNCT
bam-12939	58	10	there	there	PRON
bam-12939	58	11	was	be	VERB
bam-12939	58	12	a	a	DET
bam-12939	58	13	statistically	statistically	ADV
bam-12939	58	14	significant	significant	ADJ
bam-12939	58	15	difference	difference	NOUN
bam-12939	58	16	in	in	ADP
bam-12939	58	17	25	25	NUM
bam-12939	58	18	-	-	PUNCT
bam-12939	58	19	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	58	20	d	d	NOUN
bam-12939	58	21	levels	level	NOUN
bam-12939	58	22	between	between	ADP
bam-12939	58	23	both	both	DET
bam-12939	58	24	groups	group	NOUN
bam-12939	58	25	(	(	PUNCT
bam-12939	58	26	p<0.001	p<0.001	PROPN
bam-12939	58	27	)	)	PUNCT
bam-12939	58	28	.	.	PUNCT
bam-12939	59	1	the	the	DET
bam-12939	59	2	mean	mean	ADJ
bam-12939	59	3	serum	serum	NOUN
bam-12939	59	4	level	level	NOUN
bam-12939	59	5	of	of	ADP
bam-12939	59	6	25	25	NUM
bam-12939	59	7	-	-	PUNCT
bam-12939	59	8	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	59	9	d	d	NOUN
bam-12939	59	10	was	be	AUX
bam-12939	59	11	significantly	significantly	ADV
bam-12939	59	12	lower	low	ADJ
bam-12939	59	13	in	in	ADP
bam-12939	59	14	patients	patient	NOUN
bam-12939	59	15	with	with	ADP
bam-12939	59	16	diabetes	diabetes	NOUN
bam-12939	59	17	than	than	ADP
bam-12939	59	18	in	in	ADP
bam-12939	59	19	healthy	healthy	ADJ
bam-12939	59	20	volunteers	volunteer	NOUN
bam-12939	59	21	(	(	PUNCT
bam-12939	59	22	p<0.001	p<0.001	PROPN
bam-12939	59	23	)	)	PUNCT
bam-12939	59	24	.	.	PUNCT
bam-12939	60	1	in	in	ADP
bam-12939	60	2	the	the	DET
bam-12939	60	3	univariate	univariate	ADJ
bam-12939	60	4	conditional	conditional	ADJ
bam-12939	60	5	logistic	logistic	ADJ
bam-12939	60	6	regression	regression	NOUN
bam-12939	60	7	analysis	analysis	NOUN
bam-12939	60	8	,	,	PUNCT
bam-12939	60	9	an	an	DET
bam-12939	60	10	odds	odd	NOUN
bam-12939	60	11	ratio	ratio	NOUN
bam-12939	60	12	(	(	PUNCT
bam-12939	60	13	or	or	CCONJ
bam-12939	60	14	)	)	PUNCT
bam-12939	60	15	of	of	ADP
bam-12939	60	16	1.55	1.55	NUM
bam-12939	60	17	(	(	PUNCT
bam-12939	60	18	95	95	NUM
bam-12939	60	19	%	%	NOUN
bam-12939	60	20	ci	ci	NOUN
bam-12939	60	21	1.187–2.040	1.187–2.040	NUM
bam-12939	60	22	;	;	PUNCT
bam-12939	60	23	p	p	X
bam-12939	60	24	<	<	X
bam-12939	60	25	0.001	0.001	NUM
bam-12939	60	26	)	)	PUNCT
bam-12939	60	27	was	be	AUX
bam-12939	60	28	obtained	obtain	VERB
bam-12939	60	29	,	,	PUNCT
bam-12939	60	30	indicating	indicate	VERB
bam-12939	60	31	that	that	SCONJ
bam-12939	60	32	low	low	ADJ
bam-12939	60	33	25	25	NUM
bam-12939	60	34	-	-	PUNCT
bam-12939	60	35	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	60	36	d	d	NOUN
bam-12939	60	37	levels	level	NOUN
bam-12939	60	38	are	be	AUX
bam-12939	60	39	associated	associate	VERB
bam-12939	60	40	with	with	ADP
bam-12939	60	41	up	up	ADP
bam-12939	60	42	to	to	PART
bam-12939	60	43	551	551	NUM
bam-12939	60	44	/	/	SYM
bam-12939	60	45	increase	increase	VERB
bam-12939	60	46	the	the	DET
bam-12939	60	47	risk	risk	NOUN
bam-12939	60	48	of	of	ADP
bam-12939	60	49	developing	develop	VERB
bam-12939	60	50	ms	ms	PROPN
bam-12939	60	51	.	.	PROPN
bam-12939	61	1	this	this	DET
bam-12939	61	2	association	association	NOUN
bam-12939	61	3	was	be	AUX
bam-12939	61	4	statistically	statistically	ADV
bam-12939	61	5	significant	significant	ADJ
bam-12939	61	6	and	and	CCONJ
bam-12939	61	7	a	a	DET
bam-12939	61	8	strong	strong	ADJ
bam-12939	61	9	association	association	NOUN
bam-12939	61	10	was	be	AUX
bam-12939	61	11	observed	observe	VERB
bam-12939	61	12	(	(	PUNCT
bam-12939	61	13	p	p	X
bam-12939	61	14	<	<	X
bam-12939	61	15	0.001	0.001	NUM
bam-12939	61	16	)	)	PUNCT
bam-12939	61	17	.	.	PUNCT
bam-12939	62	1	the	the	DET
bam-12939	62	2	mean	mean	ADJ
bam-12939	62	3	and	and	CCONJ
bam-12939	62	4	standard	standard	ADJ
bam-12939	62	5	deviation	deviation	NOUN
bam-12939	62	6	of	of	ADP
bam-12939	62	7	25	25	NUM
bam-12939	62	8	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	62	9	d	d	NOUN
bam-12939	62	10	levels	level	NOUN
bam-12939	62	11	in	in	ADP
bam-12939	62	12	the	the	DET
bam-12939	62	13	patients	patient	NOUN
bam-12939	62	14	enrolled	enrol	VERB
bam-12939	62	15	in	in	ADP
bam-12939	62	16	this	this	DET
bam-12939	62	17	study	study	NOUN
bam-12939	62	18	in	in	ADP
bam-12939	62	19	the	the	DET
bam-12939	62	20	mild	mild	ADJ
bam-12939	62	21	and	and	CCONJ
bam-12939	62	22	severe	severe	ADJ
bam-12939	62	23	groups	group	NOUN
bam-12939	62	24	were	be	AUX
bam-12939	62	25	18.42±3.64	18.42±3.64	NUM
bam-12939	62	26	ng	ng	PROPN
bam-12939	62	27	/	/	SYM
bam-12939	62	28	ml	ml	PROPN
bam-12939	62	29	and	and	CCONJ
bam-12939	62	30	15.33±3.89	15.33±3.89	PRON
bam-12939	62	31	ng	ng	PROPN
bam-12939	62	32	/	/	SYM
bam-12939	62	33	ml	ml	PROPN
bam-12939	62	34	,	,	PUNCT
bam-12939	62	35	respectively	respectively	ADV
bam-12939	62	36	.	.	PUNCT
bam-12939	63	1	according	accord	VERB
bam-12939	63	2	to	to	ADP
bam-12939	63	3	the	the	DET
bam-12939	63	4	mann	mann	PROPN
bam-12939	63	5	-	-	PUNCT
bam-12939	63	6	whitney	whitney	PROPN
bam-12939	63	7	statistical	statistical	ADJ
bam-12939	63	8	test	test	NOUN
bam-12939	63	9	,	,	PUNCT
bam-12939	63	10	a	a	DET
bam-12939	63	11	statistically	statistically	ADV
bam-12939	63	12	significant	significant	ADJ
bam-12939	63	13	difference	difference	NOUN
bam-12939	63	14	was	be	AUX
bam-12939	63	15	observed	observe	VERB
bam-12939	63	16	in	in	ADP
bam-12939	63	17	25	25	NUM
bam-12939	63	18	-	-	PUNCT
bam-12939	63	19	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	63	20	d	d	NOUN
bam-12939	63	21	levels	level	NOUN
bam-12939	63	22	between	between	ADP
bam-12939	63	23	the	the	DET
bam-12939	63	24	two	two	NUM
bam-12939	63	25	light	light	ADJ
bam-12939	63	26	and	and	CCONJ
bam-12939	63	27	heavy	heavy	ADJ
bam-12939	63	28	groups	group	NOUN
bam-12939	63	29	(	(	PUNCT
bam-12939	63	30	p<0.001	p<0.001	PROPN
bam-12939	63	31	)	)	PUNCT
bam-12939	63	32	,	,	PUNCT
bam-12939	63	33	so	so	CCONJ
bam-12939	63	34	the	the	DET
bam-12939	63	35	vitamin	vitamin	NOUN
bam-12939	63	36	d	d	NOUN
bam-12939	63	37	level	level	NOUN
bam-12939	63	38	was	be	AUX
bam-12939	63	39	significantly	significantly	ADV
bam-12939	63	40	lower	low	ADJ
bam-12939	63	41	in	in	ADP
bam-12939	63	42	the	the	DET
bam-12939	63	43	heavy	heavy	ADJ
bam-12939	63	44	group	group	NOUN
bam-12939	63	45	as	as	ADP
bam-12939	63	46	the	the	DET
bam-12939	63	47	mild	mild	ADJ
bam-12939	63	48	group	group	NOUN
bam-12939	63	49	.	.	PUNCT
bam-12939	64	1	genotype	genotype	NOUN
bam-12939	64	2	of	of	ADP
bam-12939	64	3	polymorphisms	polymorphism	NOUN
bam-12939	64	4	and	and	CCONJ
bam-12939	64	5	allelic	allelic	ADJ
bam-12939	64	6	distribution	distribution	NOUN
bam-12939	64	7	according	accord	VERB
bam-12939	64	8	to	to	ADP
bam-12939	64	9	table	table	NOUN
bam-12939	64	10	1	1	NUM
bam-12939	64	11	,	,	PUNCT
bam-12939	64	12	the	the	DET
bam-12939	64	13	foki	foki	ADJ
bam-12939	64	14	genotype	genotype	NOUN
bam-12939	64	15	distribution	distribution	NOUN
bam-12939	64	16	in	in	ADP
bam-12939	64	17	rrms	rrm	NOUN
bam-12939	64	18	patients	patient	NOUN
bam-12939	64	19	was	be	AUX
bam-12939	64	20	ff	ff	INTJ
bam-12939	64	21	(	(	PUNCT
bam-12939	64	22	wild)=72	wild)=72	NUM
bam-12939	64	23	%	%	NOUN
bam-12939	64	24	,	,	PUNCT
bam-12939	64	25	ff	ff	INTJ
bam-12939	64	26	(	(	PUNCT
bam-12939	64	27	heterozygous)=28	heterozygous)=28	NOUN
bam-12939	64	28	%	%	NOUN
bam-12939	64	29	and	and	CCONJ
bam-12939	64	30	ff	ff	INTJ
bam-12939	64	31	(	(	PUNCT
bam-12939	64	32	mutant)=0	mutant)=0	PROPN
bam-12939	64	33	%	%	NOUN
bam-12939	64	34	.	.	PUNCT
bam-12939	65	1	a	a	DET
bam-12939	65	2	statistically	statistically	ADV
bam-12939	65	3	significant	significant	ADJ
bam-12939	65	4	difference	difference	NOUN
bam-12939	65	5	was	be	AUX
bam-12939	65	6	observed	observe	VERB
bam-12939	65	7	between	between	ADP
bam-12939	65	8	the	the	DET
bam-12939	65	9	percentage	percentage	NOUN
bam-12939	65	10	of	of	ADP
bam-12939	65	11	genotypes	genotype	NOUN
bam-12939	65	12	in	in	ADP
bam-12939	65	13	test	test	NOUN
bam-12939	65	14	and	and	CCONJ
bam-12939	65	15	control	control	NOUN
bam-12939	65	16	groups	group	NOUN
bam-12939	65	17	(	(	PUNCT
bam-12939	65	18	p<0.05	p<0.05	NOUN
bam-12939	65	19	)	)	PUNCT
bam-12939	65	20	.	.	PUNCT
bam-12939	66	1	statistical	statistical	ADJ
bam-12939	66	2	analyzes	analyze	NOUN
bam-12939	66	3	of	of	ADP
bam-12939	66	4	foki	foki	ADJ
bam-12939	66	5	polymorphism	polymorphism	NOUN
bam-12939	66	6	showed	show	VERB
bam-12939	66	7	a	a	DET
bam-12939	66	8	significant	significant	ADJ
bam-12939	66	9	increase	increase	NOUN
bam-12939	66	10	in	in	ADP
bam-12939	66	11	risk	risk	NOUN
bam-12939	66	12	in	in	ADP
bam-12939	66	13	patients	patient	NOUN
bam-12939	66	14	with	with	ADP
bam-12939	66	15	ff	ff	NOUN
bam-12939	66	16	genotype	genotype	NOUN
bam-12939	66	17	compared	compare	VERB
bam-12939	66	18	to	to	ADP
bam-12939	66	19	controls	control	NOUN
bam-12939	66	20	(	(	PUNCT
bam-12939	66	21	or=7.28	or=7.28	PROPN
bam-12939	66	22	:	:	PUNCT
bam-12939	66	23	95	95	NUM
bam-12939	66	24	%	%	NOUN
bam-12939	66	25	ci	ci	NOUN
bam-12939	66	26	;	;	PUNCT
bam-12939	66	27	1.86	1.86	NUM
bam-12939	66	28	,	,	PUNCT
bam-12939	66	29	28.41	28.41	NUM
bam-12939	66	30	)	)	PUNCT
bam-12939	66	31	.	.	PUNCT
bam-12939	67	1	statistical	statistical	ADJ
bam-12939	67	2	analysis	analysis	NOUN
bam-12939	67	3	of	of	ADP
bam-12939	67	4	the	the	DET
bam-12939	67	5	apai	apai	NOUN
bam-12939	67	6	polymorphism	polymorphism	NOUN
bam-12939	67	7	showed	show	VERB
bam-12939	67	8	no	no	DET
bam-12939	67	9	significant	significant	ADJ
bam-12939	67	10	increase	increase	NOUN
bam-12939	67	11	in	in	ADP
bam-12939	67	12	risk	risk	NOUN
bam-12939	67	13	in	in	ADP
bam-12939	67	14	patients	patient	NOUN
bam-12939	67	15	with	with	ADP
bam-12939	67	16	the	the	DET
bam-12939	67	17	aa	aa	PROPN
bam-12939	67	18	genotype	genotype	NOUN
bam-12939	67	19	compared	compare	VERB
bam-12939	67	20	to	to	ADP
bam-12939	67	21	the	the	DET
bam-12939	67	22	control	control	NOUN
bam-12939	67	23	group	group	NOUN
bam-12939	67	24	(	(	PUNCT
bam-12939	67	25	or=1.28	or=1.28	NOUN
bam-12939	67	26	:	:	PUNCT
bam-12939	67	27	95	95	NUM
bam-12939	67	28	%	%	NOUN
bam-12939	67	29	ci	ci	NOUN
bam-12939	67	30	;	;	PUNCT
bam-12939	67	31	0.45	0.45	NUM
bam-12939	67	32	,	,	PUNCT
bam-12939	67	33	3.62	3.62	NUM
bam-12939	67	34	;	;	PUNCT
bam-12939	67	35	p>0.05	p>0.05	PROPN
bam-12939	67	36	)	)	PUNCT
bam-12939	67	37	.	.	PUNCT
bam-12939	68	1	statistical	statistical	ADJ
bam-12939	68	2	analysis	analysis	NOUN
bam-12939	68	3	of	of	ADP
bam-12939	68	4	taqi	taqi	ADJ
bam-12939	68	5	polymorphism	polymorphism	NOUN
bam-12939	68	6	showed	show	VERB
bam-12939	68	7	no	no	DET
bam-12939	68	8	significant	significant	ADJ
bam-12939	68	9	increase	increase	NOUN
bam-12939	68	10	in	in	ADP
bam-12939	68	11	risk	risk	NOUN
bam-12939	68	12	in	in	ADP
bam-12939	68	13	patients	patient	NOUN
bam-12939	68	14	with	with	ADP
bam-12939	68	15	tt	tt	PROPN
bam-12939	68	16	genotype	genotype	NOUN
bam-12939	68	17	compared	compare	VERB
bam-12939	68	18	to	to	ADP
bam-12939	68	19	a	a	DET
bam-12939	68	20	control	control	NOUN
bam-12939	68	21	group	group	NOUN
bam-12939	68	22	(	(	PUNCT
bam-12939	68	23	or=1.89	or=1.89	PROPN
bam-12939	68	24	:	:	PUNCT
bam-12939	68	25	95	95	NUM
bam-12939	68	26	%	%	NOUN
bam-12939	68	27	ci	ci	NOUN
bam-12939	68	28	;	;	PUNCT
bam-12939	68	29	0.74	0.74	NUM
bam-12939	68	30	,	,	PUNCT
bam-12939	68	31	4.84	4.84	NUM
bam-12939	68	32	;	;	PUNCT
bam-12939	68	33	p=0.294	p=0.294	NOUN
bam-12939	68	34	)	)	PUNCT
bam-12939	68	35	.	.	PUNCT
bam-12939	69	1	statistical	statistical	ADJ
bam-12939	69	2	analysis	analysis	NOUN
bam-12939	69	3	of	of	ADP
bam-12939	69	4	bsmi	bsmi	NOUN
bam-12939	69	5	polymorphism	polymorphism	NOUN
bam-12939	69	6	showed	show	VERB
bam-12939	69	7	no	no	DET
bam-12939	69	8	significant	significant	ADJ
bam-12939	69	9	increase	increase	NOUN
bam-12939	69	10	in	in	ADP
bam-12939	69	11	risk	risk	NOUN
bam-12939	69	12	in	in	ADP
bam-12939	69	13	patients	patient	NOUN
bam-12939	69	14	with	with	ADP
bam-12939	69	15	tt	tt	PROPN
bam-12939	69	16	genotype	genotype	NOUN
bam-12939	69	17	compared	compare	VERB
bam-12939	69	18	to	to	ADP
bam-12939	69	19	controls	control	NOUN
bam-12939	69	20	(	(	PUNCT
bam-12939	69	21	or=0.94	or=0.94	ADJ
bam-12939	69	22	:	:	PUNCT
bam-12939	69	23	95	95	NUM
bam-12939	69	24	%	%	NOUN
bam-12939	69	25	ci	ci	NOUN
bam-12939	69	26	;	;	PUNCT
bam-12939	69	27	0.42	0.42	NUM
bam-12939	69	28	,	,	PUNCT
bam-12939	69	29	2.08	2.08	NUM
bam-12939	69	30	;	;	PUNCT
bam-12939	69	31	p=0.987	p=0.987	X
bam-12939	69	32	)	)	PUNCT
bam-12939	69	33	.	.	PUNCT
bam-12939	70	1	35	35	NUM
bam-12939	70	2	table	table	NOUN
bam-12939	70	3	1	1	NUM
bam-12939	70	4	.	.	X
bam-12939	70	5	association	association	NOUN
bam-12939	70	6	between	between	ADP
bam-12939	70	7	polymorphisms	polymorphism	NOUN
bam-12939	70	8	and	and	CCONJ
bam-12939	70	9	haplotypes	haplotype	NOUN
bam-12939	70	10	of	of	ADP
bam-12939	70	11	the	the	DET
bam-12939	70	12	vdr	vdr	NOUN
bam-12939	70	13	and	and	CCONJ
bam-12939	70	14	the	the	DET
bam-12939	70	15	odds	odd	NOUN
bam-12939	70	16	ratio	ratio	NOUN
bam-12939	70	17	of	of	ADP
bam-12939	70	18	polymorphisms	polymorphism	NOUN
bam-12939	70	19	.	.	PUNCT
bam-12939	71	1	snps	snps	PROPN
bam-12939	71	2	genotype	genotype	NOUN
bam-12939	71	3	genotypic	genotypic	NOUN
bam-12939	71	4	frequency	frequency	NOUN
bam-12939	71	5	(	(	PUNCT
bam-12939	71	6	%	%	INTJ
bam-12939	71	7	)	)	PUNCT
bam-12939	71	8	significance	significance	NOUN
bam-12939	71	9	odds	odd	NOUN
bam-12939	71	10	ratio	ratio	NOUN
bam-12939	71	11	rrms	rrm	NOUN
bam-12939	71	12	(	(	PUNCT
bam-12939	71	13	n=25	n=25	NOUN
bam-12939	71	14	)	)	PUNCT
bam-12939	71	15	control	control	NOUN
bam-12939	71	16	(	(	PUNCT
bam-12939	71	17	n=12	n=12	PROPN
bam-12939	71	18	)	)	PUNCT
bam-12939	71	19	(	(	PUNCT
bam-12939	71	20	95	95	NUM
bam-12939	71	21	%	%	NOUN
bam-12939	71	22	ci	ci	NOUN
bam-12939	71	23	)	)	PUNCT
bam-12939	71	24	foki	foki	ADJ
bam-12939	71	25	rs2228570	rs2228570	NOUN
bam-12939	71	26	ff	ff	NOUN
bam-12939	71	27	18	18	NUM
bam-12939	71	28	(	(	PUNCT
bam-12939	71	29	72	72	NUM
bam-12939	71	30	)	)	PUNCT
bam-12939	71	31	3	3	NUM
bam-12939	71	32	(	(	PUNCT
bam-12939	71	33	25	25	NUM
bam-12939	71	34	)	)	PUNCT
bam-12939	71	35	χ2=11.96	χ2=11.96	NUM
bam-12939	71	36	7.28	7.28	NUM
bam-12939	71	37	(	(	PUNCT
bam-12939	71	38	1.86	1.86	NUM
bam-12939	71	39	,	,	PUNCT
bam-12939	71	40	28.41	28.41	NUM
bam-12939	71	41	)	)	PUNCT
bam-12939	71	42	ff	ff	NOUN
bam-12939	71	43	7	7	NUM
bam-12939	71	44	(	(	PUNCT
bam-12939	71	45	28	28	NUM
bam-12939	71	46	)	)	PUNCT
bam-12939	71	47	5	5	NUM
bam-12939	71	48	(	(	PUNCT
bam-12939	71	49	41.7	41.7	NUM
bam-12939	71	50	)	)	PUNCT
bam-12939	71	51	p=0.003	p=0.003	NOUN
bam-12939	71	52	ff	ff	NOUN
bam-12939	71	53	0	0	NUM
bam-12939	71	54	4(33.3	4(33.3	NUM
bam-12939	71	55	)	)	PUNCT
bam-12939	71	56	apai	apai	NOUN
bam-12939	71	57	rs7975232	rs7975232	NOUN
bam-12939	71	58	aa	aa	NOUN
bam-12939	71	59	10	10	NUM
bam-12939	71	60	(	(	PUNCT
bam-12939	71	61	40	40	NUM
bam-12939	71	62	)	)	PUNCT
bam-12939	71	63	6	6	NUM
bam-12939	71	64	(	(	PUNCT
bam-12939	71	65	50	50	NUM
bam-12939	71	66	)	)	PUNCT
bam-12939	71	67	χ2=5.19	χ2=5.19	NOUN
bam-12939	71	68	1.28	1.28	NUM
bam-12939	71	69	(	(	PUNCT
bam-12939	71	70	0.45	0.45	NUM
bam-12939	71	71	,	,	PUNCT
bam-12939	71	72	3.62	3.62	NUM
bam-12939	71	73	)	)	PUNCT
bam-12939	71	74	aa	aa	NOUN
bam-12939	71	75	14	14	NUM
bam-12939	71	76	(	(	PUNCT
bam-12939	71	77	56	56	NUM
bam-12939	71	78	)	)	PUNCT
bam-12939	71	79	3	3	NUM
bam-12939	71	80	(	(	PUNCT
bam-12939	71	81	25	25	NUM
bam-12939	71	82	)	)	PUNCT
bam-12939	71	83	p=0.075	p=0.075	VERB
bam-12939	71	84	aa	aa	NOUN
bam-12939	71	85	1	1	NUM
bam-12939	71	86	(	(	PUNCT
bam-12939	71	87	4	4	NUM
bam-12939	71	88	)	)	PUNCT
bam-12939	71	89	3	3	NUM
bam-12939	71	90	(	(	PUNCT
bam-12939	71	91	25	25	NUM
bam-12939	71	92	)	)	PUNCT
bam-12939	71	93	taqi	taqi	NOUN
bam-12939	71	94	rs731236	rs731236	PROPN
bam-12939	71	95	tt	tt	PROPN
bam-12939	71	96	12	12	NUM
bam-12939	71	97	(	(	PUNCT
bam-12939	71	98	48	48	NUM
bam-12939	71	99	)	)	PUNCT
bam-12939	71	100	4	4	NUM
bam-12939	71	101	(	(	PUNCT
bam-12939	71	102	33.3	33.3	NUM
bam-12939	71	103	)	)	PUNCT
bam-12939	71	104	χ2=2.44	χ2=2.44	NOUN
bam-12939	71	105	1.89	1.89	NUM
bam-12939	71	106	(	(	PUNCT
bam-12939	71	107	0.74	0.74	NUM
bam-12939	71	108	,	,	PUNCT
bam-12939	71	109	4.84	4.84	NUM
bam-12939	71	110	)	)	PUNCT
bam-12939	71	111	tt	tt	PROPN
bam-12939	71	112	10	10	NUM
bam-12939	71	113	(	(	PUNCT
bam-12939	71	114	40	40	NUM
bam-12939	71	115	)	)	PUNCT
bam-12939	71	116	4	4	NUM
bam-12939	71	117	(	(	PUNCT
bam-12939	71	118	33.3	33.3	NUM
bam-12939	71	119	)	)	PUNCT
bam-12939	71	120	p=0.294	p=0.294	NOUN
bam-12939	71	121	tt	tt	PROPN
bam-12939	71	122	3	3	NUM
bam-12939	71	123	(	(	PUNCT
bam-12939	71	124	12	12	NUM
bam-12939	71	125	)	)	PUNCT
bam-12939	71	126	4	4	NUM
bam-12939	71	127	(	(	PUNCT
bam-12939	71	128	33.3	33.3	NUM
bam-12939	71	129	)	)	PUNCT
bam-12939	71	130	bsmi	bsmi	NOUN
bam-12939	71	131	rs1544410	rs1544410	PROPN
bam-12939	72	1	bb	bb	NUM
bam-12939	72	2	10	10	NUM
bam-12939	72	3	(	(	PUNCT
bam-12939	72	4	40	40	NUM
bam-12939	72	5	)	)	SYM
bam-12939	72	6	5	5	NUM
bam-12939	72	7	(	(	PUNCT
bam-12939	72	8	41.7	41.7	NUM
bam-12939	72	9	)	)	PUNCT
bam-12939	72	10	χ2=0.025	χ2=0.025	X
bam-12939	72	11	0.94	0.94	NUM
bam-12939	72	12	(	(	PUNCT
bam-12939	72	13	0.42,2.08	0.42,2.08	NOUN
bam-12939	72	14	)	)	PUNCT
bam-12939	72	15	bb	bb	NOUN
bam-12939	72	16	6	6	NUM
bam-12939	72	17	(	(	PUNCT
bam-12939	72	18	24	24	NUM
bam-12939	72	19	)	)	PUNCT
bam-12939	72	20	3	3	NUM
bam-12939	72	21	(	(	PUNCT
bam-12939	72	22	25	25	NUM
bam-12939	72	23	)	)	PUNCT
bam-12939	72	24	p=0.987	p=0.987	NOUN
bam-12939	72	25	bb	bb	X
bam-12939	72	26	9	9	NUM
bam-12939	72	27	(	(	PUNCT
bam-12939	72	28	36	36	NUM
bam-12939	72	29	)	)	PUNCT
bam-12939	72	30	4	4	NUM
bam-12939	72	31	(	(	PUNCT
bam-12939	72	32	33.3	33.3	NUM
bam-12939	72	33	)	)	PUNCT
bam-12939	72	34	χ2	χ2	PROPN
bam-12939	72	35	chi	chi	ADJ
bam-12939	72	36	-	-	PUNCT
bam-12939	72	37	square	square	NOUN
bam-12939	72	38	test	test	NOUN
bam-12939	72	39	;	;	PUNCT
bam-12939	72	40	p	p	X
bam-12939	72	41	,	,	PUNCT
bam-12939	72	42	p	p	NOUN
bam-12939	72	43	-	-	PUNCT
bam-12939	72	44	value	value	NOUN
bam-12939	72	45	;	;	PUNCT
bam-12939	72	46	significant	significant	ADJ
bam-12939	72	47	at	at	ADP
bam-12939	72	48	p	p	NOUN
bam-12939	72	49	≤0.05	≤0.05	NOUN
bam-12939	72	50	.	.	PUNCT
bam-12939	73	1	non	non	ADJ
bam-12939	73	2	-co	-co	PROPN
bam-12939	73	3	mmerc	mmerc	PROPN
bam-12939	73	4	ial	ial	PROPN
bam-12939	73	5	us	us	PROPN
bam-12939	73	6	e	e	NOUN
bam-12939	73	7	o	o	NOUN
bam-12939	73	8	nly	nly	ADV
bam-12939	73	9	vitamin	vitamin	VERB
bam-12939	73	10	d	d	NOUN
bam-12939	73	11	receptor	receptor	NOUN
bam-12939	73	12	and	and	CCONJ
bam-12939	73	13	clinical	clinical	ADJ
bam-12939	73	14	and	and	CCONJ
bam-12939	73	15	inflammatory	inflammatory	ADJ
bam-12939	73	16	factors	factor	NOUN
bam-12939	73	17	in	in	ADP
bam-12939	73	18	patients	patient	NOUN
bam-12939	73	19	with	with	ADP
bam-12939	73	20	relapsing	relapse	VERB
bam-12939	73	21	-	-	PUNCT
bam-12939	73	22	remitting	remit	VERB
bam-12939	73	23	multiple	multiple	ADJ
bam-12939	73	24	sclerosis	sclerosis	NOUN
bam-12939	73	25	eur	eur	PROPN
bam-12939	73	26	j	j	PROPN
bam-12939	73	27	transl	transl	PROPN
bam-12939	73	28	myol	myol	NOUN
bam-12939	73	29	34	34	NUM
bam-12939	73	30	(	(	PUNCT
bam-12939	73	31	4	4	NUM
bam-12939	73	32	)	)	PUNCT
bam-12939	73	33	12939	12939	NUM
bam-12939	73	34	,	,	PUNCT
bam-12939	73	35	2024	2024	NUM
bam-12939	73	36	doi	doi	NOUN
bam-12939	73	37	:	:	PUNCT
bam-12939	73	38	10.4081	10.4081	NUM
bam-12939	73	39	/	/	SYM
bam-12939	73	40	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	73	41	obesity	obesity	NOUN
bam-12939	73	42	and	and	CCONJ
bam-12939	73	43	vdr	vdr	VERB
bam-12939	73	44	changes	change	NOUN
bam-12939	73	45	according	accord	VERB
bam-12939	73	46	to	to	ADP
bam-12939	73	47	table	table	NOUN
bam-12939	73	48	2	2	NUM
bam-12939	73	49	,	,	PUNCT
bam-12939	73	50	statistical	statistical	ADJ
bam-12939	73	51	analysis	analysis	NOUN
bam-12939	73	52	of	of	ADP
bam-12939	73	53	foki	foki	NOUN
bam-12939	73	54	,	,	PUNCT
bam-12939	73	55	apai	apai	NOUN
bam-12939	73	56	,	,	PUNCT
bam-12939	73	57	taqi	taqi	NOUN
bam-12939	73	58	and	and	CCONJ
bam-12939	73	59	bsmi	bsmi	NOUN
bam-12939	73	60	genotypes	genotype	NOUN
bam-12939	73	61	showed	show	VERB
bam-12939	73	62	no	no	DET
bam-12939	73	63	significant	significant	ADJ
bam-12939	73	64	increase	increase	NOUN
bam-12939	73	65	in	in	ADP
bam-12939	73	66	risk	risk	NOUN
bam-12939	73	67	in	in	ADP
bam-12939	73	68	rrms	rrm	NOUN
bam-12939	73	69	patients	patient	NOUN
bam-12939	73	70	with	with	ADP
bam-12939	73	71	higher	high	ADJ
bam-12939	73	72	bmi	bmi	NOUN
bam-12939	73	73	compared	compare	VERB
bam-12939	73	74	to	to	ADP
bam-12939	73	75	the	the	DET
bam-12939	73	76	control	control	NOUN
bam-12939	73	77	group	group	NOUN
bam-12939	73	78	(	(	PUNCT
bam-12939	73	79	obese	obese	ADJ
bam-12939	73	80	subjects	subject	NOUN
bam-12939	73	81	)	)	PUNCT
bam-12939	73	82	(	(	PUNCT
bam-12939	73	83	p>0.05	p>0.05	PROPN
bam-12939	73	84	)	)	PUNCT
bam-12939	73	85	.	.	PUNCT
bam-12939	74	1	adipokine	adipokine	PROPN
bam-12939	74	2	and	and	CCONJ
bam-12939	74	3	vdr	vdr	NOUN
bam-12939	74	4	changes	change	VERB
bam-12939	74	5	the	the	DET
bam-12939	74	6	mean	mean	NOUN
bam-12939	74	7	adiponectin	adiponectin	NOUN
bam-12939	74	8	level	level	NOUN
bam-12939	74	9	in	in	ADP
bam-12939	74	10	patients	patient	NOUN
bam-12939	74	11	with	with	ADP
bam-12939	74	12	rrms	rrm	NOUN
bam-12939	74	13	was	be	AUX
bam-12939	74	14	11995.99±620.34	11995.99±620.34	NUM
bam-12939	74	15	and	and	CCONJ
bam-12939	74	16	in	in	ADP
bam-12939	74	17	the	the	DET
bam-12939	74	18	control	control	NOUN
bam-12939	74	19	group	group	NOUN
bam-12939	74	20	was	be	AUX
bam-12939	74	21	10466.7±160.25	10466.7±160.25	ADJ
bam-12939	74	22	(	(	PUNCT
bam-12939	74	23	p	p	X
bam-12939	74	24	<	<	X
bam-12939	74	25	0.01	0.01	NUM
bam-12939	74	26	)	)	PUNCT
bam-12939	74	27	.	.	PUNCT
bam-12939	75	1	the	the	DET
bam-12939	75	2	mean	mean	ADJ
bam-12939	75	3	leptin	leptin	NOUN
bam-12939	75	4	level	level	NOUN
bam-12939	75	5	in	in	ADP
bam-12939	75	6	patients	patient	NOUN
bam-12939	75	7	with	with	ADP
bam-12939	75	8	rrms	rrm	NOUN
bam-12939	75	9	was	be	AUX
bam-12939	75	10	42441.5±571.5	42441.5±571.5	NUM
bam-12939	75	11	and	and	CCONJ
bam-12939	75	12	in	in	ADP
bam-12939	75	13	the	the	DET
bam-12939	75	14	control	control	NOUN
bam-12939	75	15	group	group	NOUN
bam-12939	75	16	was	be	AUX
bam-12939	75	17	32461.03±446.36	32461.03±446.36	NUM
bam-12939	75	18	(	(	PUNCT
bam-12939	75	19	p	p	X
bam-12939	75	20	<	<	X
bam-12939	75	21	0.01	0.01	NUM
bam-12939	75	22	)	)	PUNCT
bam-12939	75	23	.	.	PUNCT
bam-12939	76	1	adiponectin	adiponectin	NOUN
bam-12939	76	2	and	and	CCONJ
bam-12939	76	3	leptin	leptin	NOUN
bam-12939	76	4	levels	level	NOUN
bam-12939	76	5	were	be	AUX
bam-12939	76	6	higher	high	ADJ
bam-12939	76	7	in	in	ADP
bam-12939	76	8	patients	patient	NOUN
bam-12939	76	9	with	with	ADP
bam-12939	76	10	rrms	rrm	NOUN
bam-12939	76	11	than	than	ADP
bam-12939	76	12	in	in	ADP
bam-12939	76	13	the	the	DET
bam-12939	76	14	control	control	NOUN
bam-12939	76	15	group	group	NOUN
bam-12939	76	16	.	.	PUNCT
bam-12939	77	1	based	base	VERB
bam-12939	77	2	on	on	ADP
bam-12939	77	3	table	table	NOUN
bam-12939	77	4	3	3	NUM
bam-12939	77	5	,	,	PUNCT
bam-12939	77	6	statistical	statistical	ADJ
bam-12939	77	7	analysis	analysis	NOUN
bam-12939	77	8	of	of	ADP
bam-12939	77	9	foki	foki	ADJ
bam-12939	77	10	polymorphism	polymorphism	NOUN
bam-12939	77	11	showed	show	VERB
bam-12939	77	12	a	a	DET
bam-12939	77	13	significant	significant	ADJ
bam-12939	77	14	increase	increase	NOUN
bam-12939	77	15	in	in	ADP
bam-12939	77	16	risk	risk	NOUN
bam-12939	77	17	in	in	ADP
bam-12939	77	18	rrms	rrm	NOUN
bam-12939	77	19	patients	patient	NOUN
bam-12939	77	20	with	with	ADP
bam-12939	77	21	ff	ff	NOUN
bam-12939	77	22	genotype	genotype	NOUN
bam-12939	77	23	compared	compare	VERB
bam-12939	77	24	to	to	ADP
bam-12939	77	25	the	the	DET
bam-12939	77	26	control	control	NOUN
bam-12939	77	27	group	group	NOUN
bam-12939	77	28	(	(	PUNCT
bam-12939	77	29	or=7.28	or=7.28	PROPN
bam-12939	77	30	:	:	PUNCT
bam-12939	77	31	95	95	NUM
bam-12939	77	32	%	%	NOUN
bam-12939	77	33	ci	ci	NOUN
bam-12939	77	34	;	;	PUNCT
bam-12939	77	35	1.86	1.86	NUM
bam-12939	77	36	,	,	PUNCT
bam-12939	77	37	28.41	28.41	NUM
bam-12939	77	38	)	)	PUNCT
bam-12939	77	39	.	.	PUNCT
bam-12939	78	1	the	the	DET
bam-12939	78	2	odds	odd	NOUN
bam-12939	78	3	ratio	ratio	NOUN
bam-12939	78	4	was	be	AUX
bam-12939	78	5	28.7	28.7	NUM
bam-12939	78	6	.	.	PUNCT
bam-12939	79	1	statistical	statistical	ADJ
bam-12939	79	2	analyzes	analyze	NOUN
bam-12939	79	3	of	of	ADP
bam-12939	79	4	apai	apai	NOUN
bam-12939	79	5	,	,	PUNCT
bam-12939	79	6	taqi	taqi	NOUN
bam-12939	79	7	,	,	PUNCT
bam-12939	79	8	and	and	CCONJ
bam-12939	79	9	bsmi	bsmi	NOUN
bam-12939	79	10	polymorphisms	polymorphism	NOUN
bam-12939	79	11	showed	show	VERB
bam-12939	79	12	no	no	DET
bam-12939	79	13	significantly	significantly	ADV
bam-12939	79	14	increased	increase	VERB
bam-12939	79	15	risk	risk	NOUN
bam-12939	79	16	in	in	ADP
bam-12939	79	17	rrms	rrm	NOUN
bam-12939	79	18	patients	patient	NOUN
bam-12939	79	19	with	with	ADP
bam-12939	79	20	genotypes	genotype	NOUN
bam-12939	79	21	compared	compare	VERB
bam-12939	79	22	to	to	ADP
bam-12939	79	23	controls	control	NOUN
bam-12939	79	24	;	;	PUNCT
bam-12939	79	25	the	the	DET
bam-12939	79	26	odds	odd	NOUN
bam-12939	79	27	ratio	ratio	NOUN
bam-12939	79	28	was	be	AUX
bam-12939	79	29	almost	almost	ADV
bam-12939	79	30	1.00	1.00	NUM
bam-12939	79	31	.	.	PUNCT
bam-12939	80	1	the	the	DET
bam-12939	80	2	concentration	concentration	NOUN
bam-12939	80	3	of	of	ADP
bam-12939	80	4	scfas	scfas	NOUN
bam-12939	80	5	in	in	ADP
bam-12939	80	6	rrms	rrm	NOUN
bam-12939	80	7	patients	patient	NOUN
bam-12939	80	8	(	(	PUNCT
bam-12939	80	9	386.44±37.64	386.44±37.64	NUM
bam-12939	80	10	)	)	PUNCT
bam-12939	80	11	was	be	AUX
bam-12939	80	12	significantly	significantly	ADV
bam-12939	80	13	lower	low	ADJ
bam-12939	80	14	compared	compare	VERB
bam-12939	80	15	to	to	ADP
bam-12939	80	16	36	36	NUM
bam-12939	80	17	table	table	NOUN
bam-12939	80	18	2	2	NUM
bam-12939	80	19	.	.	X
bam-12939	80	20	association	association	NOUN
bam-12939	80	21	between	between	ADP
bam-12939	80	22	obesity	obesity	NOUN
bam-12939	80	23	and	and	CCONJ
bam-12939	80	24	vdr	vdr	NOUN
bam-12939	80	25	changes	change	NOUN
bam-12939	80	26	in	in	ADP
bam-12939	80	27	patients	patient	NOUN
bam-12939	80	28	with	with	ADP
bam-12939	80	29	rrms	rrm	NOUN
bam-12939	80	30	.	.	PUNCT
bam-12939	81	1	snps	snps	PROPN
bam-12939	81	2	genotype	genotype	NOUN
bam-12939	81	3	genotypic	genotypic	NOUN
bam-12939	81	4	frequency	frequency	NOUN
bam-12939	81	5	(	(	PUNCT
bam-12939	81	6	%	%	INTJ
bam-12939	81	7	)	)	PUNCT
bam-12939	81	8	significance	significance	NOUN
bam-12939	81	9	odds	odd	NOUN
bam-12939	81	10	ratio	ratio	NOUN
bam-12939	81	11	rrms	rrm	NOUN
bam-12939	81	12	(	(	PUNCT
bam-12939	81	13	n=21	n=21	NOUN
bam-12939	81	14	)	)	PUNCT
bam-12939	81	15	control	control	NOUN
bam-12939	81	16	(	(	PUNCT
bam-12939	81	17	n=6	n=6	NOUN
bam-12939	81	18	)	)	PUNCT
bam-12939	81	19	foki	foki	ADJ
bam-12939	81	20	rs2228570	rs2228570	NOUN
bam-12939	81	21	ff	ff	NOUN
bam-12939	81	22	14	14	NUM
bam-12939	81	23	(	(	PUNCT
bam-12939	81	24	66.7	66.7	NUM
bam-12939	81	25	)	)	PUNCT
bam-12939	81	26	2	2	NUM
bam-12939	81	27	(	(	PUNCT
bam-12939	81	28	33.3	33.3	NUM
bam-12939	81	29	)	)	PUNCT
bam-12939	81	30	χ2=4.72	χ2=4.72	NOUN
bam-12939	81	31	4.60	4.60	NUM
bam-12939	81	32	(	(	PUNCT
bam-12939	81	33	0.82	0.82	NUM
bam-12939	81	34	,	,	PUNCT
bam-12939	81	35	25.74	25.74	NUM
bam-12939	81	36	)	)	PUNCT
bam-12939	81	37	ff	ff	NOUN
bam-12939	81	38	7	7	NUM
bam-12939	81	39	(	(	PUNCT
bam-12939	81	40	33.3	33.3	NUM
bam-12939	81	41	)	)	PUNCT
bam-12939	81	42	3	3	NUM
bam-12939	81	43	(	(	PUNCT
bam-12939	81	44	50	50	NUM
bam-12939	81	45	)	)	PUNCT
bam-12939	81	46	p=0.094	p=0.094	NOUN
bam-12939	82	1	ff	ff	INTJ
bam-12939	82	2	0	0	NUM
bam-12939	83	1	1(16.7	1(16.7	NUM
bam-12939	83	2	)	)	PUNCT
bam-12939	83	3	apai	apai	NOUN
bam-12939	83	4	rs7975232	rs7975232	NOUN
bam-12939	83	5	aa	aa	NOUN
bam-12939	83	6	8	8	NUM
bam-12939	83	7	(	(	PUNCT
bam-12939	83	8	38.1	38.1	NUM
bam-12939	83	9	)	)	PUNCT
bam-12939	83	10	3	3	NUM
bam-12939	83	11	(	(	PUNCT
bam-12939	83	12	50	50	NUM
bam-12939	83	13	)	)	PUNCT
bam-12939	83	14	χ2=1.56	χ2=1.56	NUM
bam-12939	84	1	1.00	1.00	NUM
bam-12939	84	2	(	(	PUNCT
bam-12939	84	3	0.25	0.25	NUM
bam-12939	84	4	,	,	PUNCT
bam-12939	84	5	4.44	4.44	NUM
bam-12939	84	6	)	)	PUNCT
bam-12939	84	7	aa	aa	NOUN
bam-12939	84	8	12	12	NUM
bam-12939	84	9	(	(	PUNCT
bam-12939	84	10	57.1	57.1	NUM
bam-12939	84	11	)	)	SYM
bam-12939	84	12	2	2	NUM
bam-12939	84	13	(	(	PUNCT
bam-12939	84	14	33.3	33.3	NUM
bam-12939	84	15	)	)	PUNCT
bam-12939	84	16	p=0.457	p=0.457	PRON
bam-12939	84	17	aa	aa	NOUN
bam-12939	84	18	1	1	NUM
bam-12939	84	19	(	(	PUNCT
bam-12939	84	20	4.8	4.8	NUM
bam-12939	84	21	)	)	PUNCT
bam-12939	84	22	1	1	NUM
bam-12939	84	23	(	(	PUNCT
bam-12939	84	24	16.7	16.7	NUM
bam-12939	84	25	)	)	PUNCT
bam-12939	84	26	taqi	taqi	NOUN
bam-12939	84	27	rs731236	rs731236	PROPN
bam-12939	84	28	tt	tt	PROPN
bam-12939	84	29	10	10	NUM
bam-12939	84	30	(	(	PUNCT
bam-12939	84	31	47.6	47.6	NUM
bam-12939	84	32	)	)	PUNCT
bam-12939	84	33	3	3	NUM
bam-12939	84	34	(	(	PUNCT
bam-12939	84	35	50	50	NUM
bam-12939	84	36	)	)	PUNCT
bam-12939	84	37	χ2=2.66	χ2=2.66	NOUN
bam-12939	84	38	1.49	1.49	NUM
bam-12939	84	39	(	(	PUNCT
bam-12939	84	40	0.43	0.43	NUM
bam-12939	84	41	,	,	PUNCT
bam-12939	84	42	5.1	5.1	NUM
bam-12939	84	43	)	)	PUNCT
bam-12939	84	44	tt	tt	PROPN
bam-12939	84	45	9	9	NUM
bam-12939	84	46	(	(	PUNCT
bam-12939	84	47	42.9	42.9	NUM
bam-12939	84	48	)	)	PUNCT
bam-12939	84	49	1	1	NUM
bam-12939	84	50	(	(	PUNCT
bam-12939	84	51	16.7	16.7	NUM
bam-12939	84	52	)	)	PUNCT
bam-12939	84	53	p=0.265	p=0.265	NOUN
bam-12939	84	54	tt	tt	PROPN
bam-12939	84	55	2	2	NUM
bam-12939	84	56	(	(	PUNCT
bam-12939	84	57	9.5	9.5	NUM
bam-12939	84	58	)	)	PUNCT
bam-12939	84	59	2	2	NUM
bam-12939	84	60	(	(	PUNCT
bam-12939	84	61	33.3	33.3	NUM
bam-12939	84	62	)	)	PUNCT
bam-12939	84	63	bsmi	bsmi	NOUN
bam-12939	84	64	rs1544410	rs1544410	PROPN
bam-12939	84	65	bb	bb	INTJ
bam-12939	84	66	9	9	NUM
bam-12939	84	67	(	(	PUNCT
bam-12939	84	68	42.9	42.9	NUM
bam-12939	84	69	)	)	PUNCT
bam-12939	84	70	2	2	NUM
bam-12939	84	71	(	(	PUNCT
bam-12939	84	72	33.3	33.3	NUM
bam-12939	84	73	)	)	PUNCT
bam-12939	84	74	χ2=0.175	χ2=0.175	PROPN
bam-12939	84	75	1.22	1.22	NUM
bam-12939	84	76	(	(	PUNCT
bam-12939	84	77	0.41,3.64	0.41,3.64	NOUN
bam-12939	84	78	)	)	PUNCT
bam-12939	84	79	bb	bb	NOUN
bam-12939	84	80	6	6	NUM
bam-12939	84	81	(	(	PUNCT
bam-12939	84	82	28.6	28.6	NUM
bam-12939	84	83	)	)	SYM
bam-12939	84	84	2	2	NUM
bam-12939	84	85	(	(	PUNCT
bam-12939	84	86	33.3	33.3	NUM
bam-12939	84	87	)	)	PUNCT
bam-12939	84	88	p=0.916	p=0.916	NOUN
bam-12939	84	89	bb	bb	NUM
bam-12939	84	90	6	6	NUM
bam-12939	84	91	(	(	PUNCT
bam-12939	84	92	28.6	28.6	NUM
bam-12939	84	93	)	)	SYM
bam-12939	84	94	2	2	NUM
bam-12939	84	95	(	(	PUNCT
bam-12939	84	96	33.3	33.3	NUM
bam-12939	84	97	)	)	PUNCT
bam-12939	84	98	table	table	NOUN
bam-12939	84	99	3	3	NUM
bam-12939	84	100	.	.	X
bam-12939	84	101	association	association	NOUN
bam-12939	84	102	between	between	ADP
bam-12939	84	103	adipocyte	adipocyte	NOUN
bam-12939	84	104	and	and	CCONJ
bam-12939	84	105	vdr	vdr	NOUN
bam-12939	84	106	changes	change	NOUN
bam-12939	84	107	.	.	PUNCT
bam-12939	85	1	snps	snps	PROPN
bam-12939	85	2	genotype	genotype	NOUN
bam-12939	85	3	odds	odd	NOUN
bam-12939	85	4	ratio	ratio	NOUN
bam-12939	85	5	(	(	PUNCT
bam-12939	85	6	95	95	NUM
bam-12939	85	7	%	%	NOUN
bam-12939	85	8	ci	ci	NOUN
bam-12939	85	9	)	)	PUNCT
bam-12939	85	10	foki	foki	ADJ
bam-12939	85	11	rs2228570	rs2228570	NOUN
bam-12939	85	12	ff	ff	NOUN
bam-12939	85	13	7.28	7.28	NUM
bam-12939	85	14	ff	ff	NOUN
bam-12939	85	15	(	(	PUNCT
bam-12939	85	16	1.86	1.86	NUM
bam-12939	85	17	,	,	PUNCT
bam-12939	85	18	28.41	28.41	NUM
bam-12939	85	19	)	)	PUNCT
bam-12939	85	20	ff	ff	NOUN
bam-12939	85	21	p=0.04	p=0.04	NOUN
bam-12939	85	22	apai	apai	NOUN
bam-12939	85	23	rs7975232	rs7975232	NOUN
bam-12939	86	1	aa	aa	NOUN
bam-12939	86	2	1.28	1.28	NUM
bam-12939	86	3	aa	aa	NOUN
bam-12939	86	4	(	(	PUNCT
bam-12939	86	5	0.45	0.45	NUM
bam-12939	86	6	,	,	PUNCT
bam-12939	86	7	3.62	3.62	NUM
bam-12939	86	8	)	)	PUNCT
bam-12939	86	9	aa	aa	NOUN
bam-12939	86	10	p=0.636	p=0.636	ADP
bam-12939	86	11	taqi	taqi	ADV
bam-12939	86	12	rs731236	rs731236	PROPN
bam-12939	86	13	tt	tt	PROPN
bam-12939	86	14	1.89	1.89	NUM
bam-12939	86	15	tt	tt	PROPN
bam-12939	86	16	(	(	PUNCT
bam-12939	86	17	0.74	0.74	NUM
bam-12939	86	18	,	,	PUNCT
bam-12939	86	19	4.84	4.84	NUM
bam-12939	86	20	)	)	PUNCT
bam-12939	86	21	tt	tt	PROPN
bam-12939	86	22	p=0.180	p=0.180	NOUN
bam-12939	86	23	bsmi	bsmi	PROPN
bam-12939	86	24	rs1544410	rs1544410	PROPN
bam-12939	86	25	bb	bb	PROPN
bam-12939	86	26	0.94	0.94	NUM
bam-12939	86	27	bb	bb	NOUN
bam-12939	86	28	(	(	PUNCT
bam-12939	86	29	0.42,2.08	0.42,2.08	NOUN
bam-12939	86	30	)	)	PUNCT
bam-12939	87	1	bb	bb	NOUN
bam-12939	87	2	p=0.887	p=0.887	PUNCT
bam-12939	87	3	non	non	ADJ
bam-12939	87	4	-co	-co	PROPN
bam-12939	87	5	mmerc	mmerc	PROPN
bam-12939	87	6	ial	ial	PROPN
bam-12939	87	7	us	us	PROPN
bam-12939	87	8	e	e	NOUN
bam-12939	87	9	o	o	NOUN
bam-12939	87	10	nly	nly	ADV
bam-12939	87	11	vitamin	vitamin	VERB
bam-12939	87	12	d	d	NOUN
bam-12939	87	13	receptor	receptor	NOUN
bam-12939	87	14	and	and	CCONJ
bam-12939	87	15	clinical	clinical	ADJ
bam-12939	87	16	and	and	CCONJ
bam-12939	87	17	inflammatory	inflammatory	ADJ
bam-12939	87	18	factors	factor	NOUN
bam-12939	87	19	in	in	ADP
bam-12939	87	20	patients	patient	NOUN
bam-12939	87	21	with	with	ADP
bam-12939	87	22	relapsing	relapse	VERB
bam-12939	87	23	-	-	PUNCT
bam-12939	87	24	remitting	remit	VERB
bam-12939	87	25	multiple	multiple	ADJ
bam-12939	87	26	sclerosis	sclerosis	NOUN
bam-12939	87	27	eur	eur	PROPN
bam-12939	87	28	j	j	PROPN
bam-12939	87	29	transl	transl	PROPN
bam-12939	87	30	myol	myol	NOUN
bam-12939	87	31	34	34	NUM
bam-12939	87	32	(	(	PUNCT
bam-12939	87	33	4	4	NUM
bam-12939	87	34	)	)	PUNCT
bam-12939	87	35	12939	12939	NUM
bam-12939	87	36	,	,	PUNCT
bam-12939	87	37	2024	2024	NUM
bam-12939	87	38	doi	doi	NOUN
bam-12939	87	39	:	:	PUNCT
bam-12939	87	40	10.4081	10.4081	NUM
bam-12939	87	41	/	/	SYM
bam-12939	87	42	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	87	43	healthy	healthy	ADJ
bam-12939	87	44	subjects	subject	NOUN
bam-12939	87	45	(	(	PUNCT
bam-12939	87	46	436.08±24.82	436.08±24.82	NOUN
bam-12939	87	47	)	)	PUNCT
bam-12939	87	48	(	(	PUNCT
bam-12939	87	49	p<0.001	p<0.001	PROPN
bam-12939	87	50	)	)	PUNCT
bam-12939	87	51	.	.	PUNCT
bam-12939	88	1	the	the	DET
bam-12939	88	2	amount	amount	NOUN
bam-12939	88	3	of	of	ADP
bam-12939	88	4	acetate	acetate	NOUN
bam-12939	88	5	was	be	AUX
bam-12939	88	6	significantly	significantly	ADV
bam-12939	88	7	lower	low	ADJ
bam-12939	88	8	in	in	ADP
bam-12939	88	9	rrms	rrm	NOUN
bam-12939	88	10	patients	patient	NOUN
bam-12939	88	11	compared	compare	VERB
bam-12939	88	12	to	to	ADP
bam-12939	88	13	healthy	healthy	ADJ
bam-12939	88	14	subjects	subject	NOUN
bam-12939	88	15	(	(	PUNCT
bam-12939	88	16	364.72±37.56	364.72±37.56	NUM
bam-12939	88	17	μmol	μmol	NOUN
bam-12939	88	18	/	/	SYM
bam-12939	88	19	l	l	NOUN
bam-12939	88	20	vs.	vs.	X
bam-12939	88	21	414.58±25.26	414.58±25.26	ADJ
bam-12939	88	22	μmol	μmol	NOUN
bam-12939	88	23	/	/	SYM
bam-12939	88	24	l	l	NOUN
bam-12939	88	25	;	;	PUNCT
bam-12939	88	26	p<0.001	p<0.001	X
bam-12939	88	27	)	)	PUNCT
bam-12939	88	28	.	.	PUNCT
bam-12939	89	1	while	while	SCONJ
bam-12939	89	2	there	there	PRON
bam-12939	89	3	was	be	VERB
bam-12939	89	4	no	no	DET
bam-12939	89	5	statistically	statistically	ADV
bam-12939	89	6	significant	significant	ADJ
bam-12939	89	7	difference	difference	NOUN
bam-12939	89	8	in	in	ADP
bam-12939	89	9	propionate	propionate	NOUN
bam-12939	89	10	and	and	CCONJ
bam-12939	89	11	butyrate	butyrate	NOUN
bam-12939	89	12	levels	level	NOUN
bam-12939	89	13	(	(	PUNCT
bam-12939	89	14	p>0.05	p>0.05	PROPN
bam-12939	89	15	)	)	PUNCT
bam-12939	89	16	.	.	PUNCT
bam-12939	90	1	according	accord	VERB
bam-12939	90	2	to	to	ADP
bam-12939	90	3	table	table	NOUN
bam-12939	90	4	4	4	NUM
bam-12939	90	5	,	,	PUNCT
bam-12939	90	6	statistical	statistical	ADJ
bam-12939	90	7	analysis	analysis	NOUN
bam-12939	90	8	of	of	ADP
bam-12939	90	9	foki	foki	ADJ
bam-12939	90	10	polymorphism	polymorphism	NOUN
bam-12939	90	11	showed	show	VERB
bam-12939	90	12	a	a	DET
bam-12939	90	13	significant	significant	ADJ
bam-12939	90	14	increase	increase	NOUN
bam-12939	90	15	in	in	ADP
bam-12939	90	16	risk	risk	NOUN
bam-12939	90	17	in	in	ADP
bam-12939	90	18	rrms	rrm	NOUN
bam-12939	90	19	patients	patient	NOUN
bam-12939	90	20	with	with	ADP
bam-12939	90	21	ff	ff	NOUN
bam-12939	90	22	genotype	genotype	NOUN
bam-12939	90	23	compared	compare	VERB
bam-12939	90	24	to	to	ADP
bam-12939	90	25	the	the	DET
bam-12939	90	26	control	control	NOUN
bam-12939	90	27	group	group	NOUN
bam-12939	90	28	(	(	PUNCT
bam-12939	90	29	or=0.1	or=0.1	NOUN
bam-12939	90	30	:	:	PUNCT
bam-12939	90	31	95	95	NUM
bam-12939	90	32	%	%	NOUN
bam-12939	90	33	ci	ci	NOUN
bam-12939	90	34	;	;	PUNCT
bam-12939	90	35	0.22	0.22	NUM
bam-12939	90	36	,	,	PUNCT
bam-12939	90	37	0.49	0.49	NUM
bam-12939	90	38	)	)	PUNCT
bam-12939	90	39	.	.	PUNCT
bam-12939	91	1	statistical	statistical	ADJ
bam-12939	91	2	analyzes	analyze	NOUN
bam-12939	91	3	of	of	ADP
bam-12939	91	4	apai	apai	NOUN
bam-12939	91	5	,	,	PUNCT
bam-12939	91	6	taqi	taqi	ADJ
bam-12939	91	7	and	and	CCONJ
bam-12939	91	8	bsmi	bsmi	NOUN
bam-12939	91	9	polymorphisms	polymorphism	NOUN
bam-12939	91	10	showed	show	VERB
bam-12939	91	11	no	no	DET
bam-12939	91	12	significant	significant	ADJ
bam-12939	91	13	increase	increase	NOUN
bam-12939	91	14	in	in	ADP
bam-12939	91	15	risk	risk	NOUN
bam-12939	91	16	in	in	ADP
bam-12939	91	17	rrms	rrm	NOUN
bam-12939	91	18	patients	patient	NOUN
bam-12939	91	19	with	with	ADP
bam-12939	91	20	genotypes	genotype	NOUN
bam-12939	91	21	compared	compare	VERB
bam-12939	91	22	to	to	ADP
bam-12939	91	23	controls	control	NOUN
bam-12939	91	24	.	.	PUNCT
bam-12939	92	1	discussion	discussion	NOUN
bam-12939	92	2	based	base	VERB
bam-12939	92	3	on	on	ADP
bam-12939	92	4	the	the	DET
bam-12939	92	5	results	result	NOUN
bam-12939	92	6	of	of	ADP
bam-12939	92	7	the	the	DET
bam-12939	92	8	present	present	ADJ
bam-12939	92	9	study	study	NOUN
bam-12939	92	10	,	,	PUNCT
bam-12939	92	11	it	it	PRON
bam-12939	92	12	was	be	AUX
bam-12939	92	13	observed	observe	VERB
bam-12939	92	14	that	that	SCONJ
bam-12939	92	15	low	low	ADJ
bam-12939	92	16	serum	serum	NOUN
bam-12939	92	17	levels	level	NOUN
bam-12939	92	18	of	of	ADP
bam-12939	92	19	25	25	NUM
bam-12939	92	20	-	-	PUNCT
bam-12939	92	21	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	92	22	d	d	NOUN
bam-12939	92	23	were	be	AUX
bam-12939	92	24	observed	observe	VERB
bam-12939	92	25	in	in	ADP
bam-12939	92	26	patients	patient	NOUN
bam-12939	92	27	with	with	ADP
bam-12939	92	28	ms	ms	PROPN
bam-12939	92	29	.	.	PROPN
bam-12939	92	30	patients	patient	NOUN
bam-12939	92	31	with	with	ADP
bam-12939	92	32	ms	ms	PROPN
bam-12939	92	33	had	have	VERB
bam-12939	92	34	significantly	significantly	ADV
bam-12939	92	35	lower	low	ADJ
bam-12939	92	36	mean	mean	VERB
bam-12939	92	37	serum	serum	NOUN
bam-12939	92	38	levels	level	NOUN
bam-12939	92	39	of	of	ADP
bam-12939	92	40	25	25	NUM
bam-12939	92	41	-	-	PUNCT
bam-12939	92	42	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	92	43	d	d	NOUN
bam-12939	92	44	than	than	ADP
bam-12939	92	45	healthy	healthy	ADJ
bam-12939	92	46	individuals	individual	NOUN
bam-12939	92	47	,	,	PUNCT
bam-12939	92	48	which	which	PRON
bam-12939	92	49	was	be	AUX
bam-12939	92	50	considered	consider	VERB
bam-12939	92	51	statistically	statistically	ADV
bam-12939	92	52	significant	significant	ADJ
bam-12939	92	53	.	.	PUNCT
bam-12939	93	1	the	the	DET
bam-12939	93	2	present	present	ADJ
bam-12939	93	3	study	study	NOUN
bam-12939	93	4	observed	observe	VERB
bam-12939	93	5	a	a	DET
bam-12939	93	6	statistically	statistically	ADV
bam-12939	93	7	significant	significant	ADJ
bam-12939	93	8	association	association	NOUN
bam-12939	93	9	between	between	ADP
bam-12939	93	10	low	low	ADJ
bam-12939	93	11	serum	serum	NOUN
bam-12939	93	12	levels	level	NOUN
bam-12939	93	13	of	of	ADP
bam-12939	93	14	25hydroxyvitamin	25hydroxyvitamin	PROPN
bam-12939	93	15	d	d	NOUN
bam-12939	93	16	and	and	CCONJ
bam-12939	93	17	ms	ms	NOUN
bam-12939	93	18	progression	progression	NOUN
bam-12939	93	19	.	.	PUNCT
bam-12939	94	1	vickaryous	vickaryous	ADJ
bam-12939	94	2	et	et	PROPN
bam-12939	94	3	al	al	PROPN
bam-12939	94	4	.	.	PROPN
bam-12939	95	1	(	(	PUNCT
bam-12939	95	2	2020	2020	NUM
bam-12939	95	3	)	)	PUNCT
bam-12939	95	4	showed	show	VERB
bam-12939	95	5	that	that	SCONJ
bam-12939	95	6	serum	serum	NOUN
bam-12939	95	7	25(oh)d	25(oh)d	NUM
bam-12939	95	8	levels	level	NOUN
bam-12939	95	9	were	be	AUX
bam-12939	95	10	higher	high	ADJ
bam-12939	95	11	in	in	ADP
bam-12939	95	12	ms	ms	NOUN
bam-12939	95	13	than	than	ADP
bam-12939	95	14	in	in	ADP
bam-12939	95	15	the	the	DET
bam-12939	95	16	control	control	NOUN
bam-12939	95	17	group	group	NOUN
bam-12939	95	18	(	(	PUNCT
bam-12939	95	19	healthy	healthy	ADJ
bam-12939	95	20	subjects	subject	NOUN
bam-12939	95	21	)	)	PUNCT
bam-12939	95	22	(	(	PUNCT
bam-12939	95	23	median	median	NOUN
bam-12939	95	24	71	71	NUM
bam-12939	95	25	nmol	nmol	NOUN
bam-12939	95	26	/	/	SYM
bam-12939	95	27	l	l	NOUN
bam-12939	95	28	vs.	vs.	ADP
bam-12939	95	29	49	49	NUM
bam-12939	95	30	nmol	nmol	NOUN
bam-12939	95	31	/	/	SYM
bam-12939	95	32	l).17	l).17	PROPN
bam-12939	95	33	a	a	DET
bam-12939	95	34	population	population	NOUN
bam-12939	95	35	-	-	PUNCT
bam-12939	95	36	based	base	VERB
bam-12939	95	37	prospective	prospective	ADJ
bam-12939	95	38	cohort	cohort	NOUN
bam-12939	95	39	study	study	NOUN
bam-12939	95	40	of	of	ADP
bam-12939	95	41	145	145	NUM
bam-12939	95	42	people	people	NOUN
bam-12939	95	43	with	with	ADP
bam-12939	95	44	rrms	rrm	NOUN
bam-12939	95	45	living	live	VERB
bam-12939	95	46	in	in	ADP
bam-12939	95	47	southern	southern	ADJ
bam-12939	95	48	tasmania	tasmania	PROPN
bam-12939	95	49	and	and	CCONJ
bam-12939	95	50	australia	australia	PROPN
bam-12939	95	51	from	from	ADP
bam-12939	95	52	2002	2002	NUM
bam-12939	95	53	to	to	ADP
bam-12939	95	54	2005	2005	NUM
bam-12939	95	55	found	find	VERB
bam-12939	95	56	that	that	SCONJ
bam-12939	95	57	higher	high	ADJ
bam-12939	95	58	25(oh)d	25(oh)d	NUM
bam-12939	95	59	levels	level	NOUN
bam-12939	95	60	were	be	AUX
bam-12939	95	61	associated	associate	VERB
bam-12939	95	62	with	with	ADP
bam-12939	95	63	a	a	DET
bam-12939	95	64	reduced	reduced	ADJ
bam-12939	95	65	risk	risk	NOUN
bam-12939	95	66	of	of	ADP
bam-12939	95	67	relapse	relapse	NOUN
bam-12939	95	68	.	.	PUNCT
bam-12939	96	1	every	every	DET
bam-12939	96	2	10	10	NUM
bam-12939	96	3	nmol	nmol	NOUN
bam-12939	96	4	/	/	SYM
bam-12939	96	5	l	l	NOUN
bam-12939	96	6	increase	increase	NOUN
bam-12939	96	7	in	in	ADP
bam-12939	96	8	25(oh)d	25(oh)d	NOUN
bam-12939	96	9	leads	lead	VERB
bam-12939	96	10	to	to	ADP
bam-12939	96	11	a	a	DET
bam-12939	96	12	12	12	NUM
bam-12939	96	13	%	%	NOUN
bam-12939	96	14	reduction	reduction	NOUN
bam-12939	96	15	in	in	ADP
bam-12939	96	16	the	the	DET
bam-12939	96	17	risk	risk	NOUN
bam-12939	96	18	of	of	ADP
bam-12939	96	19	recurrence	recurrence	NOUN
bam-12939	96	20	.	.	PUNCT
bam-12939	97	1	these	these	DET
bam-12939	97	2	clinical	clinical	ADJ
bam-12939	97	3	findings	finding	NOUN
bam-12939	97	4	are	be	AUX
bam-12939	97	5	also	also	ADV
bam-12939	97	6	related	relate	VERB
bam-12939	97	7	to	to	ADP
bam-12939	97	8	the	the	DET
bam-12939	97	9	radiological	radiological	ADJ
bam-12939	97	10	signs	sign	NOUN
bam-12939	97	11	of	of	ADP
bam-12939	97	12	ms	ms	PROPN
bam-12939	97	13	disease	disease	NOUN
bam-12939	97	14	activity.18	activity.18	VERB
bam-12939	97	15	a	a	DET
bam-12939	97	16	prospective	prospective	ADJ
bam-12939	97	17	cohort	cohort	NOUN
bam-12939	97	18	study	study	NOUN
bam-12939	97	19	of	of	ADP
bam-12939	97	20	1482	1482	NUM
bam-12939	97	21	participants	participant	NOUN
bam-12939	97	22	with	with	ADP
bam-12939	97	23	ms	ms	PROPN
bam-12939	97	24	in	in	ADP
bam-12939	97	25	the	the	DET
bam-12939	97	26	beyond	beyond	ADJ
bam-12939	97	27	study	study	NOUN
bam-12939	97	28	treated	treat	VERB
bam-12939	97	29	with	with	ADP
bam-12939	97	30	interferon	interferon	ADJ
bam-12939	97	31	beta1b	beta1b	PROPN
bam-12939	97	32	showed	show	VERB
bam-12939	97	33	that	that	SCONJ
bam-12939	97	34	a	a	DET
bam-12939	97	35	50.0	50.0	NUM
bam-12939	97	36	nmol	nmol	NOUN
bam-12939	97	37	/	/	SYM
bam-12939	97	38	l	l	NOUN
bam-12939	97	39	increase	increase	NOUN
bam-12939	97	40	in	in	ADP
bam-12939	97	41	25(oh)d	25(oh)d	NUM
bam-12939	97	42	blood	blood	NOUN
bam-12939	97	43	levels	level	NOUN
bam-12939	97	44	was	be	AUX
bam-12939	97	45	associated	associate	VERB
bam-12939	97	46	with	with	ADP
bam-12939	97	47	a	a	DET
bam-12939	97	48	31	31	NUM
bam-12939	97	49	%	%	NOUN
bam-12939	97	50	lower	low	ADJ
bam-12939	97	51	rate	rate	NOUN
bam-12939	97	52	of	of	ADP
bam-12939	97	53	new	new	ADJ
bam-12939	97	54	lesions	lesion	NOUN
bam-12939	97	55	was	be	AUX
bam-12939	97	56	connected	connect	VERB
bam-12939	97	57	in	in	ADP
bam-12939	97	58	the	the	DET
bam-12939	97	59	mri	mri	NOUN
bam-12939	97	60	.	.	PUNCT
bam-12939	98	1	is	be	AUX
bam-12939	98	2	.	.	PUNCT
bam-12939	99	1	patients	patient	NOUN
bam-12939	99	2	with	with	ADP
bam-12939	99	3	25(oh)d	25(oh)d	NOUN
bam-12939	99	4	levels	level	NOUN
bam-12939	99	5	above	above	ADP
bam-12939	99	6	100.0	100.0	NUM
bam-12939	99	7	nmol	nmol	NOUN
bam-12939	99	8	/	/	SYM
bam-12939	99	9	l	l	NOUN
bam-12939	99	10	had	have	VERB
bam-12939	99	11	the	the	DET
bam-12939	99	12	lowest	low	ADJ
bam-12939	99	13	rate	rate	NOUN
bam-12939	99	14	of	of	ADP
bam-12939	99	15	new	new	ADJ
bam-12939	99	16	lesions	lesion	NOUN
bam-12939	99	17	on	on	ADP
bam-12939	99	18	mri	mri	NOUN
bam-12939	99	19	.	.	PUNCT
bam-12939	100	1	however	however	ADV
bam-12939	100	2	,	,	PUNCT
bam-12939	100	3	no	no	DET
bam-12939	100	4	significant	significant	ADJ
bam-12939	100	5	association	association	NOUN
bam-12939	100	6	with	with	ADP
bam-12939	100	7	recurrence	recurrence	NOUN
bam-12939	100	8	rate	rate	NOUN
bam-12939	100	9	was	be	AUX
bam-12939	100	10	observed.19	observed.19	NOUN
bam-12939	100	11	in	in	ADP
bam-12939	100	12	a	a	DET
bam-12939	100	13	large	large	ADJ
bam-12939	100	14	multicenter	multicenter	NOUN
bam-12939	100	15	study	study	NOUN
bam-12939	100	16	,	,	PUNCT
bam-12939	100	17	1047	1047	NUM
bam-12939	100	18	cases	case	NOUN
bam-12939	100	19	of	of	ADP
bam-12939	100	20	clinically	clinically	ADV
bam-12939	100	21	isolated	isolate	VERB
bam-12939	100	22	syndrome	syndrome	NOUN
bam-12939	100	23	(	(	PUNCT
bam-12939	100	24	cis	cis	NOUN
bam-12939	100	25	)	)	PUNCT
bam-12939	100	26	from	from	ADP
bam-12939	100	27	17	17	NUM
bam-12939	100	28	different	different	ADJ
bam-12939	100	29	countries	country	NOUN
bam-12939	100	30	were	be	AUX
bam-12939	100	31	observed	observe	VERB
bam-12939	100	32	over	over	ADP
bam-12939	100	33	a	a	DET
bam-12939	100	34	period	period	NOUN
bam-12939	100	35	of	of	ADP
bam-12939	100	36	4.31	4.31	NUM
bam-12939	100	37	years	year	NOUN
bam-12939	100	38	.	.	PUNCT
bam-12939	101	1	clinical	clinical	ADJ
bam-12939	101	2	and	and	CCONJ
bam-12939	101	3	biochemical	biochemical	ADJ
bam-12939	101	4	variables	variable	NOUN
bam-12939	101	5	were	be	AUX
bam-12939	101	6	evaluated	evaluate	VERB
bam-12939	101	7	to	to	PART
bam-12939	101	8	determine	determine	VERB
bam-12939	101	9	their	their	PRON
bam-12939	101	10	value	value	NOUN
bam-12939	101	11	in	in	ADP
bam-12939	101	12	predicting	predict	VERB
bam-12939	101	13	progression	progression	NOUN
bam-12939	101	14	from	from	ADP
bam-12939	101	15	cis	cis	NOUN
bam-12939	101	16	to	to	ADP
bam-12939	101	17	clinically	clinically	ADV
bam-12939	101	18	confirmed	confirm	VERB
bam-12939	101	19	multiple	multiple	ADJ
bam-12939	101	20	sclerosis	sclerosis	NOUN
bam-12939	101	21	(	(	PUNCT
bam-12939	101	22	cdms	cdms	PROPN
bam-12939	101	23	)	)	PUNCT
bam-12939	101	24	.	.	PUNCT
bam-12939	102	1	patients	patient	NOUN
bam-12939	102	2	with	with	ADP
bam-12939	102	3	high	high	ADJ
bam-12939	102	4	25(oh)d	25(oh)d	NUM
bam-12939	102	5	levels	level	NOUN
bam-12939	102	6	significantly	significantly	ADV
bam-12939	102	7	reduced	reduce	VERB
bam-12939	102	8	the	the	DET
bam-12939	102	9	risk	risk	NOUN
bam-12939	102	10	of	of	ADP
bam-12939	102	11	conversion	conversion	NOUN
bam-12939	102	12	in	in	ADP
bam-12939	102	13	the	the	DET
bam-12939	102	14	univariate	univariate	ADJ
bam-12939	102	15	analysis	analysis	NOUN
bam-12939	102	16	.	.	PUNCT
bam-12939	103	1	multivariate	multivariate	NOUN
bam-12939	103	2	analysis	analysis	NOUN
bam-12939	103	3	did	do	AUX
bam-12939	103	4	not	not	PART
bam-12939	103	5	reproduce	reproduce	VERB
bam-12939	103	6	the	the	DET
bam-12939	103	7	same	same	ADJ
bam-12939	103	8	results	result	NOUN
bam-12939	103	9	,	,	PUNCT
bam-12939	103	10	but	but	CCONJ
bam-12939	103	11	at	at	ADP
bam-12939	103	12	the	the	DET
bam-12939	103	13	same	same	ADJ
bam-12939	103	14	time	time	NOUN
bam-12939	103	15	reduced	reduce	VERB
bam-12939	103	16	the	the	DET
bam-12939	103	17	risk	risk	NOUN
bam-12939	103	18	of	of	ADP
bam-12939	103	19	conversion	conversion	NOUN
bam-12939	103	20	and	and	CCONJ
bam-12939	103	21	statistical	statistical	ADJ
bam-12939	103	22	significance.20	significance.20	PROPN
bam-12939	103	23	yu	yu	PROPN
bam-12939	103	24	et	et	PROPN
bam-12939	103	25	al	al	PROPN
bam-12939	103	26	.	.	PROPN
bam-12939	104	1	(	(	PUNCT
bam-12939	104	2	2020	2020	NUM
bam-12939	104	3	)	)	PUNCT
bam-12939	104	4	examined	examine	VERB
bam-12939	104	5	the	the	DET
bam-12939	104	6	association	association	NOUN
bam-12939	104	7	between	between	ADP
bam-12939	104	8	vdr	vdr	PROPN
bam-12939	104	9	snp	snp	PROPN
bam-12939	104	10	and	and	CCONJ
bam-12939	104	11	obesity	obesity	NOUN
bam-12939	104	12	(	(	PUNCT
bam-12939	104	13	bmi	bmi	X
bam-12939	104	14	≥	≥	PROPN
bam-12939	104	15	28	28	NUM
bam-12939	104	16	kg	kg	PROPN
bam-12939	104	17	/	/	SYM
bam-12939	104	18	m2	m2	PROPN
bam-12939	104	19	)	)	PUNCT
bam-12939	104	20	and	and	CCONJ
bam-12939	104	21	reported	report	VERB
bam-12939	104	22	that	that	SCONJ
bam-12939	104	23	rs3847987	rs3847987	PROPN
bam-12939	104	24	(	(	PUNCT
bam-12939	104	25	ac	ac	PROPN
bam-12939	104	26	vs.	vs.	ADP
bam-12939	104	27	cc	cc	PROPN
bam-12939	104	28	,	,	PUNCT
bam-12939	104	29	adjusted	adjust	VERB
bam-12939	104	30	or	or	CCONJ
bam-12939	104	31	:	:	PUNCT
bam-12939	104	32	1.938	1.938	NUM
bam-12939	104	33	,	,	PUNCT
bam-12939	104	34	95	95	NUM
bam-12939	104	35	%	%	NOUN
bam-12939	104	36	ci	ci	NOUN
bam-12939	104	37	:	:	PUNCT
bam-12939	104	38	1.359–2.763	1.359–2.763	NUM
bam-12939	104	39	,	,	PUNCT
bam-12939	104	40	p=0.000405	p=0.000405	PROPN
bam-12939	104	41	)	)	PUNCT
bam-12939	104	42	was	be	AUX
bam-12939	104	43	associated	associate	VERB
bam-12939	104	44	with	with	ADP
bam-12939	104	45	obesity	obesity	NOUN
bam-12939	104	46	.	.	PUNCT
bam-12939	105	1	it	it	PRON
bam-12939	105	2	was	be	AUX
bam-12939	105	3	relevant	relevant	ADJ
bam-12939	105	4	.	.	PUNCT
bam-12939	106	1	the	the	DET
bam-12939	106	2	c	c	PROPN
bam-12939	106	3	allele	allele	NOUN
bam-12939	106	4	of	of	ADP
bam-12939	106	5	rs3847987	rs3847987	PROPN
bam-12939	106	6	was	be	AUX
bam-12939	106	7	a	a	DET
bam-12939	106	8	risk	risk	NOUN
bam-12939	106	9	factor	factor	NOUN
bam-12939	106	10	for	for	ADP
bam-12939	106	11	obesity.21	obesity.21	PROPN
bam-12939	106	12	in	in	ADP
bam-12939	106	13	the	the	DET
bam-12939	106	14	present	present	ADJ
bam-12939	106	15	study	study	NOUN
bam-12939	106	16	,	,	PUNCT
bam-12939	106	17	foki	foki	ADJ
bam-12939	106	18	polymorphism	polymorphism	NOUN
bam-12939	106	19	showed	show	VERB
bam-12939	106	20	a	a	DET
bam-12939	106	21	significant	significant	ADJ
bam-12939	106	22	increase	increase	NOUN
bam-12939	106	23	in	in	ADP
bam-12939	106	24	risk	risk	NOUN
bam-12939	106	25	with	with	ADP
bam-12939	106	26	an	an	DET
bam-12939	106	27	odds	odd	NOUN
bam-12939	106	28	ratio	ratio	NOUN
bam-12939	106	29	of	of	ADP
bam-12939	106	30	28.7	28.7	NUM
bam-12939	106	31	in	in	ADP
bam-12939	106	32	rrms	rrm	NOUN
bam-12939	106	33	patients	patient	NOUN
bam-12939	106	34	with	with	ADP
bam-12939	106	35	ff	ff	NOUN
bam-12939	106	36	genotype	genotype	NOUN
bam-12939	106	37	who	who	PRON
bam-12939	106	38	had	have	VERB
bam-12939	106	39	high	high	ADJ
bam-12939	106	40	adiponectin	adiponectin	NOUN
bam-12939	106	41	levels	level	NOUN
bam-12939	106	42	compared	compare	VERB
bam-12939	106	43	to	to	ADP
bam-12939	106	44	the	the	DET
bam-12939	106	45	control	control	NOUN
bam-12939	106	46	group	group	NOUN
bam-12939	106	47	(	(	PUNCT
bam-12939	106	48	or=7.28	or=7.28	PROPN
bam-12939	106	49	:	:	PUNCT
bam-12939	106	50	95	95	NUM
bam-12939	106	51	%	%	NOUN
bam-12939	106	52	ci	ci	NOUN
bam-12939	106	53	;	;	PUNCT
bam-12939	106	54	1.86	1.86	NUM
bam-12939	106	55	,	,	PUNCT
bam-12939	106	56	28.41	28.41	NUM
bam-12939	106	57	)	)	PUNCT
bam-12939	106	58	.	.	PUNCT
bam-12939	107	1	further	further	ADJ
bam-12939	107	2	studies	study	NOUN
bam-12939	107	3	are	be	AUX
bam-12939	107	4	needed	need	VERB
bam-12939	107	5	to	to	PART
bam-12939	107	6	clarify	clarify	VERB
bam-12939	107	7	the	the	DET
bam-12939	107	8	contribution	contribution	NOUN
bam-12939	107	9	of	of	ADP
bam-12939	107	10	vdr	vdr	NOUN
bam-12939	107	11	genetic	genetic	PROPN
bam-12939	107	12	snps	snps	PROPN
bam-12939	107	13	on	on	ADP
bam-12939	107	14	serum	serum	NOUN
bam-12939	107	15	25(oh)d	25(oh)d	NOUN
bam-12939	107	16	in	in	ADP
bam-12939	107	17	people	people	NOUN
bam-12939	107	18	with	with	ADP
bam-12939	107	19	ms	ms	PROPN
bam-12939	107	20	.	.	PROPN
bam-12939	108	1	the	the	DET
bam-12939	108	2	exact	exact	ADJ
bam-12939	108	3	molecular	molecular	ADJ
bam-12939	108	4	mechanism	mechanism	NOUN
bam-12939	108	5	explaining	explain	VERB
bam-12939	108	6	the	the	DET
bam-12939	108	7	association	association	NOUN
bam-12939	108	8	between	between	ADP
bam-12939	108	9	vdr	vdr	NOUN
bam-12939	108	10	polymorphisms	polymorphism	NOUN
bam-12939	108	11	and	and	CCONJ
bam-12939	108	12	serum	serum	NOUN
bam-12939	108	13	25(oh)d	25(oh)d	NUM
bam-12939	108	14	levels	level	NOUN
bam-12939	108	15	remains	remain	VERB
bam-12939	108	16	unknown	unknown	ADJ
bam-12939	108	17	.	.	PUNCT
bam-12939	109	1	levin	levin	PROPN
bam-12939	109	2	et	et	PROPN
bam-12939	109	3	al	al	PROPN
bam-12939	109	4	.	.	PROPN
bam-12939	110	1	(	(	PUNCT
bam-12939	110	2	2012	2012	NUM
bam-12939	110	3	)	)	PUNCT
bam-12939	110	4	reported	report	VERB
bam-12939	110	5	that	that	SCONJ
bam-12939	110	6	greater	great	ADJ
bam-12939	110	7	vdr	vdr	NOUN
bam-12939	110	8	activity	activity	NOUN
bam-12939	110	9	for	for	ADP
bam-12939	110	10	a	a	DET
bam-12939	110	11	given	give	VERB
bam-12939	110	12	amount	amount	NOUN
bam-12939	110	13	of	of	ADP
bam-12939	110	14	25(oh)d	25(oh)d	NOUN
bam-12939	110	15	can	can	AUX
bam-12939	110	16	provide	provide	VERB
bam-12939	110	17	protection	protection	NOUN
bam-12939	110	18	under	under	ADP
bam-12939	110	19	low	low	ADJ
bam-12939	110	20	25(oh)d	25(oh)d	NOUN
bam-12939	110	21	substrate	substrate	NOUN
bam-12939	110	22	conditions.22	conditions.22	NOUN
bam-12939	110	23	however	however	ADV
bam-12939	110	24	,	,	PUNCT
bam-12939	110	25	no	no	DET
bam-12939	110	26	study	study	NOUN
bam-12939	110	27	was	be	AUX
bam-12939	110	28	found	find	VERB
bam-12939	110	29	that	that	PRON
bam-12939	110	30	could	could	AUX
bam-12939	110	31	accurately	accurately	ADV
bam-12939	110	32	compare	compare	VERB
bam-12939	110	33	the	the	DET
bam-12939	110	34	results	result	NOUN
bam-12939	110	35	of	of	ADP
bam-12939	110	36	the	the	DET
bam-12939	110	37	present	present	ADJ
bam-12939	110	38	study	study	NOUN
bam-12939	110	39	.	.	PUNCT
bam-12939	111	1	in	in	ADP
bam-12939	111	2	the	the	DET
bam-12939	111	3	present	present	ADJ
bam-12939	111	4	study	study	NOUN
bam-12939	111	5	,	,	PUNCT
bam-12939	111	6	the	the	DET
bam-12939	111	7	foki	foki	ADJ
bam-12939	111	8	polymorphism	polymorphism	NOUN
bam-12939	111	9	caused	cause	VERB
bam-12939	111	10	a	a	DET
bam-12939	111	11	significant	significant	ADJ
bam-12939	111	12	increase	increase	NOUN
bam-12939	111	13	in	in	ADP
bam-12939	111	14	risk	risk	NOUN
bam-12939	111	15	in	in	ADP
bam-12939	111	16	rrms	rrm	NOUN
bam-12939	111	17	patients	patient	NOUN
bam-12939	111	18	with	with	ADP
bam-12939	111	19	ff	ff	PROPN
bam-12939	111	20	geno37	geno37	NOUN
bam-12939	111	21	table	table	NOUN
bam-12939	111	22	4	4	NUM
bam-12939	111	23	.	.	X
bam-12939	111	24	association	association	NOUN
bam-12939	111	25	between	between	ADP
bam-12939	111	26	short	short	ADJ
bam-12939	111	27	-	-	PUNCT
bam-12939	111	28	chain	chain	NOUN
bam-12939	111	29	fatty	fatty	NOUN
bam-12939	111	30	acids	acid	NOUN
bam-12939	111	31	and	and	CCONJ
bam-12939	111	32	vdr	vdr	NOUN
bam-12939	111	33	changes	change	NOUN
bam-12939	111	34	.	.	PUNCT
bam-12939	112	1	snps	snps	PROPN
bam-12939	112	2	genotype	genotype	NOUN
bam-12939	112	3	odds	odd	NOUN
bam-12939	112	4	ratio	ratio	NOUN
bam-12939	112	5	(	(	PUNCT
bam-12939	112	6	95	95	NUM
bam-12939	112	7	%	%	NOUN
bam-12939	112	8	ci	ci	NOUN
bam-12939	112	9	)	)	PUNCT
bam-12939	112	10	foki	foki	ADJ
bam-12939	112	11	rs2228570	rs2228570	NOUN
bam-12939	112	12	ff	ff	NOUN
bam-12939	112	13	0.10	0.10	NUM
bam-12939	112	14	ff	ff	NOUN
bam-12939	112	15	(	(	PUNCT
bam-12939	112	16	0.22	0.22	NUM
bam-12939	112	17	,	,	PUNCT
bam-12939	112	18	0.49	0.49	NUM
bam-12939	112	19	)	)	PUNCT
bam-12939	112	20	ff	ff	NOUN
bam-12939	112	21	p=0.004	p=0.004	NOUN
bam-12939	112	22	apai	apai	NOUN
bam-12939	112	23	rs7975232	rs7975232	NOUN
bam-12939	112	24	aa	aa	NOUN
bam-12939	112	25	0.77	0.77	NUM
bam-12939	112	26	aa	aa	NOUN
bam-12939	112	27	(	(	PUNCT
bam-12939	112	28	0.186	0.186	NUM
bam-12939	112	29	,	,	PUNCT
bam-12939	112	30	3.242	3.242	NUM
bam-12939	112	31	)	)	PUNCT
bam-12939	113	1	aa	aa	PROPN
bam-12939	113	2	p=0.729	p=0.729	X
bam-12939	113	3	taqi	taqi	PROPN
bam-12939	113	4	rs731236	rs731236	PROPN
bam-12939	113	5	tt	tt	PROPN
bam-12939	113	6	0.82	0.82	NUM
bam-12939	113	7	tt	tt	PROPN
bam-12939	113	8	(	(	PUNCT
bam-12939	113	9	0.28	0.28	NUM
bam-12939	113	10	,	,	PUNCT
bam-12939	113	11	2.42	2.42	NUM
bam-12939	113	12	)	)	PUNCT
bam-12939	113	13	tt	tt	PROPN
bam-12939	113	14	p=0.825	p=0.825	PROPN
bam-12939	113	15	bsmi	bsmi	VERB
bam-12939	113	16	rs1544410	rs1544410	PROPN
bam-12939	113	17	bb	bb	NUM
bam-12939	113	18	3.10	3.10	NUM
bam-12939	113	19	bb	bb	NOUN
bam-12939	113	20	(	(	PUNCT
bam-12939	113	21	0.86,11.13	0.86,11.13	NOUN
bam-12939	113	22	)	)	PUNCT
bam-12939	113	23	bb	bb	NOUN
bam-12939	114	1	p=0.0.83	p=0.0.83	PROPN
bam-12939	114	2	non	non	ADJ
bam-12939	114	3	-co	-co	PROPN
bam-12939	114	4	mmerc	mmerc	PROPN
bam-12939	114	5	ial	ial	PROPN
bam-12939	114	6	us	us	PROPN
bam-12939	114	7	e	e	NOUN
bam-12939	114	8	o	o	NOUN
bam-12939	114	9	nly	nly	ADV
bam-12939	114	10	vitamin	vitamin	VERB
bam-12939	114	11	d	d	NOUN
bam-12939	114	12	receptor	receptor	NOUN
bam-12939	114	13	and	and	CCONJ
bam-12939	114	14	clinical	clinical	ADJ
bam-12939	114	15	and	and	CCONJ
bam-12939	114	16	inflammatory	inflammatory	ADJ
bam-12939	114	17	factors	factor	NOUN
bam-12939	114	18	in	in	ADP
bam-12939	114	19	patients	patient	NOUN
bam-12939	114	20	with	with	ADP
bam-12939	114	21	relapsing	relapse	VERB
bam-12939	114	22	-	-	PUNCT
bam-12939	114	23	remitting	remit	VERB
bam-12939	114	24	multiple	multiple	ADJ
bam-12939	114	25	sclerosis	sclerosis	NOUN
bam-12939	114	26	eur	eur	PROPN
bam-12939	114	27	j	j	PROPN
bam-12939	114	28	transl	transl	PROPN
bam-12939	114	29	myol	myol	NOUN
bam-12939	114	30	34	34	NUM
bam-12939	114	31	(	(	PUNCT
bam-12939	114	32	4	4	NUM
bam-12939	114	33	)	)	PUNCT
bam-12939	114	34	12939	12939	NUM
bam-12939	114	35	,	,	PUNCT
bam-12939	114	36	2024	2024	NUM
bam-12939	114	37	doi	doi	NOUN
bam-12939	114	38	:	:	PUNCT
bam-12939	114	39	10.4081	10.4081	NUM
bam-12939	114	40	/	/	SYM
bam-12939	114	41	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	114	42	type	type	NOUN
bam-12939	114	43	compared	compare	VERB
bam-12939	114	44	to	to	ADP
bam-12939	114	45	the	the	DET
bam-12939	114	46	control	control	NOUN
bam-12939	114	47	group	group	NOUN
bam-12939	114	48	with	with	ADP
bam-12939	114	49	an	an	DET
bam-12939	114	50	odds	odd	NOUN
bam-12939	114	51	ratio	ratio	NOUN
bam-12939	114	52	of	of	ADP
bam-12939	114	53	0.1	0.1	NUM
bam-12939	114	54	(	(	PUNCT
bam-12939	114	55	or=0.1	or=0.1	NOUN
bam-12939	114	56	:	:	PUNCT
bam-12939	114	57	95	95	NUM
bam-12939	114	58	%	%	NOUN
bam-12939	114	59	ci	ci	NOUN
bam-12939	114	60	;	;	PUNCT
bam-12939	114	61	0.22	0.22	NUM
bam-12939	114	62	,	,	PUNCT
bam-12939	114	63	0.49	0.49	NUM
bam-12939	114	64	)	)	PUNCT
bam-12939	114	65	.	.	PUNCT
bam-12939	115	1	however	however	ADV
bam-12939	115	2	,	,	PUNCT
bam-12939	115	3	apai	apai	NOUN
bam-12939	115	4	,	,	PUNCT
bam-12939	115	5	taqi	taqi	NOUN
bam-12939	115	6	and	and	CCONJ
bam-12939	115	7	bsmi	bsmi	NOUN
bam-12939	115	8	polymorphisms	polymorphism	NOUN
bam-12939	115	9	in	in	ADP
bam-12939	115	10	rrms	rrm	NOUN
bam-12939	115	11	patients	patient	NOUN
bam-12939	115	12	with	with	ADP
bam-12939	115	13	genotypes	genotype	NOUN
bam-12939	115	14	did	do	AUX
bam-12939	115	15	not	not	PART
bam-12939	115	16	show	show	VERB
bam-12939	115	17	a	a	DET
bam-12939	115	18	significant	significant	ADJ
bam-12939	115	19	increase	increase	NOUN
bam-12939	115	20	in	in	ADP
bam-12939	115	21	risk	risk	NOUN
bam-12939	115	22	compared	compare	VERB
bam-12939	115	23	to	to	ADP
bam-12939	115	24	the	the	DET
bam-12939	115	25	control	control	NOUN
bam-12939	115	26	group	group	NOUN
bam-12939	115	27	.	.	PUNCT
bam-12939	116	1	a	a	DET
bam-12939	116	2	positive	positive	ADJ
bam-12939	116	3	correlation	correlation	NOUN
bam-12939	116	4	between	between	ADP
bam-12939	116	5	vdr	vdr	NOUN
bam-12939	116	6	levels	level	NOUN
bam-12939	116	7	and	and	CCONJ
bam-12939	116	8	il-6	il-6	NOUN
bam-12939	116	9	-	-	PUNCT
bam-12939	116	10	encoding	encoding	NOUN
bam-12939	116	11	genes	gene	NOUN
bam-12939	116	12	was	be	AUX
bam-12939	116	13	observed	observe	VERB
bam-12939	116	14	in	in	ADP
bam-12939	116	15	rrms	rrm	NOUN
bam-12939	116	16	patients	patient	NOUN
bam-12939	116	17	.	.	PUNCT
bam-12939	117	1	in	in	ADP
bam-12939	117	2	this	this	DET
bam-12939	117	3	regard	regard	NOUN
bam-12939	117	4	,	,	PUNCT
bam-12939	117	5	no	no	DET
bam-12939	117	6	study	study	NOUN
bam-12939	117	7	was	be	AUX
bam-12939	117	8	found	find	VERB
bam-12939	117	9	that	that	PRON
bam-12939	117	10	could	could	AUX
bam-12939	117	11	accurately	accurately	ADV
bam-12939	117	12	compare	compare	VERB
bam-12939	117	13	the	the	DET
bam-12939	117	14	results	result	NOUN
bam-12939	117	15	of	of	ADP
bam-12939	117	16	the	the	DET
bam-12939	117	17	present	present	ADJ
bam-12939	117	18	study	study	NOUN
bam-12939	117	19	.	.	PUNCT
bam-12939	118	1	conclusions	conclusion	NOUN
bam-12939	118	2	the	the	DET
bam-12939	118	3	results	result	NOUN
bam-12939	118	4	of	of	ADP
bam-12939	118	5	the	the	DET
bam-12939	118	6	current	current	ADJ
bam-12939	118	7	study	study	NOUN
bam-12939	118	8	suggest	suggest	VERB
bam-12939	118	9	that	that	SCONJ
bam-12939	118	10	the	the	DET
bam-12939	118	11	foki	foki	ADJ
bam-12939	118	12	polymorphism	polymorphism	NOUN
bam-12939	118	13	is	be	AUX
bam-12939	118	14	associated	associate	VERB
bam-12939	118	15	with	with	ADP
bam-12939	118	16	a	a	DET
bam-12939	118	17	significant	significant	ADJ
bam-12939	118	18	increase	increase	NOUN
bam-12939	118	19	in	in	ADP
bam-12939	118	20	risk	risk	NOUN
bam-12939	118	21	compared	compare	VERB
bam-12939	118	22	to	to	ADP
bam-12939	118	23	healthy	healthy	ADJ
bam-12939	118	24	individuals	individual	NOUN
bam-12939	118	25	,	,	PUNCT
bam-12939	118	26	with	with	ADP
bam-12939	118	27	an	an	DET
bam-12939	118	28	odds	odd	NOUN
bam-12939	118	29	ratio	ratio	NOUN
bam-12939	118	30	of	of	ADP
bam-12939	118	31	7.28	7.28	NUM
bam-12939	118	32	for	for	ADP
bam-12939	118	33	individuals	individual	NOUN
bam-12939	118	34	with	with	ADP
bam-12939	118	35	the	the	DET
bam-12939	118	36	ff	ff	NOUN
bam-12939	118	37	genotype	genotype	NOUN
bam-12939	118	38	and	and	CCONJ
bam-12939	118	39	rrms	rrm	NOUN
bam-12939	118	40	(	(	PUNCT
bam-12939	118	41	or=7.28	or=7.28	ADV
bam-12939	118	42	:	:	PUNCT
bam-12939	118	43	95	95	NUM
bam-12939	118	44	%	%	NOUN
bam-12939	118	45	ci	ci	NOUN
bam-12939	118	46	;	;	PUNCT
bam-12939	118	47	1.86	1.86	NUM
bam-12939	118	48	,	,	PUNCT
bam-12939	118	49	28.41	28.41	NUM
bam-12939	118	50	)	)	PUNCT
bam-12939	118	51	.	.	PUNCT
bam-12939	119	1	none	none	NOUN
bam-12939	119	2	of	of	ADP
bam-12939	119	3	the	the	DET
bam-12939	119	4	polymorphisms	polymorphism	NOUN
bam-12939	119	5	examined	examine	VERB
bam-12939	119	6	showed	show	VERB
bam-12939	119	7	a	a	DET
bam-12939	119	8	significant	significant	ADJ
bam-12939	119	9	risk	risk	NOUN
bam-12939	119	10	in	in	ADP
bam-12939	119	11	obese	obese	ADJ
bam-12939	119	12	patients	patient	NOUN
bam-12939	119	13	with	with	ADP
bam-12939	119	14	different	different	ADJ
bam-12939	119	15	genotypes	genotype	NOUN
bam-12939	119	16	compared	compare	VERB
bam-12939	119	17	to	to	ADP
bam-12939	119	18	the	the	DET
bam-12939	119	19	control	control	NOUN
bam-12939	119	20	group	group	NOUN
bam-12939	119	21	(	(	PUNCT
bam-12939	119	22	obese	obese	ADJ
bam-12939	119	23	people	people	NOUN
bam-12939	119	24	)	)	PUNCT
bam-12939	119	25	.	.	PUNCT
bam-12939	120	1	the	the	DET
bam-12939	120	2	presence	presence	NOUN
bam-12939	120	3	of	of	ADP
bam-12939	120	4	a	a	DET
bam-12939	120	5	foki	foki	ADJ
bam-12939	120	6	polymorphism	polymorphism	NOUN
bam-12939	120	7	significantly	significantly	ADV
bam-12939	120	8	increases	increase	VERB
bam-12939	120	9	the	the	DET
bam-12939	120	10	likelihood	likelihood	NOUN
bam-12939	120	11	of	of	ADP
bam-12939	120	12	developing	develop	VERB
bam-12939	120	13	rrms	rrm	NOUN
bam-12939	120	14	in	in	ADP
bam-12939	120	15	individuals	individual	NOUN
bam-12939	120	16	with	with	ADP
bam-12939	120	17	the	the	DET
bam-12939	120	18	ff	ff	NOUN
bam-12939	120	19	genotype	genotype	NOUN
bam-12939	120	20	compared	compare	VERB
bam-12939	120	21	to	to	ADP
bam-12939	120	22	healthy	healthy	ADJ
bam-12939	120	23	individuals	individual	NOUN
bam-12939	120	24	,	,	PUNCT
bam-12939	120	25	with	with	ADP
bam-12939	120	26	an	an	DET
bam-12939	120	27	odds	odd	NOUN
bam-12939	120	28	ratio	ratio	NOUN
bam-12939	120	29	of	of	ADP
bam-12939	120	30	28.7	28.7	NUM
bam-12939	120	31	.	.	PUNCT
bam-12939	121	1	rrms	rrm	NOUN
bam-12939	121	2	patients	patient	NOUN
bam-12939	121	3	with	with	ADP
bam-12939	121	4	genotypes	genotype	NOUN
bam-12939	121	5	did	do	AUX
bam-12939	121	6	not	not	PART
bam-12939	121	7	show	show	VERB
bam-12939	121	8	a	a	DET
bam-12939	121	9	significantly	significantly	ADV
bam-12939	121	10	increased	increase	VERB
bam-12939	121	11	risk	risk	NOUN
bam-12939	121	12	of	of	ADP
bam-12939	121	13	foki	foki	NOUN
bam-12939	121	14	,	,	PUNCT
bam-12939	121	15	apai	apai	NOUN
bam-12939	121	16	,	,	PUNCT
bam-12939	121	17	taqi	taqi	NOUN
bam-12939	121	18	and	and	CCONJ
bam-12939	121	19	bsmi	bsmi	NOUN
bam-12939	121	20	polymorphisms	polymorphism	NOUN
bam-12939	121	21	compared	compare	VERB
bam-12939	121	22	to	to	ADP
bam-12939	121	23	controls	control	NOUN
bam-12939	121	24	.	.	PUNCT
bam-12939	122	1	foki	foki	ADJ
bam-12939	122	2	polymorphisms	polymorphism	NOUN
bam-12939	122	3	demonstrated	demonstrate	VERB
bam-12939	122	4	the	the	DET
bam-12939	122	5	association	association	NOUN
bam-12939	122	6	of	of	ADP
bam-12939	122	7	vdr	vdr	NOUN
bam-12939	122	8	changes	change	NOUN
bam-12939	122	9	under	under	ADP
bam-12939	122	10	the	the	DET
bam-12939	122	11	influence	influence	NOUN
bam-12939	122	12	of	of	ADP
bam-12939	122	13	inflammatory	inflammatory	ADJ
bam-12939	122	14	factors	factor	NOUN
bam-12939	122	15	in	in	ADP
bam-12939	122	16	rrms	rrm	NOUN
bam-12939	122	17	patients	patient	NOUN
bam-12939	122	18	.	.	PUNCT
bam-12939	123	1	to	to	PART
bam-12939	123	2	understand	understand	VERB
bam-12939	123	3	how	how	SCONJ
bam-12939	123	4	vdr	vdr	NOUN
bam-12939	123	5	works	work	VERB
bam-12939	123	6	and	and	CCONJ
bam-12939	123	7	to	to	PART
bam-12939	123	8	improve	improve	VERB
bam-12939	123	9	the	the	DET
bam-12939	123	10	chances	chance	NOUN
bam-12939	123	11	of	of	ADP
bam-12939	123	12	finding	find	VERB
bam-12939	123	13	alleles	allele	NOUN
bam-12939	123	14	associated	associate	VERB
bam-12939	123	15	with	with	ADP
bam-12939	123	16	risk	risk	NOUN
bam-12939	123	17	of	of	ADP
bam-12939	123	18	common	common	ADJ
bam-12939	123	19	diseases	disease	NOUN
bam-12939	123	20	,	,	PUNCT
bam-12939	123	21	a	a	DET
bam-12939	123	22	study	study	NOUN
bam-12939	123	23	that	that	PRON
bam-12939	123	24	examines	examine	VERB
bam-12939	123	25	the	the	DET
bam-12939	123	26	polymorphic	polymorphic	ADJ
bam-12939	123	27	change	change	NOUN
bam-12939	123	28	in	in	ADP
bam-12939	123	29	the	the	DET
bam-12939	123	30	vdr	vdr	NOUN
bam-12939	123	31	gene	gene	NOUN
bam-12939	123	32	is	be	AUX
bam-12939	123	33	needed	need	VERB
bam-12939	123	34	.	.	PUNCT
bam-12939	124	1	further	further	ADJ
bam-12939	124	2	research	research	NOUN
bam-12939	124	3	,	,	PUNCT
bam-12939	124	4	including	include	VERB
bam-12939	124	5	additional	additional	ADJ
bam-12939	124	6	cases	case	NOUN
bam-12939	124	7	,	,	PUNCT
bam-12939	124	8	is	be	AUX
bam-12939	124	9	needed	need	VERB
bam-12939	124	10	to	to	PART
bam-12939	124	11	avoid	avoid	VERB
bam-12939	124	12	results	result	NOUN
bam-12939	124	13	that	that	PRON
bam-12939	124	14	could	could	AUX
bam-12939	124	15	be	be	AUX
bam-12939	124	16	inflated	inflate	VERB
bam-12939	124	17	by	by	ADP
bam-12939	124	18	small	small	ADJ
bam-12939	124	19	samples	sample	NOUN
bam-12939	124	20	or	or	CCONJ
bam-12939	124	21	low	low	ADJ
bam-12939	124	22	frequencies	frequency	NOUN
bam-12939	124	23	of	of	ADP
bam-12939	124	24	minor	minor	ADJ
bam-12939	124	25	alleles	allele	NOUN
bam-12939	124	26	.	.	PUNCT
bam-12939	125	1	list	list	NOUN
bam-12939	125	2	of	of	ADP
bam-12939	125	3	abbreviations	abbreviation	NOUN
bam-12939	125	4	ms	ms	NOUN
bam-12939	125	5	,	,	PUNCT
bam-12939	125	6	multiple	multiple	ADJ
bam-12939	125	7	sclerosis	sclerosis	NOUN
bam-12939	125	8	cns	cns	NOUN
bam-12939	125	9	,	,	PUNCT
bam-12939	125	10	central	central	ADJ
bam-12939	125	11	nervous	nervous	ADJ
bam-12939	125	12	system	system	NOUN
bam-12939	125	13	vdr	vdr	NOUN
bam-12939	125	14	,	,	PUNCT
bam-12939	125	15	vitamin	vitamin	NOUN
bam-12939	125	16	d	d	NOUN
bam-12939	125	17	receptor	receptor	NOUN
bam-12939	125	18	leptin	leptin	NOUN
bam-12939	125	19	,	,	PUNCT
bam-12939	125	20	fabs	fab	VERB
bam-12939	125	21	adoponectin	adoponectin	ADJ
bam-12939	125	22	conflict	conflict	NOUN
bam-12939	125	23	of	of	ADP
bam-12939	125	24	interest	interest	NOUN
bam-12939	125	25	the	the	DET
bam-12939	125	26	authors	author	NOUN
bam-12939	125	27	declare	declare	VERB
bam-12939	125	28	no	no	DET
bam-12939	125	29	potential	potential	ADJ
bam-12939	125	30	conflict	conflict	NOUN
bam-12939	125	31	of	of	ADP
bam-12939	125	32	interest	interest	NOUN
bam-12939	125	33	,	,	PUNCT
bam-12939	125	34	and	and	CCONJ
bam-12939	125	35	all	all	DET
bam-12939	125	36	authors	author	NOUN
bam-12939	125	37	confirm	confirm	VERB
bam-12939	125	38	accuracy	accuracy	NOUN
bam-12939	125	39	.	.	PUNCT
bam-12939	126	1	ethics	ethic	NOUN
bam-12939	126	2	approval	approval	VERB
bam-12939	126	3	the	the	DET
bam-12939	126	4	ethics	ethic	NOUN
bam-12939	126	5	committee	committee	PROPN
bam-12939	126	6	of	of	ADP
bam-12939	126	7	iran	iran	PROPN
bam-12939	126	8	university	university	PROPN
bam-12939	126	9	of	of	ADP
bam-12939	126	10	medical	medical	PROPN
bam-12939	126	11	sciences	sciences	PROPN
bam-12939	126	12	approved	approve	VERB
bam-12939	126	13	this	this	DET
bam-12939	126	14	study	study	NOUN
bam-12939	126	15	(	(	PUNCT
bam-12939	126	16	ir.iums.fmd.rec	ir.iums.fmd.rec	NOUN
bam-12939	126	17	.	.	PUNCT
bam-12939	126	18	1401.429	1401.429	NUM
bam-12939	126	19	)	)	PUNCT
bam-12939	126	20	.	.	PUNCT
bam-12939	127	1	the	the	DET
bam-12939	127	2	study	study	NOUN
bam-12939	127	3	is	be	AUX
bam-12939	127	4	conformed	conform	VERB
bam-12939	127	5	with	with	ADP
bam-12939	127	6	the	the	DET
bam-12939	127	7	helsinki	helsinki	PROPN
bam-12939	127	8	declaration	declaration	NOUN
bam-12939	127	9	of	of	ADP
bam-12939	127	10	1964	1964	NUM
bam-12939	127	11	,	,	PUNCT
bam-12939	127	12	as	as	SCONJ
bam-12939	127	13	revised	revise	VERB
bam-12939	127	14	in	in	ADP
bam-12939	127	15	2013	2013	NUM
bam-12939	127	16	,	,	PUNCT
bam-12939	127	17	concerning	concern	VERB
bam-12939	127	18	human	human	ADJ
bam-12939	127	19	and	and	CCONJ
bam-12939	127	20	animal	animal	NOUN
bam-12939	127	21	rights	right	NOUN
bam-12939	127	22	.	.	PUNCT
bam-12939	128	1	informed	inform	VERB
bam-12939	128	2	consent	consent	NOUN
bam-12939	128	3	all	all	DET
bam-12939	128	4	patients	patient	NOUN
bam-12939	128	5	participating	participate	VERB
bam-12939	128	6	in	in	ADP
bam-12939	128	7	this	this	DET
bam-12939	128	8	study	study	NOUN
bam-12939	128	9	signed	sign	VERB
bam-12939	128	10	a	a	DET
bam-12939	128	11	written	write	VERB
bam-12939	128	12	informed	inform	VERB
bam-12939	128	13	consent	consent	NOUN
bam-12939	128	14	form	form	NOUN
bam-12939	128	15	for	for	ADP
bam-12939	128	16	participating	participate	VERB
bam-12939	128	17	in	in	ADP
bam-12939	128	18	this	this	DET
bam-12939	128	19	study	study	NOUN
bam-12939	128	20	.	.	PUNCT
bam-12939	129	1	patient	patient	ADJ
bam-12939	129	2	consent	consent	NOUN
bam-12939	129	3	for	for	ADP
bam-12939	129	4	publication	publication	NOUN
bam-12939	129	5	the	the	DET
bam-12939	129	6	present	present	ADJ
bam-12939	129	7	study	study	NOUN
bam-12939	129	8	was	be	AUX
bam-12939	129	9	conducted	conduct	VERB
bam-12939	129	10	based	base	VERB
bam-12939	129	11	on	on	ADP
bam-12939	129	12	the	the	DET
bam-12939	129	13	ethical	ethical	ADJ
bam-12939	129	14	principles	principle	NOUN
bam-12939	129	15	of	of	ADP
bam-12939	129	16	helsinki	helsinki	PROPN
bam-12939	129	17	and	and	CCONJ
bam-12939	129	18	was	be	AUX
bam-12939	129	19	approved	approve	VERB
bam-12939	129	20	by	by	ADP
bam-12939	129	21	the	the	DET
bam-12939	129	22	department	department	PROPN
bam-12939	129	23	of	of	ADP
bam-12939	129	24	medical	medical	ADJ
bam-12939	129	25	ethics	ethic	NOUN
bam-12939	129	26	of	of	ADP
bam-12939	129	27	iran	iran	PROPN
bam-12939	129	28	university	university	PROPN
bam-12939	129	29	of	of	ADP
bam-12939	129	30	medical	medical	ADJ
bam-12939	129	31	sciences	science	NOUN
bam-12939	129	32	.	.	PUNCT
bam-12939	130	1	informed	inform	VERB
bam-12939	130	2	consent	consent	NOUN
bam-12939	130	3	form	form	NOUN
bam-12939	130	4	was	be	AUX
bam-12939	130	5	obtained	obtain	VERB
bam-12939	130	6	from	from	ADP
bam-12939	130	7	all	all	DET
bam-12939	130	8	patients	patient	NOUN
bam-12939	130	9	and	and	CCONJ
bam-12939	130	10	control	control	NOUN
bam-12939	130	11	group	group	NOUN
bam-12939	130	12	.	.	PUNCT
bam-12939	131	1	ethical	ethical	ADJ
bam-12939	131	2	consent	consent	NOUN
bam-12939	131	3	form	form	NOUN
bam-12939	131	4	was	be	AUX
bam-12939	131	5	obtained	obtain	VERB
bam-12939	131	6	by	by	ADP
bam-12939	131	7	the	the	DET
bam-12939	131	8	coordinator	coordinator	NOUN
bam-12939	131	9	of	of	ADP
bam-12939	131	10	the	the	DET
bam-12939	131	11	project	project	NOUN
bam-12939	131	12	before	before	SCONJ
bam-12939	131	13	the	the	DET
bam-12939	131	14	patients	patient	NOUN
bam-12939	131	15	entered	enter	VERB
bam-12939	131	16	the	the	DET
bam-12939	131	17	study	study	NOUN
bam-12939	131	18	at	at	ADP
bam-12939	131	19	rasoul	rasoul	ADJ
bam-12939	131	20	akram	akram	NOUN
bam-12939	131	21	hospital	hospital	NOUN
bam-12939	131	22	with	with	ADP
bam-12939	131	23	a	a	DET
bam-12939	131	24	complete	complete	ADJ
bam-12939	131	25	description	description	NOUN
bam-12939	131	26	of	of	ADP
bam-12939	131	27	the	the	DET
bam-12939	131	28	study	study	NOUN
bam-12939	131	29	.	.	PUNCT
bam-12939	132	1	availability	availability	NOUN
bam-12939	132	2	of	of	ADP
bam-12939	132	3	data	datum	NOUN
bam-12939	132	4	and	and	CCONJ
bam-12939	132	5	materials	material	NOUN
bam-12939	132	6	patient	patient	NOUN
bam-12939	132	7	information	information	NOUN
bam-12939	132	8	has	have	AUX
bam-12939	132	9	been	be	AUX
bam-12939	132	10	collected	collect	VERB
bam-12939	132	11	and	and	CCONJ
bam-12939	132	12	analyzed	analyze	VERB
bam-12939	132	13	based	base	VERB
bam-12939	132	14	on	on	ADP
bam-12939	132	15	ethical	ethical	ADJ
bam-12939	132	16	principles	principle	NOUN
bam-12939	132	17	and	and	CCONJ
bam-12939	132	18	full	full	ADJ
bam-12939	132	19	satisfaction	satisfaction	NOUN
bam-12939	132	20	in	in	ADP
bam-12939	132	21	rasul	rasul	PROPN
bam-12939	132	22	akram	akram	PROPN
bam-12939	132	23	hospital	hospital	PROPN
bam-12939	132	24	,	,	PUNCT
bam-12939	132	25	tehran	tehran	PROPN
bam-12939	132	26	corresponding	correspond	VERB
bam-12939	132	27	author	author	PROPN
bam-12939	132	28	mohammad	mohammad	PROPN
bam-12939	132	29	taghi	taghi	PROPN
bam-12939	132	30	joghataei	joghataei	PROPN
bam-12939	132	31	,	,	PUNCT
bam-12939	132	32	department	department	NOUN
bam-12939	132	33	of	of	ADP
bam-12939	132	34	neuroscience	neuroscience	NOUN
bam-12939	132	35	,	,	PUNCT
bam-12939	132	36	faculty	faculty	NOUN
bam-12939	132	37	of	of	ADP
bam-12939	132	38	advanced	advanced	ADJ
bam-12939	132	39	technologies	technology	NOUN
bam-12939	132	40	in	in	ADP
bam-12939	132	41	medicine	medicine	NOUN
bam-12939	132	42	,	,	PUNCT
bam-12939	132	43	iran	iran	PROPN
bam-12939	132	44	university	university	PROPN
bam-12939	132	45	of	of	ADP
bam-12939	132	46	medical	medical	ADJ
bam-12939	132	47	sciences	sciences	PROPN
bam-12939	132	48	,	,	PUNCT
bam-12939	132	49	tehran	tehran	PROPN
bam-12939	132	50	,	,	PUNCT
bam-12939	132	51	iran	iran	PROPN
bam-12939	132	52	.	.	PUNCT
bam-12939	133	1	orcid	orcid	NOUN
bam-12939	134	1	i	i	PRON
bam-12939	134	2	d	d	NOUN
bam-12939	134	3	:	:	PUNCT
bam-12939	134	4	0000	0000	NUM
bam-12939	134	5	-	-	PUNCT
bam-12939	134	6	0003	0003	NUM
bam-12939	134	7	-	-	PUNCT
bam-12939	134	8	0492	0492	NUM
bam-12939	134	9	-	-	SYM
bam-12939	134	10	8239	8239	NUM
bam-12939	134	11	e	e	NOUN
bam-12939	134	12	-	-	NOUN
bam-12939	134	13	mail	mail	NOUN
bam-12939	134	14	:	:	PUNCT
bam-12939	134	15	m_joghataei@yahoo.com	m_joghataei@yahoo.com	X
bam-12939	135	1	maryam	maryam	PROPN
bam-12939	135	2	milanifard	milanifard	VERB
bam-12939	135	3	orcid	orcid	PROPN
bam-12939	135	4	i	i	PROPN
bam-12939	135	5	d	d	NOUN
bam-12939	135	6	:	:	PUNCT
bam-12939	135	7	0000	0000	NUM
bam-12939	135	8	-	-	PUNCT
bam-12939	135	9	0002	0002	NUM
bam-12939	135	10	-	-	PUNCT
bam-12939	135	11	0888	0888	NUM
bam-12939	135	12	-	-	PUNCT
bam-12939	135	13	8847	8847	NUM
bam-12939	135	14	e	e	NOUN
bam-12939	135	15	-	-	NOUN
bam-12939	135	16	mail	mail	NOUN
bam-12939	135	17	:	:	PUNCT
bam-12939	135	18	marayammilani837@yahoo.com	marayammilani837@yahoo.com	X
bam-12939	136	1	soraya	soraya	PROPN
bam-12939	136	2	mehrabi	mehrabi	PROPN
bam-12939	136	3	orcid	orcid	PROPN
bam-12939	137	1	i	i	PRON
bam-12939	137	2	d	d	NOUN
bam-12939	137	3	:	:	PUNCT
bam-12939	137	4	0000	0000	NUM
bam-12939	137	5	-	-	PUNCT
bam-12939	137	6	0001	0001	NUM
bam-12939	137	7	-	-	PUNCT
bam-12939	137	8	8555	8555	NUM
bam-12939	137	9	-	-	PUNCT
bam-12939	137	10	726x	726x	NOUN
bam-12939	137	11	e	e	NOUN
bam-12939	137	12	-	-	NOUN
bam-12939	137	13	mail	mail	NOUN
bam-12939	137	14	:	:	PUNCT
bam-12939	137	15	soraya.mehrabi@gmail.com	soraya.mehrabi@gmail.com	X
bam-12939	137	16	reza	reza	PROPN
bam-12939	137	17	ahadi	ahadi	NOUN
bam-12939	138	1	orcid	orcid	PROPN
bam-12939	139	1	i	i	PRON
bam-12939	139	2	d	d	NOUN
bam-12939	139	3	:	:	PUNCT
bam-12939	139	4	0000	0000	NUM
bam-12939	139	5	-	-	PUNCT
bam-12939	139	6	0002	0002	NUM
bam-12939	139	7	-	-	PUNCT
bam-12939	139	8	3484	3484	NUM
bam-12939	139	9	-	-	SYM
bam-12939	139	10	9606	9606	NUM
bam-12939	139	11	e	e	NOUN
bam-12939	139	12	-	-	NOUN
bam-12939	139	13	mail	mail	NOUN
bam-12939	139	14	:	:	PUNCT
bam-12939	139	15	rezaahadi1353@gmail.com	rezaahadi1353@gmail.com	X
bam-12939	140	1	mohsen	mohsen	PROPN
bam-12939	140	2	nabiuni	nabiuni	PROPN
bam-12939	140	3	orcid	orcid	PROPN
bam-12939	141	1	i	i	PRON
bam-12939	141	2	d	d	NOUN
bam-12939	141	3	:	:	PUNCT
bam-12939	141	4	0000	0000	NUM
bam-12939	141	5	-	-	PUNCT
bam-12939	141	6	0002	0002	NUM
bam-12939	141	7	-	-	PUNCT
bam-12939	141	8	0841	0841	NUM
bam-12939	141	9	-	-	PUNCT
bam-12939	141	10	6612	6612	NUM
bam-12939	141	11	e	e	NOUN
bam-12939	141	12	-	-	NOUN
bam-12939	141	13	mail	mail	NOUN
bam-12939	141	14	:	:	PUNCT
bam-12939	141	15	nabiuni_m@yahoo.com	nabiuni_m@yahoo.com	PROPN
bam-12939	141	16	samaneh	samaneh	PROPN
bam-12939	141	17	azimi	azimi	PROPN
bam-12939	141	18	souteh	souteh	PROPN
bam-12939	141	19	orcid	orcid	PROPN
bam-12939	142	1	i	i	PRON
bam-12939	142	2	d	d	NOUN
bam-12939	142	3	:	:	PUNCT
bam-12939	142	4	0000	0000	NUM
bam-12939	142	5	-	-	PUNCT
bam-12939	142	6	0001	0001	NUM
bam-12939	142	7	-	-	PUNCT
bam-12939	142	8	7703	7703	NUM
bam-12939	142	9	-	-	SYM
bam-12939	142	10	1671	1671	NUM
bam-12939	142	11	e	e	NOUN
bam-12939	142	12	-	-	NOUN
bam-12939	142	13	mail	mail	NOUN
bam-12939	142	14	:	:	PUNCT
bam-12939	142	15	s.azimi.s1991@gmail.com	s.azimi.s1991@gmail.com	X
bam-12939	142	16	references	reference	NOUN
bam-12939	142	17	1	1	NUM
bam-12939	142	18	.	.	PUNCT
bam-12939	143	1	pegoretti	pegoretti	PROPN
bam-12939	143	2	v	v	PROPN
bam-12939	143	3	,	,	PUNCT
bam-12939	143	4	swanson	swanson	PROPN
bam-12939	143	5	ka	ka	PROPN
bam-12939	143	6	,	,	PUNCT
bam-12939	143	7	bethea	bethea	PROPN
bam-12939	143	8	jr	jr	PROPN
bam-12939	143	9	,	,	PUNCT
bam-12939	143	10	et	et	PROPN
bam-12939	143	11	al	al	PROPN
bam-12939	143	12	.	.	PROPN
bam-12939	144	1	inflammation	inflammation	NOUN
bam-12939	144	2	and	and	CCONJ
bam-12939	144	3	oxidative	oxidative	ADJ
bam-12939	144	4	stress	stress	NOUN
bam-12939	144	5	in	in	ADP
bam-12939	144	6	multiple	multiple	ADJ
bam-12939	144	7	sclerosis	sclerosis	NOUN
bam-12939	144	8	:	:	PUNCT
bam-12939	144	9	consequences	consequence	NOUN
bam-12939	144	10	for	for	ADP
bam-12939	144	11	therapy	therapy	NOUN
bam-12939	144	12	development	development	NOUN
bam-12939	144	13	.	.	PUNCT
bam-12939	145	1	oxidative	oxidative	ADJ
bam-12939	145	2	med	med	ADJ
bam-12939	145	3	cell	cell	NOUN
bam-12939	145	4	longev	longev	NOUN
bam-12939	145	5	2020;2020:7191080	2020;2020:7191080	NUM
bam-12939	145	6	.	.	PUNCT
bam-12939	146	1	2	2	NUM
bam-12939	146	2	.	.	X
bam-12939	146	3	tobore	tobore	NOUN
bam-12939	146	4	to	to	ADP
bam-12939	146	5	.	.	PUNCT
bam-12939	147	1	oxidative	oxidative	ADJ
bam-12939	147	2	/	/	SYM
bam-12939	147	3	nitroxidative	nitroxidative	ADJ
bam-12939	147	4	stress	stress	NOUN
bam-12939	147	5	and	and	CCONJ
bam-12939	147	6	multiple	multiple	ADJ
bam-12939	147	7	sclerosis	sclerosis	NOUN
bam-12939	147	8	.	.	PUNCT
bam-12939	148	1	j	j	PROPN
bam-12939	148	2	mol	mol	PROPN
bam-12939	148	3	neurosci	neurosci	PROPN
bam-12939	148	4	2021;71:506	2021;71:506	X
bam-12939	148	5	-	-	SYM
bam-12939	148	6	14	14	NUM
bam-12939	148	7	.	.	PUNCT
bam-12939	149	1	3	3	NUM
bam-12939	149	2	.	.	NOUN
bam-12939	149	3	adamczyk	adamczyk	PROPN
bam-12939	149	4	b	b	NUM
bam-12939	149	5	,	,	PUNCT
bam-12939	149	6	adamczyk	adamczyk	NOUN
bam-12939	149	7	-	-	PUNCT
bam-12939	149	8	sowa	sowa	PROPN
bam-12939	149	9	m.	m.	NOUN
bam-12939	149	10	new	new	ADJ
bam-12939	149	11	insights	insight	NOUN
bam-12939	149	12	into	into	ADP
bam-12939	149	13	the	the	DET
bam-12939	149	14	role	role	NOUN
bam-12939	149	15	of	of	ADP
bam-12939	149	16	oxidative	oxidative	ADJ
bam-12939	149	17	stress	stress	NOUN
bam-12939	149	18	mechanisms	mechanism	NOUN
bam-12939	149	19	in	in	ADP
bam-12939	149	20	the	the	DET
bam-12939	149	21	pathophysiology	pathophysiology	NOUN
bam-12939	149	22	and	and	CCONJ
bam-12939	149	23	treatment	treatment	NOUN
bam-12939	149	24	of	of	ADP
bam-12939	149	25	multiple	multiple	ADJ
bam-12939	149	26	sclerosis	sclerosis	NOUN
bam-12939	149	27	.	.	PUNCT
bam-12939	150	1	oxidative	oxidative	ADJ
bam-12939	150	2	med	med	ADJ
bam-12939	150	3	cell	cell	NOUN
bam-12939	150	4	longev	longev	NOUN
bam-12939	150	5	2016;2016:1973834	2016;2016:1973834	NUM
bam-12939	150	6	.	.	PUNCT
bam-12939	151	1	4	4	NUM
bam-12939	151	2	.	.	X
bam-12939	151	3	lee	lee	PROPN
bam-12939	152	1	d	d	PROPN
bam-12939	152	2	-	-	PUNCT
bam-12939	152	3	h	h	NOUN
bam-12939	152	4	,	,	PUNCT
bam-12939	152	5	gold	gold	NOUN
bam-12939	152	6	r	r	NOUN
bam-12939	152	7	,	,	PUNCT
bam-12939	152	8	linker	linker	NOUN
bam-12939	152	9	ra	ra	PROPN
bam-12939	152	10	.	.	PROPN
bam-12939	152	11	mechanisms	mechanism	NOUN
bam-12939	152	12	of	of	ADP
bam-12939	152	13	oxidative	oxidative	ADJ
bam-12939	152	14	damage	damage	NOUN
bam-12939	152	15	in	in	ADP
bam-12939	152	16	multiple	multiple	ADJ
bam-12939	152	17	sclerosis	sclerosis	NOUN
bam-12939	152	18	and	and	CCONJ
bam-12939	152	19	neurodegenerative	neurodegenerative	ADJ
bam-12939	152	20	diseases	disease	NOUN
bam-12939	152	21	:	:	PUNCT
bam-12939	152	22	therapeutic	therapeutic	ADJ
bam-12939	152	23	modulation	modulation	NOUN
bam-12939	152	24	via	via	ADP
bam-12939	152	25	fumaric	fumaric	PROPN
bam-12939	152	26	38	38	NUM
bam-12939	152	27	non	non	ADJ
bam-12939	152	28	-co	-co	PROPN
bam-12939	152	29	mmerc	mmerc	PROPN
bam-12939	152	30	ial	ial	PROPN
bam-12939	153	1	us	us	PROPN
bam-12939	153	2	e	e	NOUN
bam-12939	153	3	o	o	PROPN
bam-12939	153	4	nly	nly	ADV
bam-12939	153	5	mailto:m_joghataei@yahoo.com	mailto:m_joghataei@yahoo.com	X
bam-12939	153	6	vitamin	vitamin	NOUN
bam-12939	153	7	d	d	NOUN
bam-12939	153	8	receptor	receptor	NOUN
bam-12939	153	9	and	and	CCONJ
bam-12939	153	10	clinical	clinical	ADJ
bam-12939	153	11	and	and	CCONJ
bam-12939	153	12	inflammatory	inflammatory	ADJ
bam-12939	153	13	factors	factor	NOUN
bam-12939	153	14	in	in	ADP
bam-12939	153	15	patients	patient	NOUN
bam-12939	153	16	with	with	ADP
bam-12939	153	17	relapsing	relapse	VERB
bam-12939	153	18	-	-	PUNCT
bam-12939	153	19	remitting	remit	VERB
bam-12939	153	20	multiple	multiple	ADJ
bam-12939	153	21	sclerosis	sclerosis	NOUN
bam-12939	153	22	eur	eur	PROPN
bam-12939	153	23	j	j	PROPN
bam-12939	153	24	transl	transl	PROPN
bam-12939	153	25	myol	myol	NOUN
bam-12939	153	26	34	34	NUM
bam-12939	153	27	(	(	PUNCT
bam-12939	153	28	4	4	NUM
bam-12939	153	29	)	)	PUNCT
bam-12939	153	30	12939	12939	NUM
bam-12939	153	31	,	,	PUNCT
bam-12939	153	32	2024	2024	NUM
bam-12939	153	33	doi	doi	NOUN
bam-12939	153	34	:	:	PUNCT
bam-12939	153	35	10.4081	10.4081	NUM
bam-12939	153	36	/	/	SYM
bam-12939	153	37	ejtm.2024.12939	ejtm.2024.12939	NOUN
bam-12939	153	38	acid	acid	NOUN
bam-12939	153	39	esters	ester	NOUN
bam-12939	153	40	.	.	PUNCT
bam-12939	154	1	int	int	PROPN
bam-12939	154	2	j	j	PROPN
bam-12939	154	3	molec	molec	PROPN
bam-12939	154	4	sci	sci	PROPN
bam-12939	154	5	2012;13:11783	2012;13:11783	NUM
bam-12939	154	6	-	-	SYM
bam-12939	154	7	803	803	NUM
bam-12939	154	8	.	.	PUNCT
bam-12939	154	9	5	5	NUM
bam-12939	154	10	.	.	NOUN
bam-12939	154	11	schreiner	schreiner	PROPN
bam-12939	154	12	t	t	PROPN
bam-12939	154	13	-	-	PUNCT
bam-12939	154	14	g	g	NOUN
bam-12939	154	15	,	,	PUNCT
bam-12939	154	16	genes	gene	NOUN
bam-12939	154	17	t	t	NOUN
bam-12939	154	18	-	-	PUNCT
bam-12939	154	19	m.	m.	NOUN
bam-12939	154	20	obesity	obesity	NOUN
bam-12939	154	21	and	and	CCONJ
bam-12939	154	22	multiple	multiple	ADJ
bam-12939	154	23	sclerosis	sclerosis	NOUN
bam-12939	154	24	—	—	PUNCT
bam-12939	154	25	a	a	DET
bam-12939	154	26	multifaceted	multifaceted	ADJ
bam-12939	154	27	association	association	NOUN
bam-12939	154	28	.	.	PUNCT
bam-12939	155	1	j	j	PROPN
bam-12939	155	2	clin	clin	PROPN
bam-12939	155	3	med	med	PROPN
bam-12939	155	4	2021;10:2689	2021;10:2689	NUM
bam-12939	155	5	.	.	PROPN
bam-12939	155	6	6	6	NUM
bam-12939	155	7	.	.	PUNCT
bam-12939	155	8	correale	correale	PROPN
bam-12939	155	9	j	j	PROPN
bam-12939	155	10	,	,	PUNCT
bam-12939	155	11	marrodan	marrodan	PROPN
bam-12939	155	12	m.	m.	NOUN
bam-12939	155	13	multiple	multiple	ADJ
bam-12939	155	14	sclerosis	sclerosis	NOUN
bam-12939	155	15	and	and	CCONJ
bam-12939	155	16	obesity	obesity	NOUN
bam-12939	155	17	:	:	PUNCT
bam-12939	155	18	the	the	DET
bam-12939	155	19	role	role	NOUN
bam-12939	155	20	of	of	ADP
bam-12939	155	21	adipokines	adipokine	NOUN
bam-12939	155	22	.	.	PUNCT
bam-12939	156	1	front	front	ADJ
bam-12939	156	2	immunol	immunol	NOUN
bam-12939	156	3	2022;13	2022;13	NUM
bam-12939	156	4	:	:	PUNCT
bam-12939	156	5	1038393	1038393	NUM
bam-12939	156	6	.	.	PUNCT
bam-12939	157	1	7	7	X
bam-12939	157	2	.	.	X
bam-12939	157	3	pantazou	pantazou	PROPN
bam-12939	157	4	v	v	NOUN
bam-12939	157	5	,	,	PUNCT
bam-12939	157	6	schluep	schluep	NOUN
bam-12939	157	7	m	m	PRON
bam-12939	157	8	,	,	PUNCT
bam-12939	157	9	du	du	PROPN
bam-12939	157	10	pasquier	pasquier	PROPN
bam-12939	157	11	r.	r.	PROPN
bam-12939	157	12	environmental	environmental	PROPN
bam-12939	157	13	factors	factor	NOUN
bam-12939	157	14	in	in	ADP
bam-12939	157	15	multiple	multiple	ADJ
bam-12939	157	16	sclerosis	sclerosis	NOUN
bam-12939	157	17	.	.	PUNCT
bam-12939	158	1	la	la	PROPN
bam-12939	158	2	presse	presse	PROPN
bam-12939	158	3	médicale	médicale	PROPN
bam-12939	158	4	2015;44	2015;44	NUM
bam-12939	158	5	:	:	PUNCT
bam-12939	158	6	e113	e113	NUM
bam-12939	158	7	-	-	PUNCT
bam-12939	158	8	e20	e20	NOUN
bam-12939	158	9	.	.	PUNCT
bam-12939	159	1	8	8	NUM
bam-12939	159	2	.	.	X
bam-12939	160	1	agliardi	agliardi	PROPN
bam-12939	160	2	c	c	NOUN
bam-12939	160	3	,	,	PUNCT
bam-12939	160	4	guerini	guerini	VERB
bam-12939	160	5	fr	fr	NOUN
bam-12939	160	6	,	,	PUNCT
bam-12939	160	7	saresella	saresella	PROPN
bam-12939	160	8	m	m	PROPN
bam-12939	160	9	,	,	PUNCT
bam-12939	160	10	et	et	PROPN
bam-12939	160	11	al	al	PROPN
bam-12939	160	12	.	.	PUNCT
bam-12939	160	13	vitamin	vitamin	NOUN
bam-12939	160	14	d	d	NOUN
bam-12939	160	15	receptor	receptor	NOUN
bam-12939	160	16	(	(	PUNCT
bam-12939	160	17	vdr	vdr	NOUN
bam-12939	160	18	)	)	PUNCT
bam-12939	160	19	gene	gene	NOUN
bam-12939	160	20	snps	snps	PROPN
bam-12939	160	21	influence	influence	NOUN
bam-12939	160	22	vdr	vdr	VERB
bam-12939	160	23	expression	expression	NOUN
bam-12939	160	24	and	and	CCONJ
bam-12939	160	25	modulate	modulate	VERB
bam-12939	160	26	protection	protection	NOUN
bam-12939	160	27	from	from	ADP
bam-12939	160	28	multiple	multiple	ADJ
bam-12939	160	29	sclerosis	sclerosis	NOUN
bam-12939	160	30	in	in	ADP
bam-12939	160	31	hla	hla	PROPN
bam-12939	160	32	-	-	PUNCT
bam-12939	160	33	drb1	drb1	PROPN
bam-12939	160	34	*	*	PUNCT
bam-12939	160	35	15	15	NUM
bam-12939	160	36	-	-	PUNCT
bam-12939	160	37	positive	positive	ADJ
bam-12939	160	38	individuals	individual	NOUN
bam-12939	160	39	.	.	PUNCT
bam-12939	161	1	brain	brain	NOUN
bam-12939	161	2	behav	behav	PROPN
bam-12939	161	3	immun	immun	PROPN
bam-12939	161	4	2011;25:1460	2011;25:1460	PROPN
bam-12939	161	5	-	-	PUNCT
bam-12939	161	6	7	7	NUM
bam-12939	161	7	.	.	NOUN
bam-12939	161	8	9	9	NUM
bam-12939	161	9	.	.	X
bam-12939	162	1	pierrot	pierrot	NOUN
bam-12939	162	2	-	-	PUNCT
bam-12939	162	3	deseilligny	deseilligny	NOUN
bam-12939	162	4	c	c	NOUN
bam-12939	162	5	,	,	PUNCT
bam-12939	162	6	souberbielle	souberbielle	PROPN
bam-12939	162	7	j	j	PROPN
bam-12939	162	8	-	-	PUNCT
bam-12939	162	9	c.	c.	PROPN
bam-12939	162	10	vitamin	vitamin	NOUN
bam-12939	162	11	d	d	NOUN
bam-12939	162	12	and	and	CCONJ
bam-12939	162	13	multiple	multiple	ADJ
bam-12939	162	14	sclerosis	sclerosis	NOUN
bam-12939	162	15	:	:	PUNCT
bam-12939	162	16	an	an	DET
bam-12939	162	17	update	update	NOUN
bam-12939	162	18	.	.	PUNCT
bam-12939	163	1	multiple	multiple	ADJ
bam-12939	163	2	sclerosis	sclerosis	NOUN
bam-12939	163	3	rel	rel	PROPN
bam-12939	163	4	disord	disord	PROPN
bam-12939	163	5	2017;14:35	2017;14:35	PROPN
bam-12939	163	6	-	-	SYM
bam-12939	163	7	45	45	NUM
bam-12939	163	8	.	.	NOUN
bam-12939	163	9	10	10	NUM
bam-12939	163	10	.	.	PUNCT
bam-12939	164	1	mohammadi	mohammadi	PROPN
bam-12939	164	2	a	a	PROPN
bam-12939	164	3	,	,	PUNCT
bam-12939	164	4	azarnezhad	azarnezhad	VERB
bam-12939	164	5	a	a	DET
bam-12939	164	6	,	,	PUNCT
bam-12939	164	7	khanbabaei	khanbabaei	NOUN
bam-12939	164	8	h	h	NOUN
bam-12939	164	9	,	,	PUNCT
bam-12939	164	10	et	et	PROPN
bam-12939	164	11	al	al	PROPN
bam-12939	164	12	.	.	PUNCT
bam-12939	165	1	vitamin	vitamin	NOUN
bam-12939	165	2	d	d	NOUN
bam-12939	165	3	receptor	receptor	NOUN
bam-12939	165	4	genetic	genetic	ADJ
bam-12939	165	5	polymorphisms	polymorphism	NOUN
bam-12939	165	6	and	and	CCONJ
bam-12939	165	7	the	the	DET
bam-12939	165	8	risk	risk	NOUN
bam-12939	165	9	of	of	ADP
bam-12939	165	10	multiple	multiple	ADJ
bam-12939	165	11	sclerosis	sclerosis	NOUN
bam-12939	165	12	:	:	PUNCT
bam-12939	165	13	a	a	DET
bam-12939	165	14	systematic	systematic	ADJ
bam-12939	165	15	review	review	NOUN
bam-12939	165	16	and	and	CCONJ
bam-12939	165	17	meta	meta	ADJ
bam-12939	165	18	-	-	PUNCT
bam-12939	165	19	analysis	analysis	NOUN
bam-12939	165	20	.	.	PUNCT
bam-12939	166	1	steroids	steroid	NOUN
bam-12939	166	2	2020;158:108615	2020;158:108615	NUM
bam-12939	166	3	.	.	PUNCT
bam-12939	167	1	11	11	NUM
bam-12939	167	2	.	.	X
bam-12939	168	1	sintzel	sintzel	ADJ
bam-12939	168	2	mb	mb	NOUN
bam-12939	168	3	,	,	PUNCT
bam-12939	168	4	rametta	rametta	PROPN
bam-12939	168	5	m	m	PROPN
bam-12939	168	6	,	,	PUNCT
bam-12939	168	7	reder	reder	NOUN
bam-12939	168	8	at	at	ADP
bam-12939	168	9	.	.	PUNCT
bam-12939	169	1	vitamin	vitamin	NOUN
bam-12939	169	2	d	d	NOUN
bam-12939	169	3	and	and	CCONJ
bam-12939	169	4	multiple	multiple	ADJ
bam-12939	169	5	sclerosis	sclerosis	NOUN
bam-12939	169	6	:	:	PUNCT
bam-12939	169	7	a	a	DET
bam-12939	169	8	comprehensive	comprehensive	ADJ
bam-12939	169	9	review	review	NOUN
bam-12939	169	10	.	.	PUNCT
bam-12939	170	1	neurol	neurol	NOUN
bam-12939	170	2	therapy	therapy	NOUN
bam-12939	170	3	2018;7:59	2018;7:59	NOUN
bam-12939	170	4	-	-	SYM
bam-12939	170	5	85	85	NUM
bam-12939	170	6	.	.	PUNCT
bam-12939	170	7	12	12	NUM
bam-12939	170	8	.	.	PUNCT
bam-12939	171	1	holick	holick	NOUN
bam-12939	171	2	mf	mf	PROPN
bam-12939	171	3	,	,	PUNCT
bam-12939	171	4	editor	editor	NOUN
bam-12939	171	5	high	high	ADJ
bam-12939	171	6	prevalence	prevalence	NOUN
bam-12939	171	7	of	of	ADP
bam-12939	171	8	vitamin	vitamin	NOUN
bam-12939	171	9	d	d	NOUN
bam-12939	171	10	inadequacy	inadequacy	NOUN
bam-12939	171	11	and	and	CCONJ
bam-12939	171	12	implications	implication	NOUN
bam-12939	171	13	for	for	ADP
bam-12939	171	14	health	health	NOUN
bam-12939	171	15	.	.	PUNCT
bam-12939	172	1	mayo	mayo	PROPN
bam-12939	172	2	clinic	clinic	NOUN
bam-12939	172	3	proceedings	proceeding	NOUN
bam-12939	172	4	;	;	PUNCT
bam-12939	172	5	2006	2006	NUM
bam-12939	172	6	:	:	PUNCT
bam-12939	173	1	elsevier	elsevier	NOUN
bam-12939	173	2	.	.	PUNCT
bam-12939	174	1	13	13	NUM
bam-12939	174	2	.	.	PUNCT
bam-12939	175	1	goodyear	goodyear	PROPN
bam-12939	175	2	md	md	PROPN
bam-12939	175	3	,	,	PUNCT
bam-12939	175	4	krleza	krleza	PROPN
bam-12939	175	5	-	-	PUNCT
bam-12939	175	6	jeric	jeric	PROPN
bam-12939	175	7	k	k	PROPN
bam-12939	175	8	,	,	PUNCT
bam-12939	175	9	lemmens	lemmen	VERB
bam-12939	175	10	t.	t.	PROPN
bam-12939	175	11	the	the	DET
bam-12939	175	12	declaration	declaration	NOUN
bam-12939	175	13	of	of	ADP
bam-12939	175	14	helsinki	helsinki	PROPN
bam-12939	175	15	.	.	PUNCT
bam-12939	176	1	bmj	bmj	PROPN
bam-12939	176	2	2007;335:624	2007;335:624	PROPN
bam-12939	176	3	-	-	SYM
bam-12939	176	4	5	5	NUM
bam-12939	176	5	.	.	NOUN
bam-12939	176	6	14	14	NUM
bam-12939	176	7	.	.	PUNCT
bam-12939	177	1	lee	lee	PROPN
bam-12939	177	2	dh	dh	PROPN
bam-12939	177	3	,	,	PUNCT
bam-12939	177	4	peschke	peschke	PROPN
bam-12939	177	5	m	m	PROPN
bam-12939	177	6	,	,	PUNCT
bam-12939	177	7	utz	utz	PROPN
bam-12939	177	8	k	k	PROPN
bam-12939	177	9	,	,	PUNCT
bam-12939	177	10	linker	linker	PROPN
bam-12939	177	11	r.	r.	PROPN
bam-12939	177	12	diagnostic	diagnostic	PROPN
bam-12939	177	13	value	value	NOUN
bam-12939	177	14	of	of	ADP
bam-12939	177	15	the	the	DET
bam-12939	177	16	2017	2017	NUM
bam-12939	177	17	mcdonald	mcdonald	NOUN
bam-12939	177	18	criteria	criterion	NOUN
bam-12939	177	19	in	in	ADP
bam-12939	177	20	patients	patient	NOUN
bam-12939	177	21	with	with	ADP
bam-12939	177	22	a	a	DET
bam-12939	177	23	first	first	ADJ
bam-12939	177	24	demyelinating	demyelinate	VERB
bam-12939	177	25	event	event	NOUN
bam-12939	177	26	suggestive	suggestive	ADJ
bam-12939	177	27	of	of	ADP
bam-12939	177	28	relapsing	relapse	VERB
bam-12939	177	29	–	–	PUNCT
bam-12939	177	30	remitting	remit	VERB
bam-12939	177	31	multiple	multiple	ADJ
bam-12939	177	32	sclerosis	sclerosis	NOUN
bam-12939	177	33	.	.	PUNCT
bam-12939	178	1	eur	eur	PROPN
bam-12939	178	2	j	j	PROPN
bam-12939	178	3	neurol	neurol	PROPN
bam-12939	178	4	2019;26:540	2019;26:540	PROPN
bam-12939	178	5	-	-	SYM
bam-12939	178	6	5	5	NUM
bam-12939	178	7	.	.	NOUN
bam-12939	178	8	15	15	NUM
bam-12939	178	9	.	.	PUNCT
bam-12939	179	1	roxburgh	roxburgh	PROPN
bam-12939	179	2	r	r	NOUN
bam-12939	179	3	,	,	PUNCT
bam-12939	179	4	seaman	seaman	NOUN
bam-12939	179	5	s	s	PROPN
bam-12939	179	6	,	,	PUNCT
bam-12939	179	7	masterman	masterman	PROPN
bam-12939	179	8	t	t	PROPN
bam-12939	179	9	,	,	PUNCT
bam-12939	179	10	et	et	PROPN
bam-12939	179	11	al	al	PROPN
bam-12939	179	12	.	.	PROPN
bam-12939	179	13	multiple	multiple	ADJ
bam-12939	179	14	sclerosis	sclerosis	NOUN
bam-12939	179	15	severity	severity	NOUN
bam-12939	179	16	score	score	NOUN
bam-12939	179	17	:	:	PUNCT
bam-12939	179	18	using	use	VERB
bam-12939	179	19	disability	disability	NOUN
bam-12939	179	20	and	and	CCONJ
bam-12939	179	21	disease	disease	NOUN
bam-12939	179	22	duration	duration	NOUN
bam-12939	179	23	to	to	PART
bam-12939	179	24	rate	rate	NOUN
bam-12939	179	25	disease	disease	NOUN
bam-12939	179	26	severity	severity	NOUN
bam-12939	179	27	.	.	PUNCT
bam-12939	180	1	neurology	neurology	NOUN
bam-12939	180	2	2005;64	2005;64	NUM
bam-12939	180	3	:	:	PUNCT
bam-12939	180	4	1144	1144	NUM
bam-12939	180	5	-	-	SYM
bam-12939	180	6	51	51	NUM
bam-12939	180	7	.	.	PUNCT
bam-12939	181	1	16	16	NUM
bam-12939	181	2	.	.	PUNCT
bam-12939	182	1	holick	holick	VERB
bam-12939	182	2	mf	mf	PROPN
bam-12939	182	3	,	,	PUNCT
bam-12939	182	4	binkley	binkley	PROPN
bam-12939	182	5	nc	nc	PROPN
bam-12939	182	6	,	,	PUNCT
bam-12939	182	7	bischoff	bischoff	PROPN
bam-12939	182	8	-	-	PUNCT
bam-12939	182	9	ferrari	ferrari	PROPN
bam-12939	182	10	ha	ha	INTJ
bam-12939	182	11	,	,	PUNCT
bam-12939	182	12	et	et	PROPN
bam-12939	182	13	al	al	PROPN
bam-12939	182	14	.	.	PROPN
bam-12939	182	15	evaluation	evaluation	NOUN
bam-12939	182	16	,	,	PUNCT
bam-12939	182	17	treatment	treatment	NOUN
bam-12939	182	18	,	,	PUNCT
bam-12939	182	19	and	and	CCONJ
bam-12939	182	20	prevention	prevention	NOUN
bam-12939	182	21	of	of	ADP
bam-12939	182	22	vitamin	vitamin	NOUN
bam-12939	182	23	d	d	NOUN
bam-12939	182	24	deficiency	deficiency	NOUN
bam-12939	182	25	:	:	PUNCT
bam-12939	182	26	an	an	DET
bam-12939	182	27	endocrine	endocrine	ADJ
bam-12939	182	28	society	society	NOUN
bam-12939	182	29	clinical	clinical	ADJ
bam-12939	182	30	practice	practice	NOUN
bam-12939	182	31	guideline	guideline	NOUN
bam-12939	182	32	.	.	PUNCT
bam-12939	183	1	j	j	PROPN
bam-12939	183	2	clin	clin	PROPN
bam-12939	183	3	endocrinol	endocrinol	VERB
bam-12939	183	4	metab	metab	ADJ
bam-12939	183	5	2011;96:1911	2011;96:1911	PROPN
bam-12939	183	6	-	-	SYM
bam-12939	183	7	30	30	NUM
bam-12939	183	8	.	.	PUNCT
bam-12939	184	1	17	17	NUM
bam-12939	184	2	.	.	PUNCT
bam-12939	185	1	vickaryous	vickaryous	PROPN
bam-12939	185	2	n	n	CCONJ
bam-12939	185	3	,	,	PUNCT
bam-12939	185	4	jitlal	jitlal	PROPN
bam-12939	185	5	m	m	PROPN
bam-12939	185	6	,	,	PUNCT
bam-12939	185	7	jacobs	jacobs	PROPN
bam-12939	185	8	bm	bm	PROPN
bam-12939	185	9	,	,	PUNCT
bam-12939	185	10	et	et	PROPN
bam-12939	185	11	al	al	PROPN
bam-12939	185	12	.	.	PROPN
bam-12939	186	1	remote	remote	ADJ
bam-12939	186	2	testing	testing	NOUN
bam-12939	186	3	of	of	ADP
bam-12939	186	4	vitamin	vitamin	NOUN
bam-12939	186	5	d	d	PROPN
bam-12939	186	6	levels	level	NOUN
bam-12939	186	7	across	across	ADP
bam-12939	186	8	the	the	DET
bam-12939	186	9	uk	uk	PROPN
bam-12939	186	10	ms	ms	PROPN
bam-12939	186	11	population	population	NOUN
bam-12939	186	12	—	—	PUNCT
bam-12939	186	13	a	a	DET
bam-12939	186	14	case	case	NOUN
bam-12939	186	15	control	control	NOUN
bam-12939	186	16	study	study	NOUN
bam-12939	186	17	.	.	PUNCT
bam-12939	187	1	plos	plos	PROPN
bam-12939	187	2	one	one	NUM
bam-12939	187	3	2020;15	2020;15	NOUN
bam-12939	187	4	:	:	PUNCT
bam-12939	187	5	e0241459	e0241459	PROPN
bam-12939	187	6	.	.	PROPN
bam-12939	187	7	18	18	NUM
bam-12939	187	8	.	.	PUNCT
bam-12939	188	1	simpson	simpson	PROPN
bam-12939	188	2	jr	jr	PROPN
bam-12939	188	3	s	s	PROPN
bam-12939	188	4	,	,	PUNCT
bam-12939	188	5	taylor	taylor	PROPN
bam-12939	188	6	b	b	PROPN
bam-12939	188	7	,	,	PUNCT
bam-12939	188	8	blizzard	blizzard	PROPN
bam-12939	188	9	l	l	NOUN
bam-12939	188	10	,	,	PUNCT
bam-12939	188	11	et	et	PROPN
bam-12939	188	12	al	al	PROPN
bam-12939	188	13	.	.	PROPN
bam-12939	189	1	higher	high	ADJ
bam-12939	189	2	25hydroxyvitamin	25hydroxyvitamin	PROPN
bam-12939	190	1	d	d	NOUN
bam-12939	190	2	is	be	AUX
bam-12939	190	3	associated	associate	VERB
bam-12939	190	4	with	with	ADP
bam-12939	190	5	lower	low	ADJ
bam-12939	190	6	relapse	relapse	NOUN
bam-12939	190	7	risk	risk	NOUN
bam-12939	190	8	in	in	ADP
bam-12939	190	9	multiple	multiple	ADJ
bam-12939	190	10	sclerosis	sclerosis	NOUN
bam-12939	190	11	.	.	PUNCT
bam-12939	191	1	ann	ann	PROPN
bam-12939	191	2	neurol	neurol	PROPN
bam-12939	191	3	2010;68	2010;68	NUM
bam-12939	191	4	:	:	PUNCT
bam-12939	191	5	193	193	NUM
bam-12939	191	6	-	-	SYM
bam-12939	191	7	203	203	NUM
bam-12939	191	8	.	.	PUNCT
bam-12939	192	1	19	19	NUM
bam-12939	192	2	.	.	PUNCT
bam-12939	192	3	fitzgerald	fitzgerald	PROPN
bam-12939	192	4	kc	kc	PROPN
bam-12939	192	5	,	,	PUNCT
bam-12939	192	6	munger	munger	PROPN
bam-12939	192	7	kl	kl	PROPN
bam-12939	192	8	,	,	PUNCT
bam-12939	192	9	köchert	köchert	PROPN
bam-12939	192	10	k	k	PROPN
bam-12939	192	11	,	,	PUNCT
bam-12939	192	12	et	et	PROPN
bam-12939	192	13	al	al	PROPN
bam-12939	192	14	.	.	PROPN
bam-12939	192	15	association	association	PROPN
bam-12939	192	16	of	of	ADP
bam-12939	192	17	vitamin	vitamin	NOUN
bam-12939	192	18	d	d	PROPN
bam-12939	192	19	levels	level	NOUN
bam-12939	192	20	with	with	ADP
bam-12939	192	21	multiple	multiple	ADJ
bam-12939	192	22	sclerosis	sclerosis	NOUN
bam-12939	192	23	activity	activity	NOUN
bam-12939	192	24	and	and	CCONJ
bam-12939	192	25	progression	progression	NOUN
bam-12939	192	26	in	in	ADP
bam-12939	192	27	patients	patient	NOUN
bam-12939	192	28	receiving	receive	VERB
bam-12939	192	29	interferon	interferon	PROPN
bam-12939	192	30	beta-1b	beta-1b	PROPN
bam-12939	192	31	.	.	PUNCT
bam-12939	193	1	jama	jama	PROPN
bam-12939	193	2	neurol	neurol	PROPN
bam-12939	193	3	2015;72:1458	2015;72:1458	NUM
bam-12939	193	4	-	-	SYM
bam-12939	193	5	65	65	NUM
bam-12939	193	6	.	.	NOUN
bam-12939	194	1	20	20	NUM
bam-12939	194	2	.	.	PUNCT
bam-12939	195	1	kuhle	kuhle	PROPN
bam-12939	195	2	j	j	PROPN
bam-12939	195	3	,	,	PUNCT
bam-12939	195	4	disanto	disanto	ADP
bam-12939	195	5	g	g	PROPN
bam-12939	195	6	,	,	PUNCT
bam-12939	195	7	dobson	dobson	PROPN
bam-12939	195	8	r	r	PROPN
bam-12939	195	9	,	,	PUNCT
bam-12939	196	1	et	et	PROPN
bam-12939	196	2	al	al	PROPN
bam-12939	196	3	.	.	PROPN
bam-12939	196	4	conversion	conversion	NOUN
bam-12939	196	5	from	from	ADP
bam-12939	196	6	clinically	clinically	ADV
bam-12939	196	7	isolated	isolate	VERB
bam-12939	196	8	syndrome	syndrome	NOUN
bam-12939	196	9	to	to	ADP
bam-12939	196	10	multiple	multiple	ADJ
bam-12939	196	11	sclerosis	sclerosis	NOUN
bam-12939	196	12	:	:	PUNCT
bam-12939	196	13	a	a	DET
bam-12939	196	14	large	large	ADJ
bam-12939	196	15	multicentre	multicentre	NOUN
bam-12939	196	16	study	study	NOUN
bam-12939	196	17	.	.	PUNCT
bam-12939	197	1	multiple	multiple	ADJ
bam-12939	197	2	sclerosis	sclerosis	NOUN
bam-12939	197	3	j	j	PROPN
bam-12939	197	4	2015;21	2015;21	PROPN
bam-12939	197	5	:	:	PUNCT
bam-12939	197	6	1013	1013	NUM
bam-12939	197	7	-	-	SYM
bam-12939	197	8	24	24	NUM
bam-12939	197	9	.	.	PUNCT
bam-12939	197	10	21	21	NUM
bam-12939	197	11	.	.	X
bam-12939	198	1	yu	yu	PROPN
bam-12939	198	2	s	s	PROPN
bam-12939	198	3	,	,	PUNCT
bam-12939	198	4	li	li	PROPN
bam-12939	198	5	x	x	PROPN
bam-12939	198	6	,	,	PUNCT
bam-12939	198	7	yu	yu	PROPN
bam-12939	198	8	f	f	AUX
bam-12939	198	9	,	,	PUNCT
bam-12939	198	10	et	et	PROPN
bam-12939	198	11	al	al	PROPN
bam-12939	198	12	.	.	PUNCT
bam-12939	199	1	new	new	ADJ
bam-12939	199	2	evidence	evidence	NOUN
bam-12939	199	3	for	for	ADP
bam-12939	199	4	associations	association	NOUN
bam-12939	199	5	between	between	ADP
bam-12939	199	6	vitamin	vitamin	NOUN
bam-12939	199	7	d	d	NOUN
bam-12939	199	8	receptor	receptor	NOUN
bam-12939	199	9	polymorphism	polymorphism	NOUN
bam-12939	199	10	and	and	CCONJ
bam-12939	199	11	obesity	obesity	NOUN
bam-12939	199	12	:	:	PUNCT
bam-12939	199	13	case	case	NOUN
bam-12939	199	14	-	-	PUNCT
bam-12939	199	15	control	control	NOUN
bam-12939	199	16	and	and	CCONJ
bam-12939	199	17	family	family	NOUN
bam-12939	199	18	-	-	PUNCT
bam-12939	199	19	based	base	VERB
bam-12939	199	20	studies	study	NOUN
bam-12939	199	21	.	.	PUNCT
bam-12939	200	1	j	j	PROPN
bam-12939	200	2	human	human	PROPN
bam-12939	200	3	genetics	genetics	PROPN
bam-12939	200	4	2020;65:281	2020;65:281	NOUN
bam-12939	200	5	-	-	SYM
bam-12939	200	6	5	5	NUM
bam-12939	200	7	.	.	NOUN
bam-12939	201	1	22	22	NUM
bam-12939	201	2	.	.	PUNCT
bam-12939	202	1	levin	levin	PROPN
bam-12939	202	2	gp	gp	PROPN
bam-12939	202	3	,	,	PUNCT
bam-12939	202	4	robinson	robinson	PROPN
bam-12939	202	5	-	-	PUNCT
bam-12939	202	6	cohen	cohen	PROPN
bam-12939	202	7	c	c	PROPN
bam-12939	202	8	,	,	PUNCT
bam-12939	202	9	de	de	PROPN
bam-12939	202	10	boer	boer	PROPN
bam-12939	202	11	ih	ih	PROPN
bam-12939	202	12	,	,	PUNCT
bam-12939	202	13	et	et	PROPN
bam-12939	202	14	al	al	PROPN
bam-12939	202	15	.	.	PUNCT
bam-12939	203	1	genetic	genetic	ADJ
bam-12939	203	2	variants	variant	NOUN
bam-12939	203	3	and	and	CCONJ
bam-12939	203	4	associations	association	NOUN
bam-12939	203	5	of	of	ADP
bam-12939	203	6	25	25	NUM
bam-12939	203	7	-	-	PUNCT
bam-12939	203	8	hydroxyvitamin	hydroxyvitamin	NOUN
bam-12939	203	9	d	d	NOUN
bam-12939	203	10	concentrations	concentration	NOUN
bam-12939	203	11	with	with	ADP
bam-12939	203	12	major	major	ADJ
bam-12939	203	13	clinical	clinical	ADJ
bam-12939	203	14	outcomes	outcome	NOUN
bam-12939	203	15	.	.	PUNCT
bam-12939	204	1	jama	jama	PROPN
bam-12939	204	2	2012;308:1898	2012;308:1898	PROPN
bam-12939	204	3	-	-	PUNCT
bam-12939	204	4	905	905	NUM
bam-12939	204	5	.	.	PUNCT
bam-12939	205	1	disclaimer	disclaimer	PROPN
bam-12939	205	2	all	all	DET
bam-12939	205	3	claims	claim	NOUN
bam-12939	205	4	expressed	express	VERB
bam-12939	205	5	in	in	ADP
bam-12939	205	6	this	this	DET
bam-12939	205	7	article	article	NOUN
bam-12939	205	8	are	be	AUX
bam-12939	205	9	solely	solely	ADV
bam-12939	205	10	those	those	PRON
bam-12939	205	11	of	of	ADP
bam-12939	205	12	the	the	DET
bam-12939	205	13	authors	author	NOUN
bam-12939	205	14	and	and	CCONJ
bam-12939	205	15	do	do	AUX
bam-12939	205	16	not	not	PART
bam-12939	205	17	necessarily	necessarily	ADV
bam-12939	205	18	represent	represent	VERB
bam-12939	205	19	those	those	PRON
bam-12939	205	20	of	of	ADP
bam-12939	205	21	their	their	PRON
bam-12939	205	22	affiliated	affiliated	ADJ
bam-12939	205	23	organizations	organization	NOUN
bam-12939	205	24	,	,	PUNCT
bam-12939	205	25	or	or	CCONJ
bam-12939	205	26	those	those	PRON
bam-12939	205	27	of	of	ADP
bam-12939	205	28	the	the	DET
bam-12939	205	29	publisher	publisher	NOUN
bam-12939	205	30	,	,	PUNCT
bam-12939	205	31	the	the	DET
bam-12939	205	32	editors	editor	NOUN
bam-12939	205	33	and	and	CCONJ
bam-12939	205	34	the	the	DET
bam-12939	205	35	reviewers	reviewer	NOUN
bam-12939	205	36	.	.	PUNCT
bam-12939	206	1	any	any	DET
bam-12939	206	2	product	product	NOUN
bam-12939	206	3	that	that	PRON
bam-12939	206	4	may	may	AUX
bam-12939	206	5	be	be	AUX
bam-12939	206	6	evaluated	evaluate	VERB
bam-12939	206	7	in	in	ADP
bam-12939	206	8	this	this	DET
bam-12939	206	9	article	article	NOUN
bam-12939	206	10	or	or	CCONJ
bam-12939	206	11	claim	claim	NOUN
bam-12939	206	12	that	that	PRON
bam-12939	206	13	may	may	AUX
bam-12939	206	14	be	be	AUX
bam-12939	206	15	made	make	VERB
bam-12939	206	16	by	by	ADP
bam-12939	206	17	its	its	PRON
bam-12939	206	18	manufacturer	manufacturer	NOUN
bam-12939	206	19	is	be	AUX
bam-12939	206	20	not	not	PART
bam-12939	206	21	guaranteed	guarantee	VERB
bam-12939	206	22	or	or	CCONJ
bam-12939	206	23	endorsed	endorse	VERB
bam-12939	206	24	by	by	ADP
bam-12939	206	25	the	the	DET
bam-12939	206	26	publisher	publisher	NOUN
bam-12939	206	27	.	.	PUNCT
bam-12939	207	1	submitted	submit	VERB
bam-12939	207	2	:	:	PUNCT
bam-12939	207	3	18	18	NUM
bam-12939	207	4	august	august	PROPN
bam-12939	207	5	2024	2024	NUM
bam-12939	207	6	.	.	PUNCT
bam-12939	208	1	accepted	accept	VERB
bam-12939	208	2	:	:	PUNCT
bam-12939	208	3	2	2	NUM
bam-12939	208	4	september	september	PROPN
bam-12939	208	5	2024	2024	NUM
bam-12939	208	6	.	.	PUNCT
bam-12939	209	1	early	early	ADJ
bam-12939	209	2	access	access	NOUN
bam-12939	209	3	:	:	PUNCT
bam-12939	209	4	9	9	NUM
bam-12939	209	5	october	october	NOUN
bam-12939	209	6	2024	2024	NUM
bam-12939	209	7	.	.	PUNCT
bam-12939	210	1	39	39	NUM
bam-12939	210	2	non	non	ADJ
bam-12939	210	3	-co	-co	PROPN
bam-12939	210	4	mmerc	mmerc	PROPN
bam-12939	210	5	ial	ial	PROPN
bam-12939	210	6	us	us	PROPN
bam-12939	210	7	e	e	NOUN
bam-12939	210	8	o	o	NOUN
bam-12939	210	9	nly	nly	ADV